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Abstract 
Bone is refractory to most conventional biochemical Procedures. 
However because it is now possible to cut sections (e. g. lopm) of 
fresh, undemineralized adult bone, this tissue can be analyzed by 
suitably modified methods of quantitative cytochemistry. A new 
substrate for assaying hydroxyacyl dehydrogenase activity demonst- 
rated that bone cells may use fatty acids as a major source of 
energy: detailed analysis of the activities of key enzymes indicated 
that the paradox of 'aerobic glycolysis' of bone could be explained 
by fatty acid oxidation satisfying the requirements of the Krebs' 
cycle and directing the conversion of pyruvate to lactate The 
influence of glucose 6-phosphate dehydrogenase (G6PD) activity in 
aerobic glycolysis has been considered. The inverse relationships 
between this activity and that of Na-K-ATPase led to the develop- 
ment of a new method for the latter, based on a new concept in 
cytochemistry ('hidden-capture' procedure). 
A major feature of fracture-healingý is increased periosteal 
G6PD activity. The association with the vitamin K cycle has been 
investigated by feeding rats with dicoumarol which not only inhibited 
bone-formation but also G6PD activity. The stimulation of this 
activity in fracture-healing has been linked with ornithine decar- 
boxylase (ODC) activity, for which a new method has been developed. 
Rats deficient in pyridoxal phosphate (cofactor for ODC) had 
decreased G6PD responses and also appeared to become osteoporotic. 
Studies on osteoporotic fractures in the human showed the presence 
of relatively large apatite crystals close to the fracture-site, 
and disorganized glycosaminoglycans (demonstrated by the new 
method of 'induced birefringencel). 
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CHAPTER I. 
GENERAL INTRODUCTION 
Bone is a major tissue-component of the body. 
Although a great deal of work has been done on its various 
biomechanical and bioelectrical properties, it has proved 
to be remarkably recalcitrant to other forms of investiga- 
tion. Thus sections of bone are studied by histopathpl- 
ogists for diagnostic purposes: these sections are 
usually of pieces of bone, ground down to a thickness 
suitable for histological examination; or of methacrylate 
- embedded bone; or of decalcified bone that has been 
embedded in paraffin wax. Such special bone 
investigations are normally done only in a few, specialized 
laboratories. One of the major centres for this type 
of work is that of Professor R. Burkhardt, in Munich 
which reported that, unfortunately, such methods have 
not been successful for the application of enzyme or 
immuno-histochemistry, as would be required for extending 
the diagnostic use of such bone biopsies (Bartl et al, 
1978). 
As regards the chemistry on bone, a great deal 
of work has been done on the components of the matrix, 
including studies on collagen, the glycosaminoglycans, 
and the mineral component of bone (as reviewed in 
Bourne, 1976). Relatively little has been done on 
the metab olism of the various types of bone cells in 
intact bone, largely because bone does not readily lend 
itself to conventional biochemical investigations. 
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Thus the refractoriness of bone to conventional 
procedures of study has impeded advances in knowledge 
of its metabolism and of the possible interaction between 
the various cells and the matrix. Consequently, the 
demonstration that fresh, undemineralized adult bone 
could be sectioned, by suitably modified but relatively 
conventional cryostat microtomy (Johnstone et al, 1972; 
Johnstone, 1979), opened the way to detailed analysis 
of this tissue. The earlier studies, in this laboraýory, 
concentrated on major changes during fracture-healing 
(Shedden et al, 1976; Dunham et al, 1977). Following 
these studies, it was found (Hauschka et al, 1978) that 
mineralization might involve a cycle of events in which 
vitamin K, played a major role. This finding, discussed 
in detail in Chapter III, was a major stimulus for the 
investigations detailed in this thesis. Thus it was 
first demonstrated that elevated production of NADPH 
was associated with the early deposition of bone 
(Chapter VII). Dicoumarol was used to inhibit the vitamin 
K 1- cycle to test whether or not this cycle was operative 
in the fracture-healing in the rat. The results (Chapter 
VIII) were in accord with this hypothesis, but they 
showed that dicoumarol also influenced the production 
of NADPH which, together with vitamin Kl, was apparently 
essential for bone-formation. 
These finding led to the enquiry as to what chemical 
stimulus might be involved in the increased production 
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of NADPH. From other studies in progress in this 
laboratory there seemed a fair possibility that putrescines 
produced by ornithine decarboxylase (ODC) activity 
(discussed in Chapter IV) might be at least one of the 
material stimulators of glucose 6-phosphate dehydrogenase 
(G6PD) activity, and of the increased production of 
NADPH. Two lines of approach were investigated. 
The first involved trying to develop a cytochemical 
assay of ODC activity (Appendix II). For the second, 
the rats were kept on a. diet that was deficient in 
vitamin B6' so that they were expected to be deficient 
in pyridoxal phosphate, which is the essential cofactor 
for ODC activity. The results of this study (Chapter 
IX) were in accord with the hypothesis. However, the 
results involved such an overwhelming change in the 
nature of the bone that they open new lines of invest- 
igation, particularly in regard to osteoporosis. 
The problem of osteoporosis is one of the major 
challenges in bone pathology and in rheumatology. 
Of . particular moment are the hitherto unexplained 
fractures of the neck of femur, often induced by minimal 
trauma, in osteoporotic subjects. Such fractures 
have been investigated in some detail (Chapter X). 
Simple inspection of the sections taken from the fracture 
site showed the presence of unexpectedly large crystalst 
apparently of apatite. The development of a method 
involving the induced birefringence of the glycosamino- 
glycans (GAGS) showed that whereas they appear to be 
4 
orientated close with the collagen in the normal bone, 
they were disorientated in the fractured bone. The 
results required detailed investigation (Kent et al, 
1983) so that the proposed enzymatic studies, akin to 
those done on fracture-healing in the rat, had to be 
delayed. However. it was found that the circulating 
levels of vitamin K1 were depressed in these patients 
(Hart et al, 1984) so that it is likely that studies 
in these fractures on the activity of glucose 6- 
phosphate dehydrogenase, generating NADPH for the vitamin 
K-cycle, may be of interest. 
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CHAPTER II 
THE STRUCTURE AND BIOCHEMISTRY OF BONE 
rF' t- - 1ý -II- 
The Osteocyte. Osteocytes, which develop from osteo- 
blasts, are spidery shaped cells, found within the bone 
matrix in lacunap- from which anastomosing canaliculi 
radiate. They have as many as fifty long, fine branching 
cytoplasmic processes (Belanger, 1971) which, in newly 
formed bone, fully occupy the canaliculi. With maturity 
these cells become flatter and the processes gradually 
retract. 
The functional role of osteocytes is not known 
but. they probably play a role in maintaining the matrix. 
It has been suggested (as reviewed by Belanger, 1971) 
that osteocytes may facilitate the exchange of materials 
between tissue fluids and bone matrix and that they 
possibly synthesize and resorb the surrounding matrix. 
Osteoblasts. The osteoblasts are responsible for 
the synthesis and secretion of components Of bone matrix 
(e. g. collagen, proteoglycans and glycoproteins) (as 
reviewed by Cameron, 1972). Newly synthesized, not 
yet calcified matrix is termed osteoid; calcium phosphate 
crystals are then deposited in the osteoid, changing 
it to bone matrix (as reviewed by Pritchard, 1972). 
Osteoblasts are found on the surfaces of bone tissue 
usually as a single layer. It is claimed (Owen, 1983) 
that below the osteoblast layer there may be a mixed 
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population of proliferating cells, often termed osteo- 
progenitor cells. These cells develop into osteoblasts 
and osteoclasts. The current theory is that there 
may be two types of osteoprogenitor cells: preosteo- 
blasts and preosteoclasts (as reviewed by Owen., 1971, 
1983; Ascenzi, 1976) that have differentiated along 
divergent lines from a fixed mesenchymal precursor. 
Morphological studies indicate that osteoblasts, like 
chondrocytes, secrete membrane-bound matrix vesicles 
which are strongly implicated in the calcification 
mechanisms (as reviewed by Anderson, 1976). 
Osteoclasts. Osteoclasts are large, motile, multi- 
nucleated cells found upon bone surfaces (often in 
shallow pits called the lacunae of Howships), which 
are undergoing resorption, as shown by the solubilization 
both of mineral and of the organic components of bone. 
They are believed also to engage in the elimination 
of the resulting debris formed during bone resorption. 
However the processes involved are still not well under- 
stood. Reviews of the osteoclasts themselves and the 
process of bone resorption are given by Hancox (1972), 
Cameron (1972), Marks and Walker (1976) and Reynolds 
(1983). Osteoclasts contain numerous membrane-bound 
vesicles, thought to be lysosomes. Vaes (1969) has 
reviewed the evidence that hydrolases associated with 
the lysosomes of osteoclasts are essential for the 
resorption of organic components of bone matrix, and 
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possibly contribute to the solubilization of. the mineral. 
The hydrolytic enzymes will be discussed briefly in 
another section. 
The Organic Matrix of Bone 
Collagen. Collagen is the principle organic component 
of bone (as reviewed by Herring, 1972; Stockwell, 1979). 
Its composition is distinctive: one-third of its tota, _1 
amino acids consists of glycine, one-ninth is alanine, 
and two-ninths proline and hydroxyproline. The basic 
unit of collagen is the polypeptide a chain; upon 
denaturation, the collagen macromolecules (tropocollagen) 
dissociate into three a chains. The tropocollagen 
molecule of bone consists of two a, and one a2 chains 
coiled around each other in a right-handed helix. 
0 This is in the form of a long thin rod of about 2800 A 
in length and 14 A in diameter, and has a molecular 
0 
weight of about 300,000. The tropocollagen molecules 0 
are organized into fibrils forming native collagen. 
This long helical molecule gives bone both its tensile 
properties and overall shape. (as discussed later). 
The Glycosaminoglycans. Glycosaminoglycans (GAGs) 
are long unbranched polysaccharide chains which contain 
many acidic groups (carboxylate and su lphate groups). 
They do not exist as free chains but as proteoglycans 
in which the-chains are covalently linked by the terminal 
sugar residue to a protein. On the basis of different 
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(1) 
(III) (rv) 
Fig. 11.1. - The structure of the repeating disaccharides units 
that occur in glycosaminoglycans. I: chondroitin 
4-sulphate II : chondroitin 6-sulphate III : 
CH20S%H 
HO 
0 
NHAc 
(11) 
CH20H CH30S03H 
HO 00 
00 OH 
OH NHAc 
hyaluronateand IV : keratan sulphate. 
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repeating disaccharid8e units, there are seven types 
of GAGs (Table 11,1; taken from Hardingham, 1981). 
Fig. II. 1 gives the structures of the repeating di- 
saccharide units of the GAGs: chondroitin 4-sulphate, 
ch6ndroitin 6-sulphate, hyaluronic acid, and keratan 
sulphate. Cartilage has an extremely high proteoglycan 
content and the details of their structure have been 
studied in detail and are better understood than in, bone 
(as reviewed by Muir and Hardingham, 1975; HardinghamV 
1981). Fig. 11.2 is a schematic model of the aggregation 
of cartilage proteoglycans (taken from Hardingham, 1981). 
Proteoglycan Proteoglycan aggregate 
LO 
Link protein 
ID 
0 ýP. O 
Hyaluronate 
0.1 
Fig. 11.2 Diagrammatic representation of a model of the structure 
of proteoglycans. (From Hardingham, 1981). 
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Table 11.1. Composition of mammalian glycosaminoglycans. From 
Hardingham, 1981. 
Disaccharide repeating unit 
0 
Hexuronic acid Nexosamine* Sulphate Linkage to protein 
Hyaluronic acid D-Glucuronic acid D-Glucosamine ? 
Chondroitin 4-sulphate D-Glucuronic acid [)-Galactosamint 0 Sulphatc -Gat Gal Xyl Ser 
Chondroitin fi-sulphate D-Glucuronic acid t)-Galactosaminc 0 Sulphatc -Gal Gal Xyl-Ser 
Dermatan sulphatc L-Iduronic acid or D-Galactosamine 0 Sulphate -Gal Gal-Xyl Ser 
D g! ucuronic acid 
Keratan sulphatc [)-Galactose t)-Glucosamine 0 Sulphate (a) skeletal: -GaINAC Ser(Thr) 
AcNeu Gal 
4h) corneal: -GaINAe-Asn 
Heparan sulphate D-Glucuronic acid or i) Gluco%aminc 0 Sulphatc and Gal Gal Xyl Ser 
a iduronic acid N sulphate 
Hcparin t) Glucuronic acid or t) Glucosaminc 0 Sulphatc and -Gat Gil Xyl Ser 
L iduronic acid N %ulphaic 
Always ffacýiylatcd. except when IV sulphated. 
In this model the protein backbone is composed of a 
globular region with intramolecular disulphide bridges 
that form a specific site for binding to hyaluronate 
and to a link protein. Next to this region is an extended 
polypeptide rich in keratan sulphate chains. The largest 
portion is again a long polypeptide containing a proportion 
of the chondroitin sulphate chains; it is proposed 
that this region is of variable length. 
Other Bone Proteins. Apart from collagen, discussed 
briefly above, bone contains several other proteins 
most of which are, as yet, but poorly defined. For 
example, a specific bone sialoprotein has been reported 
(Herring, 1972). The most characteristic bone peptide 
is osteocalcin, which will be considered in detail in 
Chapter M. It is clear that other, glutamate-rich 
peptides also occur; unlike osteocalcin, these are 
not readily removed from bone and are not yet 
characterized. The non-collagenous proteins of bone 
has been the subject of a recent study (Delmas et al, 
1984). 
The Nature of the Mineral 
The mineral component of bone contains calcium, 
phosphate and carbonate, with fluoride and sometimes 
aluminium as minor components. The characteristic 
mineral is hydroxyapatite, which is commonly written 
as 3 Ca 3 (P04)2 Ca (OH )2 (Merck, 1969); or 
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Ca 10 (P04)6 (011 )2 ; it is related to apatite 
(Na 
3 (P04)2 Ca F 2) A calcium carbonate may also 
be mixed together with the hydroxyapatite (Robinson, 
1952). 
There have been many studies on the crystalline 
nature of the hydroxyapatite in bone (Robinson, 1952; 
Carlstrom, 1955; Bernard, 1969; Bocciarell], 1970; Engstrom, 
1972; Voegel and Frank, 1977 and Jackson et al, 1978). 
Most investigators seem to agree that the size of the 
crystals of normal bone is about 100 nm (range 500 - 
50 nm). It is noteworthy that x-ray crystallographic 
analysis of the crystal structure requires prior heating 
to at least 400* C, preferably above 600* C, to give 
clear x-ray diffraction patterns. Thus it is not 
impossible that the normal state is poorly crystalline 
until the hydroxyapatite is influenced by other factors, 
such as temperature or age (as discussed in Chapter IX). 
Bone Tissue 
Periosteum and Endosteum 
The internal and external surfaces of mammalian 
bones are covered by layers of connective tissue named 
endosteum and periosteum respectively (Fig. 
The periosteum consists of two layers being very 
fibrous externally but more cellular near the bone 
tissue. The periosteal cells resemble fibroblasts 
and are able to divide and differentiate into osteoblasts 
a 
C 
-d 
I 
13 
1" 
Fig. II . 3. Cryostat section of the rat metatarsal 
head and shaft. 
(a) articular cartilage (b) epiphyseal cancellous 
bone 
(c) epiphyseal growth plate (d) metaphyseal 
trabeculae 
(e) cortical bone of shaft (f) bone marrow cavity. 
Toluidine bone, X 35. 
13 
a 
b 
C 
d 
e 
Aý 
1-ft 
Fig. 11 . 3. Cryostat section of the rat metatarsal head and shaft. 
(a) articular cartilage (b) epiphyseal cancellous bone 
(c) epiphyseal growth plate (d) metaphyseal trabeculae 
(e) cortical bone of shaft (f) bone marrow cavity. 
Toluidine bone, X 35. 
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and chondrocytes. These cells have an essential role 
in bone growth and fracture repair (as discussed in 
Chapter Mand reviewed by Ham and Harris, 1971). 
The end osteum is much thinner, consisting of 
only one layer; it also plays an important role in 
bone growth. 
Types of Bone Tissue. 
The structure and histology. of bone have been CP 
extensively reviewed (e. g. Pritchard, 1972; Junqueria, 
1977). Macroscopically there are two distinguishable 
types of bone in the mature mammalian skeleton: the 
spongy (cancellous) bone and the hard compact cortical 
bone. Cancellous bone consists of fine irregular 
trabeculae, which branch and unite with one another 
forming a meshwork of interconnecting cavities filled 
with marrow. The cortical bone shows dense areas without 
cavities. 
In long bone, the extremities (called the epiphyses) 
are composed of cancellous bone covered by a thin layer 
of cortical bone (Fig. 11.3). The cylindrical part 
of the bone, called the diaphysis, is mainly compact, 
cortical bone, with a small amount of cancellous bone 
in the bone marrow cavity (not present in the rat 
metatarsal; Fig. 11.3). Likewise, the short bones 
have a core of cancellous bone completely encased by 
cortical bone. 
Within the cavities of cancellous bone and the 
marrow cavity of the diaphysis of long bones exists 
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bone marrow: the red bone marrow from which the blood 
cells form; and the yellow bone marrow, consisting 
mainly of large fat cells. 
Woven Bone. The first bone to appear in embryonic 
development or in the early fracture callus is immature. 
It forms very rapidly and rather erratically. The 
collagenous fibres are arranged in an irregular array. 
The bone consists of anastomosing trabeculae that reslemble 
a honey-comb. The intertrabecular spaces contain small 
blood vessels and osteogenic cells. The cells next 
to the bone are osteoblasts, forming a regular, one- 
cell thick 'epithelium'. If such bone is laid down 
on a scaffolding of calcified cartilage, as in the growth 
plate, and developing fracture callus, the core of the 
bone may contain remnants of this calcified cartilage. 
As soon as the woven bone is formed it is remodelled, 
some of the trabeculae being removed altogether by osteo- 
clasts, while others are further thickened by the osteo- 
blasts laying down extensive osteoid on the surface 
of the woven bone, prior to its mineralization. This 
remodelling gives rise to secondary bone, namely the 
cortical and cancellous bone. 
Compact Cortical Bone 
Secondary bone, whether cortical or cancellous, 
characteristically shows collagenous fibres arranged 
in lamallae, 3-7 Um thick, which are parallel or 
concentrically curved around a vascular canal. The 
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whole complex of concentric lamellae, surrounding a 
canal containing blood vessels, nerves and loose 
connective tissue, is called the Haversian system or 
more correctly the osteon. Rat 'cortical bone' does 
-not have the classical Haversian systems but contains 
long fibres of collagen often termed fibre bone. 
Cortical bone arises partly (a) by thickening 
of woven bone whereby osteoblasts produce layer after 
layer of bone inwards on the surfaces of the vascular 
tunnels of the woven bone, until the canals are reduced 
to narrow canals containing the blood vessels; (b) 
partly by direct, primary formation of solid bone on 
the periosteal and endosteal surfaces of an existing 
bone surface: this bone persists as concentric 
lamellae; and (c) partly by the remodelling of existing 
cortical bone, whereby tunnels, containing blood vessels 
and marrow, are eroded and then replaced, as successive 
lamellae of bone are deposited, progressively inward, 
until the tunnel is reduced to a narrow canal around 
the blood vessels. Resorption cavities appear contin- 
uously during growth of bone and even in adult bone, 
and are replaced by third, fourth, and higher orders 
of osteons. Therefore it iscommon to find developing 
osteons, that have large vascular canals lined with 
Plump osteoblasts, and eroding osteons that have large 
irregular canals, lined with osteoclasts. Osteons 
that escape destruction become "interstitial lamellae" 
that fill in between new systems. Cortical bone may 
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also arise from the consolidation of cancellous bone. 
Being essentially cylindrical, osteons, in sections, 
may appear with circular, elliptiqal. or parallel-sided 
profiles, according to the plane of the section. In 
general, most osteons have their long axis almost parallel 
with the long axis of the bone. The circular profiles 
that appear are what are classically called Haversian 
systems. Secondary Haversian systems (i. e. sections 
oi secondary osteons) are larger than primary osteons 
(aroun4 100 lim in diameter) and, unlike primary osteons, 
their organization does not conform with adjacent osteons. 
They arebound externally by a clear cement line. 
Osteons run somewhat obliquely: they tend to spiral 
clockwise on the right and anticlockwise on the left 
and pass at an angle of abýut 30* from the periosteal 
to the endosteal lamellae. They branch, either 
ana stomosing with neighbouring osteons, or ending blindly. 
(I am indebted to Mr. A. Catterall, FRCS., for his advice 
on this histology). 
Within the osteon, osteocytes are arranged regularly 
and orientatedwith respect to the central vascular canal. 
The long axis of the spidery osteocyte conforms with 
the long axis of the osteon, its fine processes running 
in a radial fashion; the canaliculi of osteocytes 
anastomose freely with those of their neighbours. 
As mentioned earlier there is evidence suggesting that 
the normal mechanism of internal bone resorption occurs 
under the influence of mature osteocytes (reviewed by 
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Belanger, 1971). 
Cancellous Bone. 
Cancellous bone of the adult mammal is very similar 
to that of cortical bone except that, rarely, are there 
complete osteons. Instead, the trabeculae consist 
of irregular haphazard fragments of osteons (Fig. 11.3 
shows the cancellous bone in the epiphyseal end of the 
rat metatarsal). They have very irregular indented 
outlines resulting from extensive resorption and deposition. 
Where new bone is being added to the trabeculae of the 
cancellous bone, the surfaces are covered with plump 
active osteoblasts. Similarly, osteoclasts are present 
where the trabecular surface is being eroded. 
The Growth of Bone. 
The growth of bone is fully discussed by Sissons 
(1971) and Stockwell (1979). There are two types of 
bone formation. The first is known as membranous oss- 
ification, which concerns the direct appositional formation 
of bone on a pre-existing surface, for instance periosteal 
and endosteal bone growth in the long bones. The second 
type is known as endochondrial ossification, which occurs. 
only when an epiphyseal plate is present, or as 
described in Chapter VII, in new bone formation during 
fracture healing. 
During active growth of bone, endochondrial ossifi- 
cation is the mechanism concerned with the rapid develop- 
ment in length and mass of the bone. The epiphyseal 
plate, or cartilaginous growth-plate is siutated between 
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the epiphysis and the shaft of a long bone (Fig. 11.3). 
The chondrocytes are arranged in columns that are parallel 
to the long axis of the bone (Fig. 11.4). Five zones 
are recognized, corresponding to the various phases 
Of the maturation process. 
1. resting zone (hyaline cartilage); 
2. proliferative zone, with stacks of 
flattened cells; 
3. hypertrophic. zone, with enlarged 
chondrocytes; 
4. degenerative zone, with calcified matrix; 
5. ossification zone, with the appearance 
of bone material. 
There are two surfaces to the growth plate: the epiphyseal 
surface and the metaphyseal surface (Fig. 11.3). Endo- 
chondrial ossification consists of the coordinated sequence 
Of multiplication, growth and degeneration of chondrocytes 
in this growth plate followed by the vascularization 
of the degenerated hypertrophic chondrocytes by capillaries 
and undifferentiated cells originating from the periosteum. 
In the hypertrophic zone, the matrix is reduced 
to a thin septum between the chondrocytes. It is these 
thin septa that are calcified with thedeposition of 
hydroxyapatite, following the degeneration of the chondro- 
cytes. The invading undifferentiated cells that originated 
from the proliferating periosteum form osteoblasts: 
they form a layer over the septa; these osteoblasts 
j 
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Fig. 11.4. Cryostat section of the rat epiphyseal growth plate; 
the resting zone is at the top of the plate and the 
ossification zone appears on the lower end. 
Toluidine blue; X 220. 
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lay down the bone matrix. This bone matrix calcifies 
and some of the osteoblasts are imprisoned as osteocytes. 
In this way a network of bone trabeculae is formed on 
the framework of the unresorbed septa. Thesemetaphyseal 
bone trabeculae extend continuously into the receding 
zone of hypertrophic cartilage, and thus increase the 
length of the bone shaft. This new bone tissue is 
extensively remodelled: simultaneously with the laying 
down of new bone on the calcifying matrix, the central 
trabeculae are continually resorbed; and there is a 
progressive reduction of the trabeculae in this region. 
The peripheral metaphyseal trabeculae contribute to the 
diaLphyseal development by being incoporated into the 
diaphysis. The shaft bone that eventually replaces 
the metaphyseal trabeculae is almost devoid of trabecular 
structure and, in contrast to the cancellous bone of 
the metaphysis, consists of compact bone (described 
earlier). In the rat, the 'compact bone' of the shaft 
does not show the classicaLy arranged osteons, but exists 
in a simple lamellar form. While these changes occur, 
bone is being laid down immediately beneath the peri- 
osteum on the shaft of the bone, this being the final 
stage in endochondrial ossification (membranous 
ossification). The bone increases in width as a result 
of this bone formation by the periosteum. Simultaneously, 
bone is resorbed from the internal surface, increasing 
the diameter of the bone marrow cavity. Similarly, 
at the metaphysis, owing to endosteal bone formation, 
bone is also deposited on the internal surface, and 
again there is continued resorption, around this area 
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on the external surface. It is the partial resorption 
of newly formed bone, coupled to the laying down of 
new bone, that permits the shape of the bone to be main- 
tained as it grows. In man the growth plate stops 
growing at around 20 years of age: it is completely 
replaced by can. cellous bone. Thus the extremities 
of long bones (epiphyses) are composed of cancellous 
bone. As discussed earlier, remodelling is considerably 
active in this cancellous bone when compared to corti cal 
bone. In our laboratory, growth-plate closure has not 
been seen in the rat, although there appears to be a 
close relationship between the rate of growth of an 
epiphyseal plate and its thickness, in that younger 
rats have a thicker growth plate. 
Even in adult life, bone (both cancellous and cortical) 
is subject to an almost continuous process of structural 
remodelling, involving successive cycles of bone deposi- 
tion and resorption. The maintenance of normal bone 
structure depends on a balance between these two processes. 
Enzyme Biochemistry of Bone. 
Relatively little work has been done on the metabolic 
biochemistry of bone. The paucity of information is 
due, to a large extent, to the refractory nature of 
the material and the sparse distribution of cells of 
different types. The practical difficulties encountered 
when conventional biochemical procedures are applied 
to bone have been considered by Hekkleman (1973) in 
a critical review of the enzyme biochemistry of bone. 
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The position is, if anything, even worse when histo- 
chemistry has been used since virtually all such studies 
have involved chemical fixation, followed by decalcif- 
ication and embedding in paraffin wax, (Some bio- 
chemical and histochemical work, to which these structures 
do. not fully apply, has been done on calvaria in embryos 
and very young animals). Thus the histochemical reports 
(e. g. Balogh et al, 1961, and reviewed by Fullmer, 1966) 
must be viewed with considerable scepticism. 
In our laboratory, the ability to cut serial sections 
of adult unfixed, undemineralized bone (Johnstoneet al, 
1972 and as discussed in this thesis) have overcome 
these difficulties, in that such sections can be examined 
by conventional methods of quantitative cytochemistry; 
in this way, biochemical activities can be related to 
histology, so avoiding the prdblems of tissue heterogeneity. 
The Enzymes of Bone 
Approximately 90% of the citrate present in the 
body of mammals is located in bone (Dixon and Perkins, 
1952). Citrate has a strong affinity for calcium 
ions, forming a chelate complex. Several authors have 
shown that citrateis produced in bone. Dixon and Perkins 
(1952) demonstrated the presence of an enzyme presently 
knownascitrate synthetase. This enzyme isresponsible 
for the synthesis ofcitrate from oxaloacetate and. acetyl- 
coenzyme A. Dixon and Perkins (1952) were, however, 
unable to detect the enzyme isocitrate dehydrogenase, 
the enzyme responsible for the breakdown of citrate 
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in the Krebs' cycle. They suggested 
of citrate could possibly result from 
enzyme isocitrate dehydrogenase. In 
did demonstrate the presence of isoci 
activity in diaphyseal bone, and thus 
and Perkins earlier hypothesis. 
that the production 
a block of the 
1959, Van Reem 
trate dehydrogenase 
discounted Dixon 
An alternative explanation for the citrate production 
was described by Hekkelman (1973); it involves the inhib- 
ition, by calcium ions, of aconitase, the enzyme converting 
citrate into isocitrate in the Krebs' cycle. Hekkelman 
(1973) showed that the inhibition occurred by the formation 
of a calcium-citrate complex, which decreased the available 
substrate for the enzyme; moreover, the complex acts 
as a competitive inhibitor. Hekkelman (1973) also 
put forward another hypothesis: if the Embden-Meyerhoff 
pathway has a capacity far larger than that of the Krebs' 
cycle, lactate, and probably citrate will accumulate. 
Bone produces a considerable amount of lactate, 
from glucose under aerobic conditions: this is known 
as. aerobic glycolysis (Neuman, 1977; Brommage et al, 
1977). This phenomena has been discussed fully in 
Chapter VI. 
Cohn and Forscher (1962) used'radioactively labelled 
substrate in studies on the relative capacity of the 
Krebs' cycle, glycolysis and pentose shunt in rabbit 
epiphyseal-metaphyseal bone slices. The yield of 
,6 
and 
14 C-lactate was assayed. They found that 
lactic acid wwas the major metabolic end-product of 
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glucose metabolism and that only minor amounts of labelled 
Krebs' cycle acids were formed. Approximately 15% 
of the lactate was formed from the pentose shunt and 
the remainder from the Embden-Meyerhof pathway. They 
showed that although the major portion of the C 
14 02 
evolved by slices arose from the Krebs' cycle, the latter 
pathway seemed to play a minor role in the overall 
metabolism of the bone. 
Hekkelman (1973) described a study in which the 
activities of a number of catabolic enzymes was determined 
in extracts of kidney, liver, brain and diaphyseal limb 
bone. The enzymes studied were: aconitase, isocitrate 
dehydrogenase, glucose 6-phosphate dehydrogenase and 
6-phosphogluconate dehydrogenase. They found that 
aconitase and isocitrate dehydrogenase activities were 
low in bone when compared with other tissues, whilst 
the pentose shunt enzymes showed comparable activities. 
The ratios of the pentose shunt pathway enzymes over 
the Krebs'. cycle enzymes were considerably higher in 
bone than in the other tissues (except brain). These 
results indicated the presence of a relatively high - 
amount of the enzymes of the pentose shunt pathway in 
bone tissue. 
Both osteoblasts and osteocytes possess the ability 
to synthesize collagen, and a great deal of 'work has 
been devoted to elucidating this process, particularly 
in relation to the post-transcriptional modification 
of proline, in protocollagen, to the characteristic 
amino acid of collagen, namely hydroxyproline. Almost 
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all this work has been done on tissues other than bone. 
Hydrolytic enzymes play a critical role in bone 
resorption (reviewed by Vaes, 1969). Evidence suggests 
that the hydrolases, associated with the lysosomes of 
bone, are essential to the resorption of the organic 
components of the bone matrix, and possibly the 
solubilization of the mineral component. The hydrolytic 
enzymes of bone cells have not been extensively studied 
by standard biochemical methods, probably because of 
the difficulty of preparing valid homogenates or extracts 
from this hard tissue (as previously discussed). A 
summary of the information provided, by histochemistry 
on hydrolytic enzymes in bone cells is presented in 
table 11.2. As shown in Table 112. acid phosphatase 
activity is present in all types of bone cells but is 
particularly active in the osteoclasts. Acid phosphatase 
activity is also observed extracellularly in subosteo- 
clastic resorption zones. In direct contrast, there 
was negligibýe alkaline phosphatase activity in the 
osteoclasts whereas this enzyme was-extremely active in 
the Osteoblasts and to 'a lesser extent present in the 
osteocytes. Quantitative biochemical studies of several 
hydrolytic enzymes have been' made on homogenates of 
bone (calvaria ) from infant rats (reviewed by Vaes, 
1969). The most'importa'nt hydrolytic activities on 
numerous substrates were evidenced at acid pH values, 
especially. those eanzymes which degrade proteoglycans 
an. d their derivatives (hyaluronidase, 0-glucuronidase, 
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Table II. Distribution and hydrolytic enzymes 
in bone cells, as 
visualized by histochemistry. 
(From Vaes, 1969) 
Distribution of hydrolytic enzymes in bone cells, as visualized by histochernistr) 
Enzyme Oileoclasts Osteoblasts osfcocytcs Rifies ellm 
(a) Acid hydrolases 2-7.10-12, 
Acid phosphatase + + 1 14,19-22 
Phosphoamidase + -f 4 0 51 15 
P-glucuronidase +4 + + 4,5,9,22 
P-galactosidase ++ + -4 16 
P-glucosidase + + + 17 
(b) Othcr hydrolases 
Protease (gelatinase) 0 0 + I 
Alkaline phosphatase 0 4+ + 2-4.6,11.12 
Arninopepticlasc ++ + + 2,3,13,22 
5'-nucleotidase 0 + ++ 2.8 
Adcnosinc triphosphatase + + + 2,7.18 
Symbols 0: no activity; 4: activ. 
ity; + +: more activity. 
References cited in Vaes (1969) 
1 Manger and Migicovsky (1963) 10 Handelman el al. (1964) 16 Schlager (1959) 
2 Burstone (1960a) 11 Jeffree(1960) 17 Schlager 0 960) 
3 Burstone (1960b) 12 Jeffree (1962) IS Severson ct al. (1967) 
4 Cabrini (1961) 13 Lipp (1959) 19 Susi ct al. (1966) 
5 Cabrini ct al. (1962) 14 Schajowic7 and Cabrini 20 Tonna, (1958) 
6 Changus (1957) (1958) 21 Vaes and Jacques (1965a) 
7 Doty et al. (1968) 15 Schajowicz and Cabrini 22 Warner (19(A) 
8 Gibson and Fullmer (1967) (1964) 
9 Gubisch and Schlager(1961) 
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N-acetyl-0-glucosaminidase, and 0-galactosidase); 
for the proteolytic actively measured with. denatured 
haemoglobin as substrate (acid protease or 'cathepsin'); 
for the hydrolysis of deoxyribonucleic acid; and for 
the hydrolysis of ribonucleic acid and of phosphate 
monoesters (either phenylphosphate or ý-glycerophos- 
phate). 
Alkaline phosphatase (non specific) has an extremely 
high. s. pecific activity in bone when compared with other 
tissues. Many hypotheses have been put forward 
concerning its function (especially its involvement 
in the calcification process) (as reviewed by Walker, 
P-G-9 1973; Bourne, G. H., 1976). However, its function 
is still obscure. 
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CHAPTER III. 
_ 
OSTEOCALCIN: A VITAMIN K-DEPENDENT 
CALCIUM-BINDING PROTEIN. 
Vitamin K1 has been associated with the blood 
clotting process and prothrombin since 1935 (as reviewed 
by Price, 1983). However it was not until the sevent-ies 
that the molecular function of vitamin K was shown 
to be the'post-translational -y-carboxylation of all 
glutamic acid residues in the first 40 N-terminal residues 
Of prothrombin (Fig. 111.1) (Stenflo and Suttie, 1974; 
and as reviewed by Bell, 1978). The evidence suggests 
that the role of -y-carboxyglutamate residues in prothro- 
mbin as well as the other vitamin K-dependent blood 
coagulation factors is to promote their binding to 
the phospholipid vesicles released by blood platelets 
which have aggregated on the exposed collagen surfaces 
of damaged blood vessels. It is generally thought 
that the function of the Gla in this interaction is 
to serve as a Ca2 + chelator (Nelsestuen, 1978) by 
virtue of its two carboxy groups. The production 
of these calcium-binding y-carboxyglutamate (Gla) 
residues was shown to be effected by a microsomal mixed- 
function oxidation -carboxylation reaction in which 
vitamin K1, or a similar naphthoquinone substituted 
at the 3 position (Olsen et al, 1978), is reduced by 
NAD (P) H (Stenflo and'Stittie, 1977; Suttie et*al, 1978). 
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HH0 
19 11 N\H/C\ Vitamin K, /C\ y 
mixed function oxidation 
CH carboxylation 
12 YH2 
CH2 CH 
C00- 00C COT 
Fig. 111.1 The transformation of glutamate residues to y-carboxy- 
glutamate(Gla) residues. 
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The reoxidation of the quinol is required for the 
process in which a proton is abstracted from the 
y -methylene of a glutamate residue (Stenflo and 
Suttie, 1977). The resulting carbanion fixes carbon 
dioxide to form the y-carboxyglutamate residue 
(Hauschka et al, 1978; Olsen et al, 1978). This is 
known as the vitamin K1 cycle (Fig. 111.2). The vitamin 
K1 antagonists dicoumarol and warfarin are believed 
to inhibit to conversion of the epoxide to the quinone. 
Their structures are shown in Fig. 111.3. When it 
was discovered that Cla was stable under conditions 
of alkaline protein hydrolysis, research into the presence 
of Gla in various Ca 2+ binding proteins and tissue 
extracts led to the independent discovery by two groups 
of workers (Hauschka et al, 1975; Price et al, 1976a) 
of a hitherto unknown polypeptide, rich in Gla residues, 
iý the bones of the chicken and the calf. This poly- 
peptide, which could be extracted intact (Price, 1983), 
was called 'osteocalcin'. 
Distribution of Gla residues in Tissues. 
One of the difficulties of evaluating the signif- 
icance of osteocalcin, and of Gla residues generally, 
has been the fact that, initially, the presence of 
these residues was considered as indicative of the 
presence of osteocalcin. . 
This'has confused the issue 
because it now seems apparent that Gla residues can 
occur in other proteins in bone. It is therefore 
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peptide-Mu"., C02 8-corboxy Glu-peptide 
H PO. 0 
CH H3 3 02 0 C* 
OH 0 
hydroquinone) NADP 
Vitamin ýepoxid e 
NADPHO clicoumorol 
H3 C&- 
ýH3 ýH3 
RR =-CHýCH-C-CH 2f CH CqCH-CJH 03 
Vitamin K, (quinonel 
Fig. 111.2 Diagrammatic representation of the vitamin K cycle. 
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-, CH2' 
OH OH 
Dicoumarol 
OH 
CHCH2COCH3 
I C, 6H5 
Warforin 
Fig. 111.3 Structural formulae of dicoumarol and warfarin. 
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necessary, in evaluating published reports, to distinguish 
whether they refer to the distribution of Gla residues, 
to the isolated osteocalcin, or to radioimmunoassay 
results ostensibly based on antibodies to osteocalcin. 
The polypeptide, osteocalcin, which is extracted 
from bone by EDTA, comprises about 1% of the total 
protein of chicken and bovine bones and about 20% of 
the non-collagenous protein Man et al, 1978). The 
distribution of Gla in calcified tissue, dentine, and 
in some soft tissues is shown in Table III. l. The 
significant finding was that the epiphysis had low 
concentrations of Gla residues compared to the diaphysis 
and metaphysis., despite being the site of high bone 
turnover. Cartilage also had low levels of Gla residues. 
Thus the concentration of Gla apparently correlated 
with the degree of mineralization (Hauschka et al, 
1978). 
Characterization 
The molecular weights of calf and chicken "osteo- 
calcin" are low: 5800 and 6500 daltons, respectively 
(Price et al, 1976b ; Hauschka and Gallop, 1977). 
It is also a very acidic protein. 
The covalent structure has been determined for 
Ifosteocalcin" from calf, swordfis'h, human, chicken, 
and monkey bone (Poser et al, 1980; Price et al, 1976 
b; Price et al, 1977; Carr et al, 1981 and Hauschka 
et al, 1982) and the N-terminal sequence has been 
reported for rat "osteocalcin" (Otawara et al, 1981). 
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Table III. 1 .y- carboxyglutamic acid content of various 3 week 
chick tissues. 
Tissue Relative Gla content 
Long bone diaphysis 100 3 
Long bone metaphysis 67 
Long bone epiphysis 23 
Long bone articular cartilage 18 
Long bone marrow <1 
Mandible 66 
Calvarium 56 
Sternum k eel bone 51 
Sternum c artilage 2-2 
Tracheal cartilage 17 
Tendon <1 
Brain <1 
Kidney 14 
Liver 10 
Long bone diaphysis = 68.9 ± 2.4 residues Gla/10 
5 
amino acid residues. 
From flauschka et al, 1978. 
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A direct comparison of these structures reveals a remarkable 
degree of conservation (as reviewed by Price, 1983) 
(Fig. 111.4). The commonest feature is 3 Gla residues 
and an associated disulphide bond. Because of this 
sequence homology there are sufficient similarities 
for most antibodies, currently used for clinical assays, 
to have been raised against bovine osteocalcin (as 
reviewed by Price, 1983). 
Osteocalcin was found to be distinctly different 
from the vitamin k-dependent blood coagulation factors 
by molecular weight, amino acid composition and sequence 
(Hauschkaet al, 1975; Hauschka and Gallop, 1977; Price 
et al, 1976). 
Interaction of Osteocalcin with Ca2+and Hydroxyapatite 
Osteocalcin binds Ca2+, although the strength of 
this association is relatively weak. Calcium binding 
studied by equilibrium dialysis of chicken osteocalcin 
demonstrated two distinct classes of calcium binding 
sites with an average dissociation constant of 0.8 mM 
(as reviewed by Hauschka ef at 1978; Price 1983). Analysis 
of Ca2 + binding to calf osteocalcin showed three distinct 
binding sites with an average dissociation constant 
of 3 mM (Poser and Price, 1979). This Ca2+ binding 
to osteocalcin is lost following thermal decarboxylation 
of Y-carboxyglutamate to glutamate. 
Osteocalcin has a much greater affinity for 
hydroxyapatite. The dissociation constant for osteo- 
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HLgnm [Tyr LeulTyr Gin Trp Leu Gly Ala Pro Vol Pro Tyr Pro Asp Pro 
Calf ITyr LeujAsp His Trp Leu Gly Alo Hyp Ala Pro Tyr Pro Asp Pro 
Swordf ish Ala Thr Arg 
[Alo 
Gly Asp Leu TfirtProjeu Gin 
20 25 30 
E Leu Gla Arg Arg Gla Vol Cys Glo Leu Asn Pro Asp Cys Asp 
Leu Glo Lys Arg Gla Vol Cys Glo Leu Asn Pro Asp Cys Asp 
Lu 10 eG Leti Arg Go Vol Cys Glo Leu AsnFVol Ala 
[Cn 
Asp 
35 40 45 
Glu Leu Alo Asp His Ile Gly Phe Gin Glu Alo Tyr Arg Arg Phe 
Glu Lau Ala Asp His Ile Gly Phe Gin Glu Ala Tyr Arg Arg Phe 
Ile Ma Tyr c4u 
f 
MetjAio Asp 
ýTtr 
Alko)12JIle Vol Ala] Ala_T 
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Tyr Gly Pro va 
Vol Tyr Gly Pro 
I 11 
Ile Gin Phe 
Fig. 111.4 The amino acid composition of osteocalcin derived from 
human, cow and swordfish. The points of dissimilarity are 
shown as open symbols. (From Price, 1983). 
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calcin binding to hydroxyapatite is around 10- 
7M (as 
reviewed by Price, 1983). The affinity of osteocalcin 
for hydroxyapatite is greatly reduced after thermal 
decarboxylation of the osteocalcin (Poser and Price, 
1979). The decarboxylated osteocalcin also exhibits 
a shift in isoelectric focussing position from pH 4.0 
to pH 4.5. This change in the property of the protein 
after decarboxylation of Gla to Glu is important, as 
will be discussed later, in determining at what point 
the protein is decarboxylated in bone primary culture. 
The affinity of osteocalcin for hydroxyapatite is selective 
in that it binds only weakly with amorphous calcium 
phosphate (Price, et al, 1976a). 
Brushite (CaHPO 4 2. H 2 0) is an important mineral 
phase in embryonic bone (as reviewed by Hauschka et al, 
1978), which undergoes metamorphosis to hydroxyapatite. 
Hauschka et al (1978) showed that the in vitro transition 
of brushite to hydroxyapatite is strongly inhibited 
by low (rv 2 uM) concentrations of osteocalcin. However 
caution should be taken in relating these in vitro 
properties of osteocalcin to its still obscure in vivo 
functions. 
Biosynthesis 
There is good evidence that that the polypeptide, 
ostpocalcin, is synthesized by bone. The most direct 
evidence has been obtained by the analysis of proteins 
labelled with 
3H 
proline in the primary culture of lmm 
thick cross-sectional wafers of calf trabecular and 
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cortical bone (Nishimoto and Price, 1979). It was// 
demonstrated that 
3 HPro is incorporated into a protein 
which is identical to osteocalcin in molecular weight, 
electrophoretic mobility, and isoelectric focussing 
position. The osteocalcin labelled with 
2 HPro is 
cleaved by trypsin into the same peptides as purified 
bovine osteocalcin. This labelled osteocalcin exhibits 
a shift in isoelectric focussing position from pH4.0 
to pH 4.5 after thermal decarboxylation of Gla to Glu, 
demonstrating that this protein is not only synthesized, 
but fully carboxylated in bone in primary culture. 
Further evidence that osteocalcin is synthesized 
in bone has been obtained by the SDS gel-electrophoretic 
analysis of proteins labelled with 
14 C in y-carboxy- 
glutamate during incubation of chick bone microsomes 
with 
14 CO 2 and vitamin K1 
(Lian and Friedman, 1978). 
However they showed vitamin K-dependent formation of 
y -carboxyglutamic acid in endogenous proteins only 
in microsomal preparations from chick embryos treated 
with sodium warfarin for 5 days pri I or to killing. A 
4 to 5 fold increase in 14 C- y-carboxyglutamate 
formation into the microsomal endogenous proteins in 
warfarin-treated embryos was found compared with that 
found in untreated embryos. This clearly demonstrated 
that precursor protein accumulated in bone microsomes. 
This finding supported previous studies that demonstrated 
in vivo formation of 
14 C- y-carboxyglutamate in embryonic 
chick organ cultures by incubation in a medium supplemented 
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with 
14 C-NaHCO 3 (Lian et al, 1976). While little vitamin 
K-dependent carboxylation of endogenous protein could 
be shown in bone microsomes prepared from normal bone, 
the presence of carboxylase activity was demonstrated 
using a synthetic peptide, Phe-Leu-Glu-Glu-Val, as 
substrate (Lian and Friedman, 1978). 
There is some evidence that indicates that osteo- 
blasts synthesize osteocalcin. Firstly osteocalcin 
has been shown to have a residue of 4-hydroxyproline 
in its structure (Price et al, 1976b). This indicates 
the presence of prolyl hydroxylase in cells synthesizing 
osteocalcin, an enzyme that is used as a marker for 
osteoblasts in culture. Osteocalcin is synthesized 
by clonal osteosarcoma cells that display common features 
of the osteoblast phenotype. These clonal osteosarcoma 
cells form fully mineralized osteosarcomas when implanted 
into rats (Nishimoto and Price, 1980; Majeska et al, 
1980; Nishimoto and Price, 1981). Analysis of the 
proteins synthesized by these osteosarcoma cells indicates 
the*presence of a precursor of osteocalcin (Price, 1983). 
Developmental Appearance of Osteocalcin (or Gla residuesl 
in Mineralizing Tissues. 
Two methods have been used to investigate the 
developmental appearance of osteocalcin in calcifying 
tissues. The first depends on the chemical detection of 
carboxyglutamate residues, assumed to be indicative 
of the presence of osteocalcin; the second has involved 
the direct radio-immunoassay of osteocalcin. These 
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two assays have presented conflicting evidence. In 
the early studies by Hauschka et al (1978) it was shown, 
by the chemical analysis of -y-carboxyglutamate, that 
Gla is first detectable in growing chick embryos when 
the first histologically detectable mineral deposition 
occurs (Fig. 111.5). Interference with the vitamin 
K status of the chick by injecting warfarin into these 
developing chick embryos, or by feeding young chicks 
either with a vitamin K deficient diet or with one 
containing added dicoumarol, depressed the rate of Gla 
formation in the forming bone. Although gross macro- 
scopic abnormalities were not observed in bones of 
chicks fed either with dicoumarol or with vitamin K 
deficient diets, there was microscopic evidence of 
impaired calcification (Hauschka et al, 1978). The 
direct chemical analysis of y-carboxyglutamate in the 
developing rat and chicken (Hauschka and Reid, 1978a) 
Price et al, 1980a .) and in 
bone induced by subcutane- 
ously implanting demineralized powder of collagenous 
bone matrix into rats showed that the content of skeletal 
y -carboxyglutamate residues rises when mineral first 
accumulates in bone (Hauschka and Reddi, 1980). In 
contrast, analysis by immunoassay for the detection. of 
osteocalcin in demineralization extracts of calcifying 
tissues or in transverse sections of rat tibiain2 and 4 week rats 
showed that the protein did not appear coincidently with 
the accumulation of mineral but much later, at about the 
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Fig. 111.5 The content of ycarboxyglutamate residues in chick 
limbs from the embryonic stage to six weeks of age. The 
effect of adding vitamin K (+K) or removing it (-K) 
from the. diet and the effect of dicoumarol is also shown. 
(From Hauschka et al, 1978) 
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same time as the initial mineral phase was maturing 
into hydroxyapatite (Price et al, 1981a This 
discrepancy is probably due to the presence of other 
Gla containing proteins, associated with the collagenous 
bone matrix, that are not extracted by the acid or EDTA 
demineralization procedures (Price, 1980a: Table 111.2). These 
other Gla-containing components appear in close temporal 
association with the accumulation of mineral, explaining 
the results of Hauschka et al (1978) whereas, osteocalcl'n 
as detected by immunoassay, appears much later. For 
example, in new born rats the amount of Gla is at 33%, 
while bone osteocalcin (as determined by radioimmuno- 
assay) is at 1% of adult levels (Price et al, 1980a 
The first mineral phase in rat, calf and human 
is almost devoid of osteocalcin, as determined by radio- 
immunoassay (Price et al, 1980 a, b ); Price et al, 
(1981 a). The overall level of osteocalcin in bone 
rises rapidly with subsequent development in all three 
species, approaching adult levels by 14 days of age 
in rats, and by the gestational age of 9 months in 
the calf and 15 weeks in humans. 
The Nature of Circulating Osteocalcin. 
Sensitive radioimmunoassays have now detected 
a protein that is apparently identical to osteocalcin 
and which is present in plasma and serum (Price and 
Nishimoto, 1980; Price et al, 1980b Patterson- 
Allen eL al, 1982). It deserves to be noted that the 
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Table 111.2 
Bone fraction 
Whole bone 
The y-carboxyglutamic acid concentration in newborn and 
adult limb bone was determined by amino acid analysis 
after alkaline hydrolysis of three fractions: the 
intact bone, the formic acid extracted proteins, and 
the insoluble collagenous residue. For comparison 
data are expressed as micromoles of y-carboxyglutamate 
per g of original bone sample. 
Extracted protein 
Insoluble residue 
Adult Newborn 
pmol Gla/g 
0.67 0.25 
0.57 <0.04 
0.09 0.21 
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antibody developed by Price and co-workers does not 
discriminate between 'osteocalcin' that contains Gla 
residues and 'osteocalcin' that lack Cla residues, for 
example, after oxidative removal of the y-carboxy group 
(Price et al, 1980 a '; Price and Nishimoto, 1980). 
The antibody developed by Patterson-Allen and co-workers 
has not been decisively characterized, although it was 
shown to respond to osteocalcin that contained Cla residues; 
it also responded to some other peptides that were equally 
rich in Cla-residues but which were not osteocalcin. 
However it was not shown to be specific for Gla-residues. 
Price and co-workers (Price and Nishimoto, 1980; 
Price and Williamson, 1981, Price et al, 1981 b) have 
used the ability of their 'osteocalcin' to bind hydroxy- 
apatite to indicate the presence of Gla residues. 
Thus they showed that the osteocalcin-like peptide, 
present in the circulation, has the same molecular weight 
as has osteocalcin that is extracted from bone and the 
same affinity for hydroxyapatite. 
The osteocalcin present in the circulation arises 
from new cellular synthesis and not from the release 
of extracellular bone matrix osteocalcin during bone 
resorption (Price et al, 1981 b This was shown 
by two experiments. The first experiment analysed 
serum osteocalcin in rats treated with warfarin and 
showed that 3 hours after a single dose of warfarin, 
serum osteocalcin had lost its ability to bind to hydroxy- 
apatite (Price et al, 1981). This is best explained 
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by the fact that warfarin had inhibited the vitamin 
K 1- dependent y-carboxylation of newly synthesized osteo- 
calcin. Osteocalcin extracted from the bone of these 
rats was normal and was able to bind hydroxyapatite 
normally. Thus the abnormal serum osteocalcin in these 
animals could not have come from. extracellular bone 
matrix osteocalcin during bone resorption. The level 
of circulating osteocalcin from these warfarin-treated 
rats was found to be 4-fold greater than that of circu- 
lating osteocalcin in control rats at day 30, the levels 
decreasing thereafter. This could be due to the fact 
that the osteocalcin which would normally accumulate 
in bone now appears in the circulation (Price and William- 
son, 1981) (see later in the section 'The effects of 
warfarin on bone'). Secondly, administration of vitamin 
K1 to chronically warfarin-treated rats caused serum 
levels of fully y-carboxylated osteocalcin (as judged 
by binding to hydroxyapatite) to return to normal within 
15 hours. Since the total osteocalcin level in the 
bones of these rats was approximately 1.5% of normal 
after 15 hours of vitamin K-administration, again it 
seems clear that the osteocalcin in serum must have 
arisen from new cellular synthesis"(Price et al, 1981b). 
The turnover of osteocalcin must be reasonably 
fast, since, as seen in the first experimentý outlined 
above, the serum osteocalcin loses its ability to bind 
to hydroxyapatite within 3 hours of a single dose of 
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warfarin (Price et al, 1981b), and as fully reviewed 
by Price, 1983). 
Circulating levels in the human 
As shown in Table 111.3, there appears to be no 
consensus on the circulating levels of osteocalcin. 
For example, two groups showed that levels in women 
are higher than in man and two groups showed the reverse. 
Equally some showed levels increasing with age and others 
showed them to decrease with age. This confusion is 
unfortunate because osteocalcin may be a useful indicator 
of bone metabolic activity, so that circulating osteocalcin 
levels could provide a valuable measurement for the diagnosis 
of metabolic bone diseases (as discussed below). 
The discrepancies between the circulating levels 
of osteocalcin with age and sex are probably due to 
the characteristics of the populations studied. Price 
et al (1980 b) and Gundberg et al (1982) reported lower 
levels of circulating osteocalcin in females. Epstein 
et al (1984) and Couch et al (1984) however showed 
higher levels of osteocalcin in women than in men. 
In all these studies the mean values of circulating 
levels of osteocalcin were taken from a wide range of 
ages in both groups. However, the ranges and means 
of ages differed in these studies. The mean age of 
female subjects studied by Price et al (1980 b) 
was 44. The mean age of the males studied was not 
indicated, nor the range of ages in both groups. In 
a personal communication by Price and as described by 
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Table 111.3. The results in some recent publications on the 
circulating levels of osteocalcin. 
Circulating levels of losteocalcin' 
0 Change Osteoporosis Author 
+ with age 
f(O) Price et ol, 1980 
t Deimos et al, 1983 cL, b 
f No chonge Gundberg et ol, 1983 
Epstein et ol, 1984 
Couch et at 1984 
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Delmas et al (1983a), only half of the normal women in 
their study were over 30 years of age (34 out of 62) 
and only 4 of them were older than 70 years of age. 
They reported however that circulating levels of osteocal- 
cin fell with age in women, with no significant variation 
with age in men. Gundberg et al (1982) measured circu- 
lating levels of osteocalcin in males and females whose 
ages ranged from 1 to 65 years. This group reported 
extremely high levels (10 - 40 ng/ml) in growing children, 
declining to the normal adult levels at about the age 
of puberty. The mean age of the adults studied in 
this group of subjects was 37 years in both males and 
females. However quite surprisingly mean values for 
the circulating levels of osteocalcin in adults were 
obtained by measuring in the age range 12 to 65 in 
males and in the age range 17 to 65 in females. Thus 
two male children with levels as high as 35 ng/ml were 
included in the male adult level of circulating osteo7 
calcin. In this study, however, it did appear that 
levels were increasing with age after 30 years but there 
was no apparent difference between male and female levels. 
Epstein et al (1984) measured the level of circulating 
osteocalcin in adults ranging from 30 to 90 years. 
The mean age of their subjects was much higher than 
in the two previously mentioned surveys: 57 and 67 years 
for females and males respectively. They showed that 
circulating osteocalcin increased with age in both men 
and women. The difference between women aged 30 and 
those aged 80 was much greater than that between men 
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of the same ages. Delmas et al (1983. a)also reported 
that circulating levels of osteocalcin increased with 
age in women, but they did not measure osteocalcin in 
men. 
Price et al (1980 b) showed that circulating 
levels of osteocalcin were elevated dramatically in 
patients with metabolic bone diseases whic! are character- 
ized by increased bone turnover, such as Paget's disease, 
hyperparathyroidism, and metastatic bone disease; 
Circulating osteocalcin levels were found to be correlated 
with circulating alkaline phosphatase levels, although 
there were discrepancies (Price et al 1980 b: ). 
Gundberg et al (1983) also showed significant increases 
in circulating osteocalcin in patients with Paget's 
disepse. Price et al (1980 b) reported that in patients 
with osteoporosis the mean concentration of circulating 
osteocalcin was slightly higher than in normal women; 
however it is not clear whether this 'osteocalcin' had 
its full complement of Gla-residues. Unfortunately, 
these two groups were not of similar ages, the mean age 
of the controls being 44 years whereas that of the osteo- 
porotics was 60 years. For all that, Epstein et al 
(1984) showed that age-matched osteoporotic patients 
had significantly raised levels of circulating osteo- 
calcin as defined by radioimmunoassay (17.3 ng/ml). Epstein 
et el'(1984. ) pointed out that it was interesting that 
the increase in circulating osteocalcin with age occurred 
most noticeably at the age when a reduction in bone 
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mass or postmenopausal octeoporosis becomes evident in 
women and also when osteoporosis is most common in the 
male population. Similar levels were reported in 
osteoporotic patients by Delmas et al (1983b). However, 
Gundberg et al (1983) showed only a slight elevation 
of circulating osteocalcin in patients with osteoporosis. 
Circulating levels of osteocalcin and alkaline 
phosphatase levels fall appreciably in patients with 
Paget's disease, following long-term treatment with 
salmon calcitonin (Deftos et al, 1982). In the same 
study these workers showed that circulating levels of 
osteocalcin fell following parathyroidectomy in women 
with primary hyperparathyroidism. Treatment with salmon 
calcitonin also reduced circulating levels of osteo- 
calcin in patients with bone cancer. Again, in this 
study, although circulating levels of osteocalcin and 
circulating alkaline phosphatase were generally correlated, 
there were dissociations between the two. Thus measure- 
ment of the circulating level of osteocalcin may be-a 
more specific index of bone turnover than is the 
measurement of the circulating levels of alkaline 
phosphatase. This, however, will depend on reliable 
immunoassays which yield equivalent results in different 
laboratories. 
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Correlations between circulating (Ysteocalcin 
and other biochemical factors and bone mass. 
Both Delmas et al (1983a)and Epstein et al (1984) 
have correlated circulating levels of osteocalcin with 
age, OTH, ionised calcium, alkaline phosphatase, 
1,25 - (OH) 2 D, midshaft bone mass, distal bone mass, 
lumbar spine bone mass, urinary hydroxyproline, urinary 
cAMP and creatinine clearance. The results are summarizýed 
in Table 111.4. In the study by Delmas et al (1983a, 
done only on women, the results suggest that overall 
bone turnover increases in women with ageing and may 
indicate that age'-related bone-loss does not result 
primarily from decreased bone formation. The measure- 
ments by Epstein et al (1984) were consistent with the 
findings of Delmas et al (198" 6). 
Urinary Y-Carboxyglutamate. 
In humans, free Y -carboxyglutamate residues are 
excreted in the final breakdown of all vitamin K I- 
dependent proteins (Shah et al, 1978). Total alkaline 
hydrolysis of whole urine yields free Gla derived from 
all the urinary constituents. Gundberg et al (1982) 
showed that 80% - 99% of total urine Gla is excreted. 
as free Gla. in normal subjects. Less than 5% protein- 
bound Gla was found. Thus this indicates that the 
measurement of free urinary Gla is an adequate assessment 
of the breakdown of Gla-containing proteins. Levy 
and Lian (1979) showed that the excretion of Cla 
b3 
Table 111.4. Some recent publications on the correlation between 
circulating levels of osteocalcin, other biochemical 
factors and bone mass. Upper table from Epstein et al, 
1984; lower table from Delmas et al, 1983rl 
Correlation coefficient with BGP 
I Women Men 
Age 
iPTH 
Ionised calcium 
Alkaline phosphatase 
1,25-(OH)2D 
Midshaft mass 
Distal, mass 
0.41(P<0.001) 
0.37(p<0.001) 
-0. lO(NS) 
0.31 (P<0.001) 
-0.20(p<0.10) 
-0.43(p<0.001) 
-0.40 (p <O. 002) 
0.29(P<0.01) 
0.20(NS) 
0.07(NS) 
0.26 (P<o. 05) 
-0.18 (NS) 
-0.57(P<0.001) 
-0.39(p<0.01) 
NS = not significant 
Correlation Coefficients Between Age, Biochemicaland Densitometric 
Variables 
BMD Urhiary Serum 
Lumbar Mid- Distal Urinary Serum 1T. - Alk. Phos. 
Age spine radius radius cAMP iPTH proline 
Serum BGP 0.44 -0.45 -0.40 -o. 46 0.17 
1 
0.36 0.39 0.43 
Serum alkaline 
phosphatase 0.31 
Urinary hydro- 
xyproline 0.29 
Serum iPTH 0.39 
Urinary cAMP 0.38 
BMD 
Lumbar spine -0.47 
Midradius -0.67 
Distal radius . 67 
-0.34 
* 
-0.26 
* 
-0.30 
* 
0.161 0.27 
* 
0.38 
* 
-0.181 -0.23 
2 
-0.25 0.25 
* 
0.26 
-0.20 
2 
-0.32* 0.32 0.15 
-0.05 -0.14 -o. 16 
p <0.001 
P <0.05 
p<0.01 
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decreased in human subjects treated with warfarin. 
Thus urinary Gla measurements may reflect bone turnover. 
Gundberg et al (1982) measured urinary Gla in patients 
with Paget's disease or with osteoporosis, and compared 
them to levels of circulating osteocalcin in these patients. 
They found that urinary Gla excretion was increased 
in patients with osteoporosis, by up to 150% of the 
normal level. However (as mentioned earlier) circulat-, 
ing levels of osteocalcin were not significantly differ- 
ent from normal. in this study. In Paget's disease, 
this pattern was reversed in that circulating levels 
of osteocalcin were increased 3-fold, while urinary 
Gla-excretion was consistently normal. This normal 
level of excreted Gla was shown regardless of the extent 
of the disease. Gundberget al (1982) had previously 
shown high levels of urinary Gla in growing children. 
These levels decreased with age until they normalized 
at puberty. These changes in urinary Gla, as a function 
of age, closely resembles those of circulating osteo- 
calcin (as discussed earlier). From these results, 
Gundberg et al (1982) suggested that, with epiphyseal 
closure, urinary Gla and circulating osteocalcin levels 
decline and that in the adult these parameters most 
likely represent the coupling of bone resorption-and 
new synthesis during normal bone turnover. Gundberg 
et al (1982) suggested that the increased Gla excretion 
in patients with osteoporosis may reflect an imbalance 
between bone resorption and bone formation, in contrast 
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to the normal levels of urinary Gla in Paget's disease 
where there is tight coupling between bone formation 
and bone resorption (i. e. no net loss of bone). 
Certainly these results suggest that measurements of 
urinary Gla and circulating osteocalcin may provide 
important insight into the metabolic disorders of bo. ne. 
The Effects of Warfarin on Bone. 
To investigate the physiological role of osteocalcin 
and other Gla-containing proteins, several workers have 
focussed on the effects of the vitamin K1 antagonists, 
dicoumarol and warfarin, on bone and calcification. 
These anticoagulants are believed to inhibit the conver- 
sion of the epoxide to the quinone in the vitamin K 
cycle, preventing the post-translational conversion 
of glutamate residues to y-carboxyglutamate residues 
(Whitlon et al, 1978); they are not believed to inhibit 
the biosynthesis or secretion of osteocalcin or the 
other Gla-containing proteins. 
Warfarin has been used for long-term anticoagu- 
lation for 25 years, and has been shown to cause nasal 
hypoplasia, stippled epiphyses and distal extremity 
hypoplasia in the offspring of women treated with 
Coumadin during pregnancy (Hall et al, 1980). However 
Piro et al (1982) showed that treatment with Coumadin 
(related to warfarin and dicoumarol) appeared to have 
no detrimental effect on cortical bone-mass in adults 
receiving long-term therapy. The effects of anti- 
coagulant therapy on bone-repair was studied by Stinchfield 
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et al (1956) who found fibrous tissue and immature bone 
in the healing fractures of rabbits and dogs given dicou- 
marol at a dose equivalent to the clinical dose for 
humans. Hahnel et al (1978) made an histological and 
histochemical investigation of the epiphysis of the 
tibia and humerus-in rats after 8 weeks of coumarin 
administration. They showed reduced cellularity in 
the zones of resting cartilage, of young proliferative 
cartilage, and especially in the bone of the epiphysis. 
There was also degenerative fibrillationof the ground 
substance. However there were no differences with 
regard to the width of the epiphyseal plates, or the 
width of metaphyseal trabeculae. It is of interest 
though, that in these studies by Stinchfield et al 
(1956) and Hahnel et al (1978), they found very similar, 
if not more pronounced effects, with heparin administra- 
tion. Hauschka et al (1976) and Hauschka et al (1978) 
showed no gross morphological abnormalities in bones 
of dicoumarol treated chicks, but there was histolog- 
ical evidence of deficient calcification. Price and 
Williamson (1981) developed a procedure by which the 
levels of osteocalcin (measured by radioimmunoassay) 
in rat bone can be reduced to 2% of normal values. 
In this procedure newborn rats are maintained on a ratio 
of a lethal dose of warfarin and sufficient vitamin 
K, to prevent bleeding and death. In this way the 
rats can be maintained in a chronically vitamin K- 
deficient state. As described earlier, because the 
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radioimmunoassay for rat osteocalcin does not discrimin- 
ate between carboxylated and non-carboxylated 'osteo- 
calcin', this low level of 'osteocalcin' in warfarin- 
treated rats reflects the suppression of the normal 
developmental accumulation of osteocalcin in bone; since 
the biosynthesis of the Glu-osteocalcin is unimpaired, 
this lack of binding of the 'osteocalcin' within the 
bone could account for the raised levels of circulating 
losteocalcin' in warfarin-treated animals. The y-car- 
boxyglutamic acid levels in alkaline hydrolysates of 
whole bone, from 52 day-old warfarin-treated rats 
containing approximately 2% of normal levels of osteo- 
calcin, was 0.16 Umol Gla/g of bone compared to normal 
levels of 0.67 Vmol Gla/g of bone at the same age. - 
Of great interest was the finding that over 80% of the 
Gla which does remain in the bones of these warfarin- 
treated rats, is associated with the collagenous bone 
matrix; this Gla-material is not extracted after formic 
acid demineralization procedures (Price and Williamson, 
1981). In the same study Price and Williamson (1981) 
showed that 17-day old rats, placed on warfarin, took 
over 4 weeks to reach this 2% level, and similarly required 
over 4 weeks to return to the normal level again. 
This is in direct contrast to results from studies on 
circulating osteocalcin, in which the Gla content changes 
dramatically within 3 hours of warfarin treatment (see 
earlier) to a normal level (Price et al, 1981b). 
Using this protocol Price and Williamson (1981) showed 
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Warfarin had no effect on the length, mass and gross 
morphology of femurs and tibias, although no results 
were shown., They also studied the degree of minerali- 
zation in bones of warfarin-treated rats in acid extracts 
of powdered femurs, by measuring phosphate levels. 
No differences were observed. Price and Williamson 
(1981) concluded that osteocalcin had no major role 
in the growth, morphology or mineralization of rat bone. 
Price and Williamson (1981) looked for a role of osteo- 
calcin in skeletal or serum calcium homeostasis, by 
placing the warfarin-treated rats on a Ca 2+ - deficient 
diet and then measuring bone and serum Ca 2+ levels. 
No differences were observed between experimental and 
control rats. These authors then studied the repair 
of fractures in young rats, in which the radius was 
fractured at 17 days of age. No significant differ- 
ences or abnormalities were observed in the repair of 
fractures in rats fed warfarin from birth. The evi- 
dence of repair was obtained radiologically. No histo- 
logical observations were made in this study. Finally 
Price and Williamson (1981) showed that demineralized 
bone matrix from control or warfarin treated rats 
implanted subcutaneously over the thorax of 1 month 
old rats showed identical abilities to induce host 
mineralization, as determined by osteocalcin and 
phosphate levels measured in each group. 
More recently Price et al (1982) maintained rats 
on warfarin for 8 months, using this same protocol, and 
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showed growth plate closure and cessation of longitudinal 
growth of the tibia. 
Finally, I have studied the effects of dicoumarol 
on the healing of closed fractures of metatarsals in 
the rat (Chapter VIII). A detailed histological and 
metabolic study has been made. 
SUMMARY 
Gamma-carboxylation, by the vitamin K1 cycle, of 
glutamate residues in existing proteins, resultsin calcium- 
binding Gla residues (Olsen et al, 1978; Stenflo and 
Suttie, 1977; Suttie et al, 1978). The major Gla-protein 
isolated from bone is osteocalcin (or bone Gla-protein) 
(Hauschka et al, 1975; Price et al 1976a): it contains 
47-51 amino acids of which 3 are Gla, and is readily 
extracted by EDTA when the bone is decalcified, leaving 
other Gla-containing proteins within the bone (Price 
et al, 1980a). Such results indicate that the primary 
binding of calcium, during mineralization, may be to 
the latter proteins, and that osteocalcin binds to pre- 
formed hydroxyapatite (Hauschka et al, 1978; Hauschka 
and Reid, 1978b; Hauschka and Reddi, 1980; Price et al, 
1980a; Price et al 1981a). 
The radioimmunoassay (RIA) of osteocalcin does not 
distinguish between the peptide with Gla or with glutamate 
(Price et al, 1980a; Price and Nishimoto, 1980). Conseq- 
uently some discrepancies have been reported, depending 
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apparently on whether the results are based on RIA or 
on the chemical demonstration of Gla. True Gla- 
containing osteocalcin strongly binds hydroxyapatite, 
and inhibits the transformation of brushite to hydroxy- 
apatite (Hauschka et al, 1978). Warfarin (or dicoumarol 
and related compounds) inhibits the reduction of the 
vitamin K epoxide back to the naphthoquinone, so antag- 
onising the vitamin K cycle (as discussed by Whitlon 
et al, 1978). Thus it can influence only the new form- 
ation of Gla-residues so that the newly formed osteocalcin 
contains glutamate and not Gla residues. 
The role of osteocalcin and of the other Gla- 
containing proteins has been tested in vitamin K-deficient 
animals. The protocol used by Price and Williamson 
(1981) in which rats were maintained on a lethal dose 
of warfarin and sufficient vitamin K1 to prevent bleeding 
and death, showed no defects in bone metabolism. In 
this protocol the levels of osteocalcin were reduced 
to 2% of normal. However it was of great interest to 
find that over 80% of the Gla which remained in these 
warfarin-treated rats, was associated with the collagenous 
bone-matrix, and could be extracted only after deminer- 
alization with formic acid (Price and Williamson, 1981). 
This non'bone Gla-protein' was shown to be associated 
with the first stages of mineralization (Hauschka et 
a, iý 
al, 1978; Hauschka and Reid, 1978biHauschka and Reddi, 
1980) unlike osteocalcin (as detected by RIA) which 
appears in calcifying tissues after the initial mineral 
phase has matured to hydroxyapatite (Price et al, 1980a; 
Price et al, 1981a). 
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CHAPTER IV 
POLYAMINES 
The polyamines spermidine and spermine, and 
their precursor 1,4 diaminobutane (putrescine) are 
ubiquitous organic cations of low molecular weight, 
found in a wide variety of eukaryotes and prokaryotes) 
their relative amounts differing markedly in differenC 
cell types. Their structures are shown in Fig. IV. 1. 
The metabolism and possible roles of these cations 
have been extensively reviewed (Tabor and Tabor, 1976; 
Maudsley, 1979; Heby, 1981; Pegg and McCann, 1982; 
Allen, 1983). Briefly the main lines of evidence 
are as follows. Firstly, several micro organisms 
have an absolute requirement for polyamines for normal 
growth and DNA-synthesis. Secondly, the concentration 
of the polyamines, and the activities of the enzymes 
involved in their biosynthesis, increases rapidly 
when resting cells are induced to proliferate. This 
increase precedes increases in RNA, DNA and protein. 
Despite extensive research, the precise physiological 
function of the polyamines is not understood. 
Polyamine Metabolism 
The pathway for mammalian polyamine synthesis 
is shown in Fig. IV. 2. In mammalian tissues 1,4 
diaminobutane (putrescine) is derived by decarboxyation 
of ornithine by the action of ornithine decarboxylase 
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Fig. IV. 1 Structural formulae of ornithine, spermidine, spermine 
and Putrescine; also shown are the formulae of various 
inhibitors. 
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Fig. IV. 2 Diagrammatic representation of the pathway of polyamine 
synthesis; ODC: ornithine decarboxylase; SAMD: 
S-adenosyl methionine decarboxylase; 1: spermidine 
synthase; 2: spermine synthase; 3: spermine or sPermidine 
N-acetyl transferase; 4: polyamine oxidase. The inhibitors 
are shown encircled and their site of action is indicated. 
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(ODC) 
. In many m3cro-organisms and higher plants 
putrescine can also be produced by decarboxylation 
of arginine, but the enzyme arginine decarboxylase 
is lacking in all mammalian cells. Ornithine is 
available for these reactions from the plasma (Allen, 
1983) and can also be formed by the enzyme arginase 
within the cell. It has been suggested that arginase, 
which is more widely distributed than the other enzymes 
of the urea cycle, is present in extra hepatic tissues 
to ensure the availability of ornithine for polyamine 
synthesis (Pegg and McCann, 1982). Ornithine decarboxy- 
lase requires pyridoxal phosphate as a coenzyme and 
is subject to feedback inhibition and repression by 
1,4-diaminobutane (putrescine) or spermidine (cited 
by Tabor and Tabor, 1976). This enzyme is present 
in very low amounts in quiescent cells but its concen- 
tration and activity increase dramatically after a 
variety of stimuli: hormonal, drugs, tissue regener- 
ation, and growth factors (as reviewed by Tabor and 
Tabor, 1976; Pegg and McCann, 1982; and Allen, 1983). 
To convert 1,4 diaminobutane (putrescine) into 
spermidine an amino propyl group, derived from metil; kohine 
is added by the action of S-adenosyl-L-methionine decarb- 
oxylase (SAMD). This converts S-(5'-adenosyl)-3-methionine 
to S-(5'-adenosyl)-3-methyl-thiopropylamine (Fig. IV. 2). 
No other reactions are known to utili'ze decarboxylated 
S-adenosyl methionine (Pegg and McCann, 1982). The 
production of decarboxylated S-adenosylmethionine is 
normally low and is the rate- 
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limiting step in spermidine formation. The donated 
aminopropyl group is transferred to putrescine by sperm- 
idine synthase to form spermidine (N-(3-aminopropyl) 
buta-1,4 diamine). The residual group-5'-methylthio- 
adenosine is rapidly degraded by a phosphorylase to 
yield adenine and5'-methylthioribose-l-phosph. ýte. 
Adenosine 5-monophosphate is formed from adenine, 
catalysed by the enzyme adenine phosphoribosyltrans- 
ferase. Kamatani and Carson (1981) estimated that 
almost 90% of the de novo synthesis of adenine is formed 
from polyamine synthesis. The 5-methylthioribose- 
1-phosphate is converted back to methionine. 
Spermine (N, N -bis (3-aminopropyl) buta-1,4- 
diamine) is formed by another aminopropyl transfer 
from S-(5'-adenosyl)-3-methylthiopropylamine, to the 
amino-butyl group of spermidine, catalysed by spermine 
synthase (Pegg and McCann, 1982) (Fig. IV. 2). 
The spermidine synthase and spermine synthase 
reactions are irreversible. However spermine can 
be converted into spermidine, and spermidine into putrescine 
by the actions of enzymes, spermine-N acetyltransferase 
and polyamine oxidase (Pegg et al, 1981) (Fig. IV. 2). 
This polyamine interconversion is thought to be of 
physiological importance in regulating the levels of 
spermidine and spermine (Pegg et al, 1981; and reviewed 
by Pegg and McCann, 1982). The degradation of poly- 
amines involves distinct polyamine oxidases, and is 
discussed by Pegg and McCann (1982; also Allen, 1983). 
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Inhibition of Polyamine Synthesis 
Many inhibitors of the enzymes involved in poly- 
amine biosynthesis, particularly the rate-limiting 
enzyme ornithine decarboxylase, are now available. 
Table IV. 1 shows some of the many polyamine synthesis 
inhibitors effective in producing polyamine deficiency 
in eukaryotic cells (taken from Heby, 1981). Fig. IV. 1 
shows the structures of the more widely used inhibitors. 
Briefly ornithine decarboxylase is inhibited competitively 
by a-methylornithine and a-hydrazino- 6-aminovaleric 
(HAVA) and irreversibly by inhibitors such as a-di- 
fluoromethyl ornithine (DFMO), a-ethynlornithine, 
and 5 hexyne-1,4-diamine. These irreversible inhibitors 
are highly specific and significantly reduce putrescine 
synthesis in vivo (reviewed by Pegg and McCann, 1982; 
and Allen, 1983). 
SAM-decarboxylase (SAMD) is strongly inhibited by 
methylglyoxal-bis (guanylhydrazone) (MGBG) which is 
also significantly inhibits polyamine synthesis in 
vivo. Administration of MGBG to rats, or exposure 
of stimulated lymphocytes to this drug prevented incor- 
poration of labelled putrescine into spermidine, and 
lead to an accumulation of putrescine in the cells 
(cited by Pegg et al, 1973). 
However, all the currently available inhibitors 
have some drawbacks when they are used to study the 
role of polyamines in cellular physiology. One test 
of specificity of the action of putative inhibitors 
of ODC or of SAMD has been to show that the metabolic 
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Table IV. 1 Some of the inhibitors of polyamine synthesis (From 
fleby, 1981) 
Target enzyme Inhibitor Mechanism of action 
Ornithine Sidlistrair analogs. 
dcc&rN)xvla%c A) D1,01-Hydrazinoornithine Reversible and competitive 
(ODC) b) vi-a-Mcth)lornithine Reversible and competiti%c 
c) ut-a-ifydrazino-a-rncthylornithine Reversible and competitive 
d) trans-3- De hydro-in -ornit hint Reversible and competitive 
C) I)L-a-Difluoromethylornithine Catalytic irreversible 
PFoduri analogs: 
f) trans-1.4-Diamina-2-butenc Reversible and competitive 
g) 1.4-Diiminobutanone Reversible and competitive 
h) 3-Hexyrie-11.4-diamine Catalytic irreversible 
i) tpans-Hex-2-en-S-yne-11,4-diamine Catalytic irreversible 
j) Homologous diamines with 3-12 C atoms Indirect. e. g.. by induction 
(1.3-disminopfopane to 1.12-disminododecane) of ODC-inhibitory protein 
(ODC-antizytne) 
k) I-VDsamino-2-propanol Indirect 
SýAdcnosyl- a) Mcthylglyoxil-bis(Suanylhydr&zone)-. Reversible and competitive 
methionme 1,1'-I(methylethjknediyljdcnc)dinitriloldiguanidine, with respect to the 
decarboxylaw (MGBG) substrate (S-adenosyl- 
(SAMDC) Lemethicinine) 
b) 1,1'-I(Methylethantdiylidtne)dinitrgojbis- InitiaBy reversible and 
(3-amiwguarxiJine). (MBAG) competidve with mvtct to 
the substrate. but 
subsequently iffeversible 
c) S-Adcnosyl-DL-2-methylmcthioninc Reversible and competitive 
with respect to the 
substrate 
Spennichric ix. *ýDiarnincs with 3-12 C atoms Reversible and competitive 
synthasir (1.5-diaminopcntant is most active) with respect to 
one of the substrates 
(putrescine) 
Spermine a, ai-Diamincs with 3-12 C atoms Reversible and competitive 
synthase (1.3-diaminopropanc and with respect to 
11.5-disminopcittane are nnost active) one of the substrates 
(spcmidine) 
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effects are reversed by the addition of polyamines 
to the cells, so indicating that the effect of the 
inhibitors is solely on the supply of polyamines. 
However, this is not entirely adequate because MGBG 
has been found also to inhibit diamine oxidase: this 
effect may not be discernable merely by supplementing 
the cells with polyamines. Moreover it must be borne 
in mind that substances, such as MGBC, that resemble 
polyamines in that they are strongly basic molecules, 
may have polyamine-like effects of their own, apart 
from inhibiting the relevant decarboxylase. Thus, 
for example, MGBG is taken up into cells by the same 
active transport system as are polyamines (as reviewed 
by Pegg and McCann, 1982). 
The most studied ODC inhibitor has been. a(-difluoro- 
methyl)-ornithine. This compound bring*s about extensive 
depletion of putrescine and spermidine in cultured 
mammalian cells, resulting in the cells growing at 
I 
a markedly reduced rate (Mamont et al, 1978). This 
has been confirmed by many workers (as reviewed by 
Pegg and McCann, 1982). The growth-inhibitory effects 
are reversed by supplementation by spermidine or by 
putrescine (cited by Pegg, 1983). However this inhibitor 
has very little effect on the spermine content. This 
could be because there is sufficient residual ODC activity 
to maintain spermine levels. The small amount of 
putrescine that is produced even in the presence of 
the inhibitor is very efficiently converted into spermine 
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(Mamonteta[1981 ). To add to the problem, as a consequence 
of the fact that ODC has an extremely high rate of 
turnover, the concentration of inhibitor must remain 
high, to prevent accumulation of newly synthesized 
active ODC. Thus this inhibitor depletes both spermidine 
a. nd putrescine but is not useful for studying the effects 
of depleting spermidine by itself (Pegg et al, 1982b). 
Thus to have a better understanding of the physio- 
logical role(s) of the polyamines in cells it was necessary 
to study the effects of the selective accumulation 
of putrescine, spermidine, or spermine. Pegg et al 
(1982b) studied the effects of the specific inhibitors 
of the amino-propyl transferases, spermidine synthase 
and spermine synthase (Fig. IV. 2). Spermidine synthase 
is strongly inhibited by the analogue, S-adenosyl-1,8- 
diamino-3-thiooctane (AdoDATO) (Pegg et al, 1982b)(Fig. 
IV. 1) and when mammalian cells (transformed mouse fibro- 
blasts or rat hepatoma cells) were exposed to this 
inhibitor there were profound changes in the intracellular 
polyamine content. Putrescine levels were increased 
and spermidine levels decreased. This is consistent 
with the potent and specific inhibition of spermidine 
synthase (Fig. IV. 2). 
The spermine content of the cells also increased 
when the cells were exposed to AdoDATO, probably because 
spermine synthase was now able to use a larger concentration 
of the available 3-(5' adenosyl)-3-methyl thiopropylamine, 
the levels of which also increased due to the increase 
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in SAMD in response to the decline in spermidine since 
SAMD is apparently also regulated by the content of 
spermidine. 
The growth of mouse fibroblasts was markedly 
reduced as a result of the inhibition by AdoDATO. 
This inhibition of growth was reversed by the addition 
of spermidine, not putrescine. They also showed that 
replenishment of either putrescine or spermidine was 
able to restore normal cellular content of spermidine 
in cells exposed to DFMO (the ODC inhibitor). As 
mentioned previously the effect of DFMO on cellular 
polyamines is to decrease the content of putrescine 
and spermidine to virtually zero levels, with a decrease 
in cell growth. But there is no change in spermine 
content. Spermine production stems from the efficient 
conversion of extremely low levels of putrescine into 
spermine (Pegg and McCann,, 1982). The combination 
of DFMO with AdoDATO lowered the spermine content of 
the transformed mouse fibroblasts by 80% pro bably by 
preventing the conversion of the residual putrescine 
into spermidine (Pegg et al, 1982b). The cellular 
content of putrescine and spermidine were reduced by 
more than 95% in these mouse fibroblasts. This is 
the lowestlevel of polyamines achieved with inhibitors. 
The cells grew very slowly as a consequence. It was 
possible to substantially increase the growth rate 
of these cells with addition of spermidine. 
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One important finding in this study by Pegg et al 
(1982 was that significant changes in polyamine levels 
could be produced by concentrations of AdoDATO that 
had very little, or no effect on the growth of the 
cells, implying that the changes were not secondary 
to changes in growth rate. 
The results by Pegg et al (1982b) using the inhib- 
itors AdoDATO and DFMO confirm previous studies, that 
mammalian cells require certain levels of polyamines 
for optimal growth, but are able to survive and grow 
in spite of large variations of these levels. 
The disadvantage of using reversible inhibitors 
of ODC activity is that they increase the actual concen- 
tration of ODC and thus reduce the inhibition (cited 
by Pegg et al, 1982b). The increase is due to the 
stabilization of the enzyme-protein which therefore 
prolongs its otherwise short half-life. 
Mamont et al (1976) nevertheless clearly demon- 
strated that inhibition of ODC by a-methylornithine, 
in proliferating HTC cells caused a rapid fall in the 
levels of putrescine followed by a huge decrease in 
spermidine. The decrease in spermidine paralleled 
inhibition of DNA synthesis and cell proliferation. 
Again, addition of polyamines resulted in proliferation 
of the cells. There were no deleterious effects on 
the cells with the inhibition by a-methylornithine. 
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As mentioned previously, ODC shows an absolute 
requirement for pyridoxal phosphate (Raina and Jýnne, 
1975). Eloranta et al(1976) and Pegg (1977) showed 
that polyamine concentrations were decreased in rats 
fed on a diet deficient in vitamin B6 (discussed in 
Chapter IX). 
Some potential physiological roles of polyamines. 
H-ýltt-ý et al (1979) demonstrated that the activ- 
ation of human peripheral blood lymphocytes by phyto- 
haemagglutinin invitro resulted in a striking increase 
in the concentrations of putrescine, spermidine and 
spermine. This enhanced accumulation of polyamines 
was almost totally abolished by DFMO and in the presence 
of MGBG, the accumulation of spermidine and spermine 
was largely prevented whereas the accumulation of putrescine 
was enhanced. The inhibition of the polyamine accumu- 
lation was associated with a marked suppression of DNA 
synthesis, which was partially or totally reversed 
by addition of low concentrations of the polyamines. 
These authors also showed that a distinct inhibition 
of protein synthesis preceded that of DNA synthesis 
in the cultures where the polyamine accumulation is 
prevented. The synthetic rates of DNA and protein 
were inhibited by upto 90% by the combination of these 
inhibitors (HLttý et al, 1979). This clearly shows 
the importance of polyamines in cell growth. In these 
and other studies it is difficult to elucidate whether 
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each polyamine exerts different effects in bringing 
about resumption of cell proliferation, since rapid 
conversion of putrescine into spermidine and spermine 
and of spermidine into spermine occurs. However 
exogenous spermine fully reversed the inhibition of 
DNA, protein and RNA synthesis. Hi; lttg et al (1979) 
did not rule out the possibility that polyamines could 
directly regulate the metabolism of nucleic acids. 
Thus the inhibition of general protein synthesis may 
be reflected in the altered nucleic acid synthesis 
in polyamine-depleted cells. 
Regulation of polyamine biosynthesis 
Part of the evidence that polyamines are important 
for normal cellular growth stems from the rapid and 
large increase in ornithine decarboxylase activity 
(ODC) that occurs in virtually all biological systems 
stimulated to grow (reviewed by Tabor and Tabor, 1976; 
Maudsley, 1979; Heby, 1981; Pegg and McCann, 1982; 
Allen, 1983). This increase in ODC activity, which 
can be very rapid, arises either from de novo synthesis 
or from the liberation of latent ODC activity (e. g. 
from an antizyme-ODC complex). In vivo, its half- 
life is less than 1 hour (as reviewed by Allen, 1983), 
implying that rapid inactivation of the enzyme must 
occur. ODC activity may also be subject to some form 
of feedback inhibition and repression by putrescine 
or spermidine. 
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Fong et al (1976) showed that the 'feed back' 
inhibition may involve the induction of a macromolecular 
inhibitor, the so-called 'antizyme'. Despite the fact 
that this 'antizyme' has been well characterized 
(Cannellakis et al, 1981) its precise role is not clear 
ever since the discovery ofposttranslational modifications- 
of ODC in mammalian and non-mammalian systems to an 
inactive form of ODC. Two posttranslational modifications 
have been found: a phosphorylated ODC (Kuehn and Atmar, 
1982; Sekar et al, 1982) and an ODC-putrescine conjugate. 
ODC from rat liver is capable of being post-translationally 
modified on its y-glutamyl side-chains by the addition 
of 4 moles of putrescine, a reaction catalysed by a 
transglutaminase (Russell and Manen, 1982; and reviewed 
by Allen, 1983). A polyamine-dependent kinase has 
been reported in many cell types that specifically 
phosphorylates ODC (Kuehn and Atmar, 1982; Sekar et 
al, 1982). 
Despite the fact that these post-translational. 
modifications lead to a loss of ODC activity, Russell 
and Manon (1982) showed that when the ODC-putrescine 
conjugate was added to a preparation of rat liver 
nuclei (in vitro), there was a subsequent increase 
in RNA polymerase I activity. Allen (1983) put forward 
a hypothetical regulatory role for ODC incorporating 
a role for the ODC-putrescine conjugate. 
In mammalian cells, SAM decarboxylation is also 
regulated by polyamines. The enzyme is activated by 
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putrescine and inhibited by spermidine so that the supply 
of S-(5'-adenosyl)-3-methylthiopropylamine is regulated 
by the requirement for spermidine and the availability 
of putrescine (Pegg, 1984). A detailed review of 
polyamine and ODC regulation is given by Canellakis 
et al (1979). 
Polyamine synthesis and the cell cycle 
Polyamines and their biosynthesis are closely 
associated with the cell cycle (reviewed by Tabor and 
Tabor, 1976; Maudsley, 1979; Heby, 1981; Pegg and McCann, 
1982; Allen, 1983). Early studies suggested that 
some cells required exogenous polyamines to achieve 
maximu m growth-rate (as reviewed by Heby, 1981). 
Heby et al (1982) showed that cellular putrescine, 
spermidine, and spermine increased progressively as 
the cell cycle proceeded from G1 to mitosis, in a manner 
reflecting the order of biosynthesis of these polyamines. 
Heby et al (1982) also showed that spermidine levels 
of cells in culture showed a direct linear correlation 
with their growth rate. They interpreted this result 
as indicating that the accumulation of spermidine is 
directly associated with cell replication. They also 
showed that a high content of putrescine and spermidine 
increased and that a low content restrained, the growth- 
rate; they concluded that putrescine and spermidine 
played a part in the regulation of the cellular growth- 
rate (Heby, 1981; Heby et al, 1982). However, Allen 
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(1982) pointed out that the accumulation of polyamines 
in cells during the cell cycle may be accounted for 
by the concurrent increase in cell volume. For all 
that, in a study using Chinese hamster ovary (CHO) 
fibroblasts synchronised by mitotic detachment, Heby 
and Anderson (1980) (as. reviewed by Pegg and McCann, 
1982) found that polyamine synthesis started in mid 
G1 and polyamines began to accumulate towards the end 
of the G, phase. Polyamine synthesis peaked as DNA 
synthesis (S phase) began. The levels of putrescine, 
spermidine and spermine, and ODC activity decreased 
markedly during mid-S but rose again towards the end 
of the S-phase. Just before cell division, ODC activity 
and the level of polyamines reached a second peak, 
falling rapidly after mitosis. It was concluded that 
the two peaks ofODC activity and polyamine-accumulation 
may be connected with the preparation of cells for 
DNA synthesis and division. Similar results, using 
rat hepatoma cells, were reported by McCann et al (1975). 
However it has ýeen reported that cells in Gl, that 
have been rendered unable to synthesize polyamines, 
have enough polyaminesto allow some DNA synthesis to 
occur (as reviewed by Allen, 1983). 
JWnne et al (1975) studied the effect of polyamines 
on the in vitro transcription cf.. DNA and chromatin. 
They showed that physiological levels of spermidine 
and spermine stimulated transcription by DNA-dependent 
RNA polymerases by increasing the rate of RNA-chain 
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elongation whereas higher concentrations inhibited 
chain-elongation. They suggested that this mechanism 
indicated a possible role for these polyamines as intra- 
cellular regulators of transcription. 
The effects of polyamine depletion, induced 
by the. use of inhibitors of polyamine synthesis, on 
the stages of the cell cycle have been investigated 
and reviewed by Pegg and McCann (1982) and Allen (1983). 
Briefly, non-transformed cells, depleted of polyamines, 
eventually arrest in G1 whereas transformed cells similarly 
depleted of polyamines, are able to progress to S or 
G 2' Sunkara et al (1979 a, b) partly resolved this 
difference between normal and transformed cells and 
postulated that polyamines may play a role in stabilizing 
cellular structures, as for example during the mitotic 
process. Evidence for this stems from the finding 
that transformed cells (CHO and HeLa) depleted of poly- 
amines by MGBG or a-methylornithine, had altered chromo- 
some condensation and reduced cytokinesis (Sunkara 
et al, 1979, a, b). H61tt; Y and Pohjanpelto (1983) 
showed that CHO cells, depleted of polyamines in this 
manner, undergo mitosis at a reduced rate. 
In a wide variety of animal tumours there is 
a general pattern of increased putrescine and spermidine 
synthesis; this is also observed in other types of 
hyperproliferative conditions, such as the skin abnorm- 
ality, psoriasis. 
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Polyamines and Differentiation 
There is a lot of good evidence that polyamines 
play a role in mammalian cell differentiation, and 
that interference with polyamine biosynthesis can influ- 
ence differentiation (reviewed by Heby, 1981; Pegg and 
McCann, 1982). For example DFMO has profound effects 
on embryonic development in a wide variety of species 
(cited by Pegg and McCann, 1982). 
Polyamines have been implicated in the complex 
process of bone differentiation. Briefly, Rath and 
Reddi (1981) showed enhanced polyamine synthesis during 
osteogenesis, using a matrix-induced endochondrial 
bone formation model. Takano et al (1982) showed 
a requirement for polyamines during the differentiation 
of rabbit costal chondrocytes in culture and that exposure 
to HAVA blocked glycosaminoglycan synthesis in these 
cultured chondrocytes. These effects were reversed 
by the addition of putrescine. An important finding 
by these authors was that these effects were observed 
in non-proliferating culture and thus indicated that 
polyamines are not required solely for cell growth. 
In Chapter IX the effects of vitamin B6 deficiency 
on fracture healing are studied. 
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CHAPTER V 
METHODS 
The main procedures used in these studies were 
(A) those for preparing sections; and (B) those for 
measuring the amount of chromogenic product produced 
per cell. The use of quantitative polarized light 
microscopy is discussed in Chapter X. The materials 
and methods used for each study are given in the 
relevant chapters in this thesis. 
A. Preparatory Procedures. 
1. Chilling. 
The basis of the chilling procedures has been 
discussed by Chayen and Bitensky (1968). It depends 
on chilling to -70*C, to produce supercooling (Lynch 
et al, 1966). and then sectioning in a cryostat with 
the cabinet temperature at -25'C and with the knife 
cooled further by packing solid carbon dioxide around 
its. shaft, to dissipate the heat of the cutting onto 
the knife and away from the tissue (e. g. Chayen, 1980). 
These procedures were developed for soft tissues. 
For bone, I found it necessary to-coat the specimen 
with a 5% solution of polyvinyl alcohol (PVA) before 
it was chilled. This was beneficial as it prevented 
the bone from cracking during the chilling procedure. 
The 5% PVA also successfully filled the marrow spaces 
in the bone especially in the large human pieces and 
in doing so, bound the sparse trabeculae. Finally 
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when the bones were mounted on chucks prior to sectioning 
(Chayen et al, 1973), the pieces were embedded in a 
solution of 5% PVA: the original coating protects the 
tissue from thawing. This embedding of the bone in 
the 5% solution of PVA greatly enhances the ease with 
which sections can be cut. 
Sectionin 
For this work, a tungsten carbide-tipped knife, 
set in a special Jung 1130 heavy duty rotary microtone 
(in a Bright's cryostat) was used to section fresh, 
unfixed, undemineralized bone (as described fully by 
Johnstone etal, 1972; Johnstone, 1979). As in the 
soft tissue procedure, the knife was cooled with solid 
carbon dioxide and the cabinet was maintained at -25 
to -300C. 
In conventional soft tissue cryostat microtomy, 
the sections were flash-dried off the knife (Chayen _ 
et al, 1973). This was possible with the small sections 
of rat growth-plate described in Chapter VI. However 
with the larger pieces of bone used in the various 
studies in this thesis, it was necessary to lightly 
press the slide against the knife to pick the section 
off. It proved beneficial to coat the knife with a 
thin layer of low temperature oil: this prevented the 
section from sticking to the knife. 
Cytochemical reactions. 
The procedures were the same as for cryostat 
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sections of fresh tissue (Chayen et al, 1973). Details 
of the reactions are given in the relevant chapters 
and in the Appendix. 
A major difference is the fact that the Gomori 
calcium-trapping method for alkaline phosphatase activity 
cannot be applied to-sections of undemineralized bone 
because of the calcium-content of the bone. It was 
replaced by the naphthol phosphate method (described 
by Chayen et al, 1973) as was used by Shedden et al 
(1976). The substrate, (1-napthol acid phosphate 
(sodium salt) was used at a considerably lower concen- 
tration (1/5th) compared with that used for other 
tissues, because of the exceptionally high alkaline 
phosphatase activity in growing bone. 
The use of Alcian blue to stain for glycosamino- 
glycans (GAGs) by the critical electrolyte method of 
Scott and Dorling (1965; and as described by Chayen 
et al, 1973) is described fully in Chapter X. 
B. Measurement. 
The chromogenic reactions were measured by scanning 
and integrating microdensitometry by means of a Vickers 
M85 or M85A microdensitometer. The theory of the 
procedure has been described by Chayen (1978; 1980); 
possible pitfalls have been discussed by Bitensky (1980). 
For the studies on bone a x40 objective was used and 
a flying spot that had a diameter of 0.4 Wm in the plane 
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of the section. In Chapter XI(Develoýment of a 
Method for Measurement of Na+ K+-ATPase) a x1OO 
objective was used in part of the study. Details 
of the exact procedures used for each study are given 
in the relevant place. 
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CHAPTER VI. 
OXIDATIVE METABOLISM OF NORMAL BONE: 
THE PARADOX OF 'AEROBIC GLYCOLYSIS'. 
PART I. CYTOCHEMICAL STUDIES ON 
FATTY ACID OXIDATION. 
Introduction 
Although many cytochemical methods have been developed 
for assaying the activity of enzymes that oxidize suga r- 
based substrates, virtually no methods exist for those 
that are involved in the oxidation of fatty acids. 
Yet fatty acids are oxidized to carbon dioxide and water 
in almost all tissues of the vertebrates (Lehninger, 
1976); in some, fatty acids comprise around half, or 
more, of the substrates for the production of energy. 
Thus even in rat liver, up to about 40% of the energy- 
production comes from fatty acids; in well oxygenated 
cardiac tissue, fatty acid oxidation accounts for 60%- 
70% of the total oxidative activity, increasing in certain 
conditions (Neely et al, 1972) or becoming suppressed 
in anoxic conditions (Neely and Morgan, 1974). 
There was no information as to whether cells of 
bone, or of the associated cartilage of the growth plate, 
oxidize fatty acids as a source of energy or not. It 
was therefore of some moment to develop a method for 
assaying fatty acid oxidation to test this question. 
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Consequently, Part I of this Chapter will be devoted firstly 
to a description of the development of a quantitative 
cytochemical assay of the activity of one of the enzymes 
involved in fatty acid oxidation, based largely on the 
method developed by Chambers et al (1982) and done during 
that work, and secondly to the validation of this method 
as applied to bone and to the growth plate. In the 
second part of this Chapter, the peculiar metabolic 
paradox of 'aerobic glycolysis' in bone and cartilage- 
will be considered. 
Oxidation of Fatty Acids. 
Briefly the oxidation of fatty acids is as follows. 
Fatty acids enter the cell and are activated by formation 
of a CoA derivative. These acyl CoA derivatives are 
unable to permeate through the mitochondrial membrane 
into the mitochondria, to the site of fatty acyl CoA 
oxidation. The acyl group is transferred to the carrier 
molecule carnitine. The movement of the acyl carnitine 
across the membranes of the mitochondria is mediated 
by. acyl transferases (Fritz, 1963; Fritz and Yue, 1963). 
Then the acyl group from the fatty acyl carnitine is 
transferred to intramitochondrial CoA, occurring on 
the inner surface of the inner membrane of the mitochondrion, 
releasing carnitine. The acyl CoA derivatives are 
oxidized by a sequence of reactions in which the fatty 
acyl chain is shortened by O-oxidation, involving the 
removal, of two carbon atoms at a time. The inter- 
mediates in these reactions are CoA derivatives. 
85 
This shortening of the fatty acid chain by two 
carbon atoms requires 4 steps: 
(1) 
(fatty acyl-CoA-thioester) 
( 3') (2) 
R CH2 CH2 CH2 COSCoA + FAD 
acyl CoA > RCH2 CH = CHCOSCoA + 
FADH2 
dehydrogenase (a, a- unsaturated acyl-CoA) 
(2) 
R CH2 CH = CH COSCoA + 
H20 
enovl CoA 
(3) (2) 
R CH2 CH OH CH2 COSCoA 
transferase (0-hydroxyacyl-CoA) 
(3) 
RCH2 CHOHCH2 COSCoA + NAD 
hydroxyacyl CoA (3) (2) 
RCH2 CO CH2 COSCoA 
dehydrogenase 
+ NADH +R+ 
(a-ke toacyl-CoA) 
G (Z) 
RCH2 CO CH2 COSCoA + HSCoA 
acetyl CoA %%, RCH2 CO SCoA 
acetyltransferase (fatty acyl-CoA) 
CH3 COSCoA 
The long-chain saturated fatty acyl-CoA product, 
having two fewer carbon atoms than the original fatty 
acid, becomes the substrate for another ý-oxidation. 
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Thus at each passage through this spiral the fatty acid 
chain loses a two-carbon fragment as acetyl CoA. 
During the dehydrogenation steps the hydrogen atoms 
removed enter the respiratory chain. Each molecule 
of FADH2 donates a pair of reducing equivalents to 
ubiquinone of the respiratory chain: two molecules 
of ATP are generated from ADP and phosphate during the 
transport of the reducing equivalents to oxygen and 
the coupled phosphorylations. Similarly each molecule 
of NADH formed donates a pair of reducing equivalents 
to the NADH dehydrogenase of the respiratory chain: 
the subsequent transport of the reducing equivalents 
to oxygen results in the formation of 3 ATP molecules 
from ADP and phosphate. Thus 5 molecules of ATP are 
formed per molecule of acetyl-CoA removed during each 
a -oxidation. The other product, acetyl CoA then enters 
the Krebs' cycle and is oxidised to C02 and H20. 
The overallequation (Lehninger, 1982) for the complete 
oxidation of palmitic acid (16 carbons) for example 
is: 
Palmitic acid + 2302 + 129 Pi + 129 ADP 
16 C02 + 145 H20 + 129 ATP 
i. e. 35 ATPs from 7 cycles of a-oxidation and 96 from 
8 oxidations of acetyl CoA by the Krebs' cycle. Two 
molecules of ATP are utilized to form palmitoyl CoA. 
About 40% of the standard free energy of oxidation 
of palmitic acid is recovered as high-energy phosphate. 
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Development of the Method 
Background 
In conventional biochemistry the activity of 
lp 
hydroxyacyl-coenzyme A dehydrogenase (step 3) is assayed 
by measuring the reversal of the reaction, i. e. the 
reduction of aceto-acetyl-coenzyme A by NADH. However 
this substrate is very expensive and has now been taken 
off the market because of the carcinogenic properties 
of the intermediates used in its synthesis. Even when 
this substrate was used, the less expensive N-acetyl 
cysteamine derivative was often used instead of coenzyme 
A. The aceto-acetyl-cysteamine was about 5 times less 
efficient so that increased concentrations of the sub- 
strate had to be used to compensate (Biochemica Catalogue, 
15336EHAB ). Unfortunately this reaction, involving the 
oxidation of NADH, cannot be linked to a cytochemical 
chromogenic reaction. These problems were overcome 
by the synthesis of a new substrate (by Mr. G. T. B. Frost, 
Sigma), namely DL-S-a-hydroxybutyryl-N-acetyl cysteamine. 
The reaction is thus: 
CH3 CF12CH2 COO-cysteamine + NAD+ 
hydroxybutyryl cysteamine 
CHI CO CH2 COO-cysteamine +NADH 
acetoacetyl cysteamine 
and the reducing equivalents from the NADH can easily be 
transferred directly or indirectly by way of an inter- 
mediate electron acceptor (e. g. PMS or menadione) to a 
tetrazolium salt. The resulting reduced tetrazolium, a 
formazan, is a purple precipitate that can be measured 
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quantitatively using a scanning and integrating micro- 
densitometer. 
Materials and Methods 
Metatarsals were removed from 50 g female Wistar 
rats, killed by cervical dislocation. The metatarsals 
were cut in half and the distal half, with the epiphyseal 
plate, was removed. Two metatarsals from each of six 
rats were used in this study. The bones were dipped 
in 5% polyvinyl alcohol before being chilled in n-hexane 
at -65 to 70*C. These techniques have been fully described 
by Chayen et al (1973) and in Chapter V. The bones 
were sectioned (10 pm) on a Jung 1130 rotary microtome 
set in a Bright's cryostat (cabinet temperature -25 to 30*C, 
with the knife cooled with solid carbon dioxide: Johnstone 
et al, 1972; Johnstone, 1979). 
The reaction-medium contained 0.6% (10 mM) chloroform 
purified neotetrazolium chloride (Serva) in a 30% (w/v) 
solution of polyvinyl alcohol (grade G04/140; Wacker 
Chemicals Ltd., Walton-on-Thames, Surrey, U. K. ) in glycyl- 
glycine buffer (50 mM; pH 8.0). Two intermediate electron- 
acceptors were studied, namely phenazine methosulphate 
and menadione (2-methyl-1-4 naphthoquinone). The reaction 
medium also contained NAD as the required co-factor. 
Sodium nitroprusside was included to inhibit the effects 
of any acetyl cysteamine liberated by non-enzymic hydrolysis 
of the substrate. Sodium nitro-prusside forms a complex 
with any cysteamine released during the reaction. The 
reaction-medium also contained either the substrate 
DL-S-hydroxybutyryl-N-acetyl cysteamine or cysteamine 
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(0-mercapto ethylamine )f or control experiments. The 
hydroxybutyryl cysteamine substrate is a viscous 
liquid, and about 90 - 95% pure. The menadione 
and the substrate were first dissolved in a small volume 
of ethanol to give a final concentration of alcohol 
in the reaction-medium of 1%. 
The reactions were done at 37' C in an atmosphere 
of nitrogen, since oxygen competes with neotetrazolium 
chloride for reducing equivalents. 
Measurement. The coloured formazan produced in the 
sections was measured with a Vickers M85 scanning and 
integrating mi. crodensitometer with a x40 objective and 
a flying spot that had a diameter of 0.4- lim in the 
plane of the section, and at a wavelength of 585 nm 
(Butcher and Altman, 1973). The mask encompassed one 
cell of each type studied. Thus the results were expressed 
as units of extinction (M. I. E. xlOO) per cell; correction 
had to be made for the time of reaction. 
The cell types that were measured were as follows: 
1. chondrocytes in the (a) hypertrophic zone 
(b) proliferating zone 
(c) resting zone 
2. osteoblasts in the metýaphysis 
3. osteocytes in the metaphysis 
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Results 
Initial work on the cytochemical demonstration 
of a-hydroxyacyl CoA dehydrogenase activity had been 
done on dog cartilage (Nahir, 1983). The concentra- 
tions of the reactants used in that study were used 
as a basis for the present optimization experiments 
on rat bone. The basic reaction-medium contained 30% 
PVA (G04/140 grade) in 0.05 M glycyl-glycine buffer, 
pH 8.0, to which was added 0.6% neotetrazolium chloride; 
5 mM sodium nitroprusside; 3 mM menadione; and 2 mM 
NAD +. The final pH after the addition of the sub- 
strate (or cysteamine as a control) was pH 8.5. The 
reaction-medium was saturated with nitrogen and warmed 
to 37' C. Preliminary experiments showed that, in 
bone, 45 minutes reaction-time gave an adequate level 
of activity for microdensitometric measurements. 
Optimal Concentrations of Reactants 
Concentrations of substrate and cysteamine. Measure- 
ments made in osteoblasts and chondrocytes, in the growth 
plate, with increasing concentrations of substrate 
produced typical substrate-activity graphs with a rapid 
initial rise in activity at lower concentrations (up 
to 5- 10 mM)and a much slower rise in activity at higher 
concentrations, up to 100 mM (Fig. VI. 1). 
Because of the small differences found at higher 
concentrations, and also the high cost of the substrate, 
37 mM was taken as an adequate compromise. 
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Fig. VI. 1 Upper graph. The activity of hydroxyacyl dehydrogenase 
(MIE x 100; mean ± SEM) in osteoblasts (open circles) 
and chondrocytes (closed circles) with increasing 
concentrations of the substrate. 
Fig. VI. 2 Lower graph. Sections of growth plate incubated with 
increasing concentrations of cysteamine (in place of the 
substrate DL-S-a hydroxybutyryl-N-acetyl cysteamine); 
this 'activity' would indicate the maximum 'non-specific' 
reduction of the tetrazolium salt by spontaneous hydrolysis 
of the substrate to yield free cysteamine. Chondrocytes: 
lower; osteoblasts: upper. 
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The substrate can be hydrolysed at the pH of the 
reaction medium (8.5) to yield free N-acetyl-cysteamine, 
that in the presence of an intermediate electron acceptor, 
could reduce the neotetrazolium chloride. The amount 
of cysteamine liberated in the reaction-medium over 
a period of 90 minutes, measured spectrophotometrically 
(Jocelyn, 1972), gave values equivalent to 3.1,4.0 
and 2.7 mM of free cysteamine (in 3 separate determination5). 
When sections were reacted with various concentr at- 
ions of cysteamine instead of the substrate, the "activity" 
recorded was maximal with 2.5 mM cysteamine. This 
level of activity persisted up to 10 mM, but at higher 
concentrations the "activity" dropped. At 50 mM no 
activity was recorded (Fig. VI. 2). 
Because the greatest concentration that was actually 
found in the reaction-medium did not exceed 5 mM, this 
concentration was used for 'control' reactions. 
Optimal concentration of NAD+. Fig. VI. 3 shows the 
graph relating activity to various concentrations of 
cofactor, measured in osteoblasts and chondrocytes. 
The activity was broad with around 2 mM NAD + giving 
maximum activity. Higher concentrations showed little 
sign of inhibition. 
Optimal__pH. The optimal PH was PH 8.5 for osteoblasts 
and PH 8.0 for chondrocytes (Fig. VI. 4). In the final 
method the pH of the medium was adjusted to pH 8.9 before 
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Fig. VI. 3 ACtiVity of hydroxyacyl dehydrogenase (MIE x 100; " mean 
SEM; solid line) in osteoblasts (upper graph) and 
chondrocytes (lower graph) with increasing concentrations 
Of NAD. The activity recorded with cysteamine in the place 
of the substrate is indicated by the dotted line. 
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Fig. vi. 4 The hydroxyacyl dehydrogenase activiety (MIE x 100: 
mean ± SEM; 'open circles) at various pH values measured 
in osteoblasts (upper graph) and chondrocytes (lower 
graph). Cysteamine in place of the substrate; filled 
circles. 
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the substrate, or cysteamine, was added to it and brought 
down to pH 8.5 with IM HC1. 
Optimal concentration of neotetrazolium 
chloride (NT). The concentration of this final hydrogen- 
acceptor had a strong influence on the activity recorded. 
Measurements in the osteoblasts showed mean extinction 
of 0.29 with 0.6% NT (10 mM); maximal (0.32) at 0.9% 
NT (15 mM): there was some inhibition (extinction 
of 0.23) at 1.2% NT (20 mM). A concentration of 0.6% 
NT was used in all subsequent studies (Fig. VI. 5). 
Optimal concentration of nitroprusside. Nitroprusside 
increased activity in osteoblasts and in chondrocytes 
up to a concentration of 5 mM with considerable inhibition 
at higher concentrations (Fig. VI. 6). There was total 
inhibition of activity when 50 mM nitroprusside was 
used. A concentration of 5 mM was used in all subsequent 
studies. 
Optimal concentration of menadione or of 
phenazine methosulphate (PMS). Menadione is the preferred 
intermediate hydrogen-acceptor for this reaction (Chambers 
et al, 1982). Menadione forms an adduct with thiols 
(Olson et al, 1978) so that it might be expected to 
react with any cysteamine liberated by the spontaneous 
hydrolysis of the substrate. Increasing the concentration 
of menadione (Fig. VI. 7) up to 3 mM, increased the activity 
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Fig. VI. 5 Hydroxyacyl dehydrogenase activity (MIE X 100; mean ± SEM) 
with different concentrations of neotetrazolium chloride 
measured in osteoblasts (upper graph) and chondrocytes 
(lower graph). The activity with cysteamine in the place 
of the substrate is shown by the dotted line. 
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Fig. VI. 6 The effect of increasing concentrations of sodium 
nitroprusside on the activity of hydroxyacyl dehydrogenase 
(MIE x 100; mean ± SEM) in osteoblasts (closed circles) 
and chondrocytes (open circles); cysteamine in place of 
substrate is shown by the dotted line. 
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Fig. VI. 7 The effect of increasing concentrations of menat-Ilione on 
the activity of hydroxyacyl dehydrogenase (MIE x 100; 
mean ± SEM) in osteoblasts (upper graph) and 
chondrocytes (lower graph); cysteamine in place of 
substrate is shown by the dotted lines. 
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in the osteoblasts and chondrocytes. There was no 
further increase, or inhibition, at concentrations up 
to 5 mM. 
A concentration of 3 mM was used in all subsequent 
studies. 
Fig. VI. 8 shows a graph of enzyme activity with 
various concentrations of the intermediate hydrogen- 
acceptor, phenazine methosulphate (PMS). Maximal 
activity was found at a concentration of 1 MM. 
Linearity of response. The reaction was linear with 
time over the first 45 minutes (Fig. VI. 9). Over the 
subsequent 20 minutes there was only a small increase 
in activity. With longer reaction times there was 
no increase in activity. 
Cell-types that show activity. When sections of bone 
were incubated in the final reaction-medium for 45 
minutes at 37' C there was 0-hydroxyacyl dehydrogenase 
activity in all the cell-types of normal bone, including 
the osteocytes deeply embedded in adult bone; with 
most cytochemical procedures, these cells show remarkably 
little metabolic activity. 
Discussion 
With the development (by Mr. G. T. B. Frost) of 
this new substrate, namely DL -S--O-hydroxybutyryl-N- 
acetyl cysteamine and this method for measuring fatty 
acid oxidation, it has been possible to demonstrate, 
for the first time, that all the cells of the growth plate, 
even the differentiated osteocytes, are capable of oxidizing 
fatty acids. 
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Fig. VI. 8 The effect of increasing concentrations of phenazine 
methosulphate (in place of menadione) on hydroxyacyl 
dehydrogenase activity (MIE x 100; mean ± SEM) measured 
in osteoblasts (upper graph) and chondrocytes (lower 
graph). Dotted lines: cysteamine in place of the 
substrate. 
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Fig. VI. 9 Hydroxyacyl dehydrogenase activity (MIE X 100; 
mean ± SEM) with increasing times of incubation 
measured in osteoblasts (upper line). Lower line: activity 
with cysteamine in place of the substrate. 
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PART II. OXIDATIVE METABOLISM 
OF BONE AND CARTILAGE 
Introduction 
Bone and cartilage are capable of producing consider- 
able amounts of lactic acid from glucose (Hekkelman, 
1973; Neuman, 1977; Stockwell, 1979; Maroudas, 
1980). Cartilage is very avascular and therefore relatively 
anaerobic which could explain the high glycolytic activity. 
However, bone is a highly vascular tissue so this argument 
cannot apply. Also, bone and cartilage show the phenomenon 
of "aerobic glycolysis": that is a high rate of formation 
of lactic acid from glucose, even when studied, in vitro, 
at high oxygen tensions in the medium, effectively defying 
the Pasteur effect. This phenomenon of aerobic glyco- 
lyses is not peculiar to bone and cartilage, but occurs 
in many cell-types, e. g. in erythrocytes, renal medulla, 
striated muscle, tissues of the foetus, intestinal mucosa, 
retina and particularly in growing malignant cells (Krebs, 
1972; Eigenbrodt and Glossmann, 1980). 
In bone it is believed that lactate production 
is the principle mechanism by which the bone cells control 
the effluxes of ions from the bone fluid (Neuman, 1977). 
So far, no single cause for the high glycolytic activity 
of tumours has been identified, although it has been 
claimed by Eigenbrodt and Glossmann (1980) that 'aerobic 
glycolysis' may be a prerequisite for the synthesis 
of 5-phosphoribose-1-pyrophosphate and of nucleic acids; 
this. is particularly apparent in tumour cells which 
have an increased demand for precursors of nucleic acid 
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synthesis (Eigenbrodt and Glossmann, 1980). 
The current view (Eigenbrodt and Glossmann, 1980) 
is that the inhibition of glycolysis by oxygen is due 
to the allosteric inhibition of phosphofructokinase 
by mitochondrial ATP from the Krebs' cycle (Krebs, 1972). 
Under sufficient oxygen supply normal cells adjust their 
pyruvate production to the level of acetyl-CoA consump- 
tion by the Krebs' cycle and their energy requirement. 
The inhibition by ATP of phosphofructokinase results 
in a decrease in the conversion rate of fructose 6- 
phosphate to fructose 1,6 diphosphate. Fructose 1,6 
diphosphate is rapidly converted to pyruvate so that 
steady state levels of fructose 1,6 diphosphate are 
very low and not sufficient to overcome the ATP inhib- 
ition of phosphofructokinase. Glucose 6-phosphate 
accumulates as a result of this inhibition and blocks 
its own synthesis by hexokinase. In this way mito- 
chondrial ATP production regulates the glycolytic 
sequence (Krebs, 1972). Citrate and Mg2+ also inhibit 
phosphofructokinase. Two kinds. of activators of phospho- 
fructokinase can be distinguished; enhancers which 
increase the activity of the enzyme in the absence of 
inhibitors and deinhibitors which counteract the effects 
of inhibitors. Passonneau and Lowry (1964) classified 
the inhibitors, enhancers and deinhibitors (Table VI. 1). 
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Table VI. 1 Factors which influence phosphofructokinase 
activity. 
Deinhibitors of 
Inhibitors Enhancers ATP, citrate or 
M2+ 
ATP NH 4+ Fructose diphosphate 
Citrate K Cyclic 3'-5'-AMP 
Mg 2+ Pi 5'-AMP 
5'-AMP ADP 
Cyclic 3'-5'-AMP Fructose 6-phosphate 
ADP Pi 
Fructose diphos- 
phate 
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Under anaerobic conditions, mitochondrial ATP 
production from acetyl CoA is blocked. Thus ATP 
levels decrease; phosphofructokinase is de-inhibited; 
and fructose 1,6-diphosphatase is blocked by the increased 
AMP levels. The accumulation of fructose 1,6-diphos- 
phate increases the phosphofructokinase activity. 
The fall in glucose 6-phosphate increases hexokinase 
activity. Therefore, under totally anaerobic 
conditions, glycolytic activity can be enhanced, wittv 
a concomitant increase in the oxygen-independent 
production of ATP by the Embden-Meyerhof pathway. 
However, the activity of glyceraldehyde 3-phosphate 
dehydrogenase (GAPD) generates NADH. Normally it may 
be that this is reoxidized to NAD for example by the 
glycerophosphate-hydroxyacetone phosphate shuttle. 
However ultimately, this shuttle too is dependent 
on th, e-, presence of an adequate supply of oxygen, in 
the mitochondria,, for the oxidation of the reducing 
equivalents of this shuttle. Consequently, under 
strictly anaerobic conditions, the NADH, generated by 
GAPD activity, is used to reduce pyruvate to lactic 
acid which is excreted from the cell. 
To explain the high production of lactic acid 
in bone and cartilage, under normal aerobic conditions 
and oxidative metabolism by the Krebs' cycle, with a 
functioning mitochondrial electron-transport chain, 
the step by which pyruvate is oxidized to acetyl CoA 
may be crucial. The pyruvate dehydrogenase complex 
is fundamental in determining the fate of pyruvate 
produced by glycolysis (Fig. VI. 10). The complex is 
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Fig. VI. 10 Diagram of the oxidative metabolic pathways indicating 
the enzymes tested or discussed. 
1: glucose 6-phosphate dehydrogenase 
2: glyceraldehyde 3-phosphate dehydrogenase 
3: pyruvate dehydrogenase complex 
4: hydroxyacyl dehydrogenase 
5: lactate dehydrogenase 
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regulated by phosphorylation and dephosphrylation, by 
the enzymes pyruvate dehydrogenase kinase and pyruvate 
dehydrogenase phosphatase, respectively. The kinase 
catalyzes the ATP-dependent phosphorylation of one of 
the subunits of pyruvate dehydrogenase, a reaction which 
requires Mg2 +; this phosphorylation inactivates the enzyme. 
The inactive enzyme is reactivated by the phosphatase 
by hydrolytic removal of the inhibitory phosphate groups, 
again in the presence of Mg2+. 
The oxidative decarboxylation of pyruvate to acetyl 
CoA and Co2 requires three different enzymes and five 
different co-enzymes organized into a multienzyme complex. 
The overall equation is: 
Pyruvate + NAD ++ CoA > acetyl CoA + NADH +H++ C02 
in the presence of thiamine pyrophosphate (TPP) and Mg' 
The reactions are as follows: 
1) Pyruvate + TPP ENZ (1) --> C02 + Hydroxyethyl-TPP ENZ (1) 
where ENZ (1) is pyruvate decarboxylase. 
2) Hydroxyethyl-TPP ENZ (1)\ -, Acetoin + TPP ENZ (1) 
3) Hydroxyethyl-TPP ENZ (1) + LIP (S. S) ENZ (2)- 
N, 
N- 
Acetyl-CoA + LIP (SH. SH) ENZ (2) 
where ENZ (2) is dihydrolipoate acetyltransferase and 
LIP (S. S) and LIP (SH. SH) are lipoate and acetylhydro- 
lipoate. 
4) LIP (SH. S-acetyl) ENZ (2) + CoA 
acetyl-CoA + LIP (SH. SH) ENZ (2) 
where LIP (SH. SH acetyl) is dihydrolipoate. 
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ENZ (3) 
5) LIP (SH. SH) ENZ (2) + NAD 
LIP (SS) ENZ (2) + NADH 
where ENZ (3) is dihydrolypyl dehydrogenase 
(Lehninger, 1975; Kerby et al, 1975). 
The activity of this complex is inhibited by the 
products of fatty acid oxidation, particularly by acetyl 
CoA (Kerby et al, 1976; Linn et al, 1969). Kerby et al 
(1975) came to the conclusion that increasing ratios of 
NADH /NAD+ and of acetyl CoA / CoA favour phosphorylation 
and inactivation of pyruvate dehydrogenase. Kerby et al 
(1975) studied alloxan-diabetes where pyruvate oxidation 
is inhibited and postulated that the cause was an enhance- 
ment of fatty acid oxidation. 
It therefore seemed appropriate to try to evaluate 
the oxidative metabolism of the various cellular compo- 
nents of bone and of cartilage to determine whether 
these tissues could oxidize fatty acids at such a rate, 
that the acetyl CoA, so produced, might become a factor 
in controlling the pyruvate dehydrogenase activity. 
Materials and Methods 
The materials and methods are identical to those 
in Part I together with the measurements of one oxidative 
enzyme of each of the major pathways in the same region 
of the growth plate of the metatarsals. The selected 
enzymes were as follows. 
(1) Embden-Meyerhof pathway : glyceraldehyde 3-phosphate 
dehydrogenase (GAPD); 
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(2) Pentose-shunt: glucose 6-phosphate dehydrogenase (G6PD); 
(3) Tricarboxylic acid cycle : succinate dehydrogenase (SDH); 
(4) Lactate dehydrogenase (LDH); 
(5) Fatty acid oxidation: hydroxyacyl dehydrogenase 
(HOAD) (as described in Part I). 
For these reactions, the specific reactants were as 
follows: 
Lactate dehydrogenase: sodium lactate, 60 mM; NAD+, 2.5 mM. 
Glucose 6-phosphate dehydrogenase: glucose 6-phosphate, 
disodium salt, 5mM; NADP+, 3mM. 
Glyceraldehyde 3-phosphate dehydrogenase: fructose 1-6 
diphosphate, 5mM; aldolase, 10 units ml- 
I NAD +, 1.5 mM. 
Succinate dehydrogenase: sodium succinate, 50 mM. 
0-hydroxyacyl dehydrogenase: NAD+ (2 mM); sodium nitro- 
prusside (5 mM); menadione (3 mM) DL-S-0 hydroxybutyryl- 
N-acetyl cysteamine (37 mM) or cysteamine (5 mM). 
Except for the studies on succinate dehydrogenase, all 
the reaction-media contained 0.6% (10 mM) chloroform- 
purified neotetrazolium chloride (Serva) in a 30% (w/v) 
solution of polyvinyl alcohol (grade G04/140; Wacker 
Chemicals Ltd., Walton on Thames, Surrey, U. K. ) in 
glycyl-glycine buffer (50 mM; pH 8.0). 
For demonstrating the activity of succinate dehy- 
drogenase, which is tightly bound within the mitochondria, 
a 0.1 M phosphate buffer, pH 7.8, was used. Except 
for the demonstration of hydroxy-acyl dehydrogenase 
activity, the media contained the intermediate hydrogen 
acceptor, phenazine methosulphate (0.7 mM) added to the 
medium just before use. All reactions were done at 37*C 
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in an atmosphere of nitrogen. The reactions were run 
for 45 minutes except for lactate dehydrogenase activity 
which was run for 10 minutes (the results being multi- 
plied by 4.5 for comparison). Over these reaction times, 
the responses were linear with time. 
Measurements. Again, measurements were as performed 
in Part I. The cell-types measured were again: 
chondrocytes in the resting, proliferating, and hyper- 
trophic zones of the growth plate; and osteoblasts ana 
osteocytes in the metaphysis. 
To test the oxidative activity in a tissue that 
does not show "aerobic glycolysis", small pieces (3x3x3 mm) 
of the liver from three female Wistar rats (200 g) were 
chilled in hexane at -65 to 70*C and sectioned at 10 pm 
in a Bright's cryostat. The same reactions were done 
on the liver sections as done on the metatarsals. 
The pentose-shunt involves the oxidation of glucose 
6-phosphate, NADP + being the obligate co-factor. if 
the system is to remain an active cycle, there must 
be a feed-back into the normal glycolytic pathway, supply- 
ing either fructose 6-phosphate or glyceraldehyde 3- 
phosphate (Krebs and Kornberg, 1957). This feed-back 
is mediated by the enzymes, transketolase and transal- 
dolase, and reflects the requirements of the cell for 
NADPH and ribose 5-phosphate. Thus the maximum activity 
of GAPD must be considered to be rate-limiting both 
for the pentose shunt and for the Embden-Meyerhof path- 
way. In fact, it reflects the maximum oxidation of 
glucose 6-phosphate by either route. 
In the Embden-Meyerhof pathway, the substrate- 
products of GAPD activity are finally converted to 
pyruvate. For this to be used by the Krebs' cycle, 
for the generation of ATP for the energy requirements 
of the cell, it is converted to acetate and linked to 
coenzyme A (CoA) to form acetyl-CoA. The oxidation 
of fatty acids yields acetyl-CoA directly. Thus the 
amount of activity of GAPD and HOAD is a measure of the; 
total amount of acetyl-CoA available for the Krebs' 
cycle. SDH activity can be taken as the maximum Krebs' 
cycle activity of which the cell is capable (Lehninger, 
1975). Thus the calculation of GAPD + HOAD activity 
minus SDH activity, gives a measure of whether there 
could be sufficient, or excessive amounts of acety17 
CoA produced in the cells, relative to the maximum amounts 
that could be dealt with by the Krebs' cycle. 
. 
Results and Discussion 
Oxidative Activities in the Various Cell-types 
of the Bone and Cartilage 
The results (Table VI. 2) showed firstly, that 
under the conditions used, the hydroxyacyl dehydrogenase 
activity (HOAD) was equivalent to that of glyceraldehyde 
3-phosphate dehydrogenase (GAPD); secondly the results 
showed that the succinate dehydrogenase activity was 
too small to accommodate the combined GAPD plus HOAD 
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activities; and thirdly, that there was a direct correl- 
ation (r = 0.85; p=0.02) between the lactate dehydro- 
genase activities (LDH) and the value of (GAPD + HOAD) - 
SDH. The activities recorded when these reactions 
were done in the absence of the substrate (or with the 
Icontrol' substrate) were so low that they were not 
taken into account. 
Oxidative Activities in Rat Liver 
In the liver, the activities recorded using the 
reaction media without exogenous substrate were apprec- 
iable (Table VI. 2). This probably reflects the consider- 
able store of endogenous substrates in liver. However, 
whether or not these "control" values were taken into 
account, the combined activities recorded for glycer- 
aldehyde 3-phosphate dehydrogenase and for hydroxyacyl 
dehydrogenase (GAPD + HOAD; Table VI. 2) were far less 
than that recorded for succinate dehydrogenase activity,, 
giving a negative value for (GAPD + HOAD) - SDH (Table 
VI. 2). 
General Conclusions 
Thus these results may advance our understanding 
of the oxidative metabolism of bone in the following 
ways: 
I. They indicate that fatty acid oxidation could 
play a significant part in the oxidative metabolism 
S of bone-cells, even of established osteocytes which, 
until the development of the HOAD reaction, appeared inert, 
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metabolically. If, indeed, fatty acids are used, to 
an appreciable extent, as one of the 'energy-fuels' 
of bone, it will become of interest to investigate 
whether fatty, pathological changes of bone are related 
to altered oxidative metabolic activities. 
2. They have suggested a different possible explan- 
ation of the phenomenon of 'aerobic glycolysis' that 
seems to pertain to bone, but which may have much wider 
implications. Thus it is postulated that lactic acid 'ý 
will be produced either when lack of oxygen causes blockade 
of the mitochondrial electron-transport chain as occurs 
under anaerobic conditions (and as discussed, above) 
or when the blockade occurs at the level of pyruvate 
dehydrogenase, as it is suggested might occur when the 
production of acetyl-CoA, by fatty acid oxidation, becomes 
disproportionately great. 
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CHAPTER VII 
FRACTURE-HEALING IN THE 
SPRAGUE-DAWLEY RAT 
Introduction 
Shedden et al (1976) showed that the closed 
fracture of the metatarsals of one leg of the Wistar rat 
formed a useful, and remarkably reproducible, model for 
studying fracture-healing. Unfixed undecalcified 
sections from closed fractures of Wistar rat metatarsals 
were examined for histological change and for metabolic 
activity at various times after the fracture. The 
fracture of the metatarsal. was produced by digital 
pressure. Histological changes were examined in 
sections stained with toluidine blue and quantitative 
cytochemistry was used for the study of the metabolic 
changes during the formation of the callus. As well 
as the study of the various cell types found in the 
callus, a detailed study was made of the histological 
and metabolic changes along the periosteum during 
the early development of the callus. 
The two enzymes studied were glucose 6-phosphate 
dehydrogenase (G6PD) and alkaline phosphatase (Alk Phos). 
The first enzyme, G6PD, is the first and rate-limiting 
step in the pentose shunt which is important for supplying 
NADPH, to be used as reducing equivalents in many bio- 
synthetic reactions, and in producing ribose phosphate 
for nucleic acid synthesis. Coulton (1977), in an 
116 
investigation into the relation between the pentose 
shunt and the effect of a wound in the skin of a guinea 
pig, found that the greatest glucose 6-phosphate dehydro- 
genase activity preceded DNA synthesis, as would be 
expected if this pathway is involved with biosynthetic 
processes required for cell proliferation. The fracture 
provides a situation where both cellular proliferation and 
biosynthesis of more specialized components are very 
active. The second enzyme, Alk Phos, is classically 
used as an indicator of bone-activity. Since Robison 
(1923) found alkaline phosphatase associated with bone 
formation, many workers have concentrated on determining 
the role of this enzyme in bone metabolism. Although 
it is obviously important in the development and growth 
of bone, in the maintenance of mature bone, and is 
affected by metabolic bone diseases, the actual function 
of this enzyme in bone is still not known. Some of 
the theories put forward as to its function are discussed 
by Bourne (1972); and Anderson (1976). 
These two enzymes, together with other relevant 
enzymes involved in bone metabolism are described in 
Chapter II. The cytochemical demonstration of the 
enzyme activities and their measurement are described 
in Chapter V and in the Appendix I. 
ng Healing-fractures in 
the Sprague-Dawley Rat 
As outlined in Chapter III, over the last few years 
bone has been shown to contain the amino acid residue 
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y -carboxyglutamic acid, in a small acidic protein that 
has been named osteocalcin (or bone Gla-protein). 
This comprises about 1% of the total bone-protein 
(Hauschka et al, 1975; Price et al, 1976a; Hauschka et 
al, 1978). The y-carboxylation of this protein is 
dependent on the vitamin K 1- cycle 
(Stenflow and Suttie, 
1977). There is considerable evidence that calcification 
of bone may involve this y-carboxylation of glutamate 
residues, as is found in osteocalcin (Hauschka et al, 
1975; Price et al, 1976a; Hauschka, 1978; Price et 
al, 1981a). It has been claimed that the anticoagulant, 
dicoumarol, inhibits the vitamin K-cycle by blocking 
the conversion of the vitamin-K epoxide back to the 
quinone (Whitlon et al, 1978). 1 therefore wanted to 
test the relevance of this cycle in ossification by 
feeding dicoumarol to rats in which a closed fracture 
of the metatarsal had been induced. However it was 
found that the Wistar rats, used by Shedden and colleagues, 
were too sensitive to dicoumarol: they died apparently 
from the anticoagulant effect. Sprague-Dawley rats 
were found to be more resistant to dicoumarol. Therefore 
before studying the effect of dicoumarol on fracture- 
healing, it was necessary to follow the fracture-healing 
process and the associated metabolic changes, in the 
Sprague-Dawley rat, making a direct comparison with 
the earlier work done on the Wistar rat by Shedden 
et al (1976) and Dunham et al (1977). 
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Materials and Methods 
Sprague-Dawley rats (230-250 g) were anaesthetized 
with pentobarbitone sodium (usuallyO. 15 ml) given intra- 
peritoneally. Closed fractures were imposed by digital 
pressure on two metatarsals of one hind-limb; the rats 
were allowed to revive and were killed at various times, 
up to six weeks later, by asphyxiation with nitrogen. 
The fractured bone, with its associated plantar muscle'. 
was dissected free and immersed briefly in a 5% (w/v) 
solution of polyvinyl alcohol (G04/140). The bone 
was then chilled to -70*C in hexane (BDH 'low in aromatic 
hydrocarbons' grade, boiling range 67-70*C) and stored 
in dry tubes, at this temperature, for up to seven days. 
These methods have been fully described in Chapter VI. 
Cytochemical Reactions. The sections were reacted 
in triplicate for G6PD activity and Alk Phos activity. 
Serial sections were stained with toluidine blue for 
histological study (Chayen et al, 1973). For G6PD 
activity the reaction-medium contained glucose 6- 
phosphate (5mM), NADP+ (3mM), phenazine methosulphate 
(0.7mM) and 0.3% (5mM) purified neotetrazolium chloride 
in 0.05M glycyl glycine buffer, pH 8.0, containing 30% 
(w/v) of the G04/140 grade of polyvinyl alcohol. The 
reactions were done in an atmosphere of nitrogen and 
at 370C. The medium for demonstrating alkaline 
phosphatase activity contained: a-naphthyl acid phos- 
phate (Sigma; 2 mg), Fast blue RR (Sigma; 50 mg), with 
0.2 ml of a 10% solution of magnesium chloride, in 50 
ml of a 2% solution of sodium 5-diethylbarbiturate 
at a final pH of pH 9.2. This reaction was done in 
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Coplin jars at room temperature. 
The coloured reaction-product of these cytochemical 
reactions was measured at discrete sites in the peri- 
osteum, and in histologically defined cell-types in 
the developing callus, by means of a Vickers M85 scanning 
and integrating microdensitometer, with a x40 objective, 
spot size 1 (equivalent to 0.4 Wm. in the plane of the 
specimen), with light corresponding to the absorption- 
maximum of the chromophore for the alkaline phosphatase 
reaction (580 nm) and to the isobestic point for the 
formazan from the dehydrogenase methods (585 nm). 
The reaction-times required to obtain ideal concentrations 
of the coloured reaction-product for measurement were 
10 minutes for G6PD, and 3 minutes for alkaline phosphatase 
activity (multiplied by 10/3to give a comparable value 
for a 10-minute reaction: Table VII. 1). 
Results 
Histology 
The sequence of events in the healing 
process of fractured metatarsals in the Sprague-Dawley 
ra ts, proved to be very reproducible and remarkably 
similar to that in the Wistar rat. However there were 
differences. The major difference was the time-scale, 
the fracture healing considerably faster in the Sprague- 
Dawley than in the Wistar rat. As in the Wistar rat, 
during the first few days after the fracture, a 
relatively undifferentiated callus comprised of few 
cells developed, surrounding the two fractured surfaces 
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(Fig. VII. 1). Around 3 days the periosteum had consider- 
ably thickened and cells had apparently proliferated 
from it and migrated into the callus; the first indi- 
cation of the formation of new bone was seen on the 
shaft of the bone at about 1.2mm -1.8 mm from the fracture- 
site (Fig. VII. 2). This was much earlier than the 
appearance of new bone in the Wistar rat (around 5 days). 
By 5 days, the callus consisted of a large number of 
undifferentiated cell types (Fig. VII. 3); it consisted 
of the fibroblastic, loose granulation tissue that grew 
out from the periosteum, and the compact cellular gran- 
ulation tissue (spindle shaped and rounded cells) that, 
from their position in the callus, appeared to be the 
precursers of cartilage and bone. The callus had the 
standard fusiform shape, the dense ground-substance 
and cells completely surrounding the fracture. The 
first appearance of differentiation and the first 
cartilage was seen at about 5 days around the new bone 
forming on the side of the shaft. Toluidine blue is 
a useful stain for acidic mucopolysaccharides which 
it may stain metachromatically. Different regions 
of the matrix of the callus showed various shades of 
metachromasia. As the wedge of bone on the shaft 
enlarged, the perisoteum became elevated and extended 
into the callus. 
By 8 days, a large external callus was present. 
In all cases, the callus on the dorsal side of the fracture 
was considerably larger than that on the plantar side. 
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Fig. VII. 1 Cryostat section through the mid-plane of a fractured 
Sprague-Dawley rat metatarsal shaft, one day post- 
fracture. The fracture site is filled with haematoma 
and undifferentiated callus. Thluidine blue; X20 
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Fig. VII. 2 Cryostat section of a three-day fracture showing more 
bone formation starting on the periosteal edge about 
lmm. from the fracture, seen on the dorsal surface distal 
to the fracture, and on the ventral surface (with 
the plantar muscle) proximal to it. Toluidine blue; 
X20. 
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Fig. VII. 3 Cryostat section of a five-day fracture in which the 
callus is comprised of (a) cartilage forming as a cap 
on (b) new bone forming on the shaft distal. to the 
fracture; (c) compact granulation tissue and (d) 
loose granulation tissue which still form the bulk 
of the callus. Toluidine blue: X12. 
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Together with the undifferentiated granulation tissue, 
there were large areas of cartilage, showing various 
degrees of proliferation, hypertrophy and calcificaion: 
all showed different shades of metachromasia; they 
surrounded the new bone on the shaft and extended into 
the callus. The gap between the two fragments was 
filled with undifferentiated granulation tissue (Fig. 
VII. 4). In the Wistar rat the two fracture ends had 
overlapped up to this stage. This overlapping was 
not present in the Sprague-Dawley rat, the two fragments 
being closely aligned throughout. 
Between 10 and 15 days the amount of new bone 
increased extensively, moving deeper into the callus 
(Fig. VII. 5). Most of the metabolic studies involved 
in investigating the effects of dicoumarol were done 
on material of the 12 day post-fracture. The external 
callus gradually diminished in size and by 21 days there 
was generally very little external callus. The gap 
was filled with fibrocartilage-like material and 
cartilage (Fig. VII. 6). The new bone on either fragment 
gradually replaced this material and by around 33 days, 
woven bone had almost completely united the two ends 
(Fig. VII. 7). By 6 weeks the fracture was fully united, 
with extensive remodelling of the woven bone into adult 
bone (detected by the appearance of ordered collagen 
as seen by its birefringence under crossed polars ). 
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Fig. VII. 4 Two examples of sections of eight-day-old fractures to 
show the predominant callus on the dorsal side. The 
angulation of the fractures is minimal and there is 
no overlap. The gap between the fractured ends is 
still filled with undifferentiated callus. Toluidine 
blue: upper X15; lower X20. 
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Fig. VII. 5 Cryostat section of a twelve-day callus in which external 
callus now consists almost entirely of new bone, separated 
at the fracture line by calcified and mature cartilage. 
Toluidine blue; X24. 
127 
Fig. VII. 6 Before bony union, the fracture gap is filled with 
granulation tissue and fibro-cartilage. 
Toluidine blue; X38. 
- 
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Fig. VII. 7 By six weeks post fracture, the fracture gap is closed by 
new bone. Toluidine blue; X15. 
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Cytochemistry 
Glucose 6-phosphate dehydrogenase activity 
in the periosteum. 
The G6PD activity in the fully differentiated 
periosteum of normal bone was unmeasurably low, in agree- 
ment with Sheddon and colleagues'(1976) work on the 
Wistar rat. The activity was measured in individual 
periosteal cells at measured distances from the fracture. 
In three rats, three days post-fracture, there was 
considerable activity close to the fracture reaching 
a mean extinction value of 22 units at 0.4 mm from the 
fracture; this was the region of very active prolifer- 
ation where osteogenic cells and fibroblasts move outwards 
from the periosteum and into the callus. The activity 
rose to 27 units 1.2 mm from the fracture. This second 
peak corresponded to the site of the first formation 
of new bone seen on the side of the shaft of the bone 
3 to 4 days after fracture (Fig. VII. S). This activity 
was observed to precede bone formation. 
In the periosteum of the fractured bones from 
15 rats taken 5 days after fracture, there were again 
two regions of elevated G6PD activity. However the 
precise location and value of these elevated activities 
varied from one rat to the next so that the overall 
mean values did not clearly show these variations (Fig. 
VII-9). The mean results showed considerable activity 
close to the fracture, reaching a mean extinction value 
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Fig. vjj. 8 Glucose 6-phosphate dehydrogenase activity (G6PD; 
MIE X 100) in the periosteal cells measured (a) in a 
control metatarsal without fracture (dotted line) and 
(b) in each of three 3-day fractures from three 
different rats (circles, squares and triangles). In 
all the fractures, there is increased G6PD activity 
close to the fracture site and a second peak of 
activity 1.2mm away from it. 
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Fig. VII. 9 Combined results (mean ± SEM; n= 15) of glucose 
6-phosphate dehydrogenase activity (MIE x 100) in the 
periosteum measured at set distances from the fracture 
site five days post-fracture. Because of small 
variations between rats, the precise location and 
magnitude of the second peak of activity (as seen in 
Fig. VII. 8 in three-day fractures) is obscured. The 
dotted line is the G6PD activity in the periosteum 
of control unfractured bone. 
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of 29 units at 0.6 mm from the fracture. The activity 
then dropped slowly to a mean value of 23 units at 1.2 
mm from the fracture, and then fell rapidly thereafter 
(Fig. VII. 9). In contrast, Fig. VII. 10 represents 
G6PD activity along the periosteum from 1 rat. The 
second peak of activity occurred in the region of 1.2 
to 1.8 mm from the fracture in all cases studied. 
This pattern of G6PD activity along the periosteum was 
similar to that found in the Wistar rat by Dunham and: 
colleagues (1977). The appearance of the second peak 
of G6PD activity as early as 3 days post-fracture 
reflected the different time-scale in the Sprague- 
Dawley rats, compared to the Wistar rat. 
The periosteum extended around the developing 
callus at about 5 days onwards and could be easily defined 
up to 12 days post-fracture. The G6PD activity was 
still high at 12 days post-fracture (20 units 
The periosteum was difficult to define in 
the later fractures; however where it was definable, 
there was negligible G6PD activity. By around 33 
days, when full union had occurred, there was no 
measurable activity present. 
Alkaline Phosphatase Activity in the Periosteum 
Three days after fracture there was low activity 
up to 0.8 mm from the fracture-site, becoming markedly 
elevated thereafter to values (around 57 units) exceeding 
those values (about 33 units) found uniformly throughout 
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Fig. VII. 10 In contrast to the results shown in Fig. VII. 9, the 
two peaks of glucose 6-phosphate dehydrogenase activity 
(M. I. E. X 100) in periosteal cells of any one specimen 
are readily distinguished. 
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this region in intact metatarsal bones of this strain 
of rat (Fig. VII. 11). This pattern was found in 14 
rats five days after fracture (Fig. VII. 12). These 
results were very similar to those found by Sheddon 
and colleagues (1976). 
The alkaline phosphatase activity remained high 
in periosteal cells as the periosteum extended around 
the callus from 5 days onwards and up to complete union 
of the fracture, maintaining similar activities to tha. t 
found in the intact metatarsals, i. e. 37 units, at 42 
days post-fracture. 
Enzyme Activity in the Cells of the Callus 
Glucose 6-phosphate Dehydrogenase.. G6PD activity was 
measured in 5 specified cell types in the callus: mature 
chondrocytes, chondrocytes in calcified cartilage, cellular 
granulation tissue, loose granulation tissue, and osteo- 
blasts, 5 days (n=3), 8 days (n=3) and 12 days (n=10) 
post-fracture (Table VII. 1). Measurements were also 
made 19 days, 33 days and 42 days post-fracture whenever 
it was possible to define the cell types (Table VII-1). 
In the specimens taken 5,8 and 12 days post-fracture, 
G6PD activity was moderately high in the undifferentiated 
cells of the loose granulation tissue that grew out 
from the periosteum. The increased activity was even 
greater in the more compact cellular granulation tissue; 
the activity increased from 28 units at 5 days post- 
fracture to 51 units 12 days post-fracture (Table VII. O. 
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Fig. VII. 11 Alkaline phosphate activity (MIE X 100) of periosteal 
cells in a3 day fracture. Up to O. 8=n from the 
fracture site, the activity is depressed below that of 
normal periosteal cells, shown by bars (mean SEM; 
n=5 rats; left-hand side). 
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Fig. VII. 12 Combined results (M. I. E. x 100; mean t SEM; n= 14) of 
alkaline phosphatase activity in the periosteum of 
five-day fractures; the depressed activity close to the 
fracture site is similar to that shown in Fig. VII. 11. 
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G6PD activity was also just as high in the mature chondro- 
cytes. However the activity declined from 39 units, 5 
days post-fracture, to 28 units, 12 days post-fracture. 
The activity further declined in the calcifying cartilage 
to a value of 11 units by 12 days post-fracture (Table 
VII. 1). 
The G6PD activity in the osteoblasts increased 
to a high level by the 12th day post-fracturej namely 
from 9 units at 5 days post-fracture to 37 units at 
12 days post-fracture (Table VII. 1). By 19 days post- 
fracture very little external callus remained, as described 
earlier, but when it was possible to define cell-types 
there was negligible G6PD activity in such chondro- 
cytes as remained in the callus. However the activity 
remained high in the osteoblasts, even 33 days post- 
fracture when woven bone had completely united the two 
ends (22 units at 19 days and 13 units at 33 days: Table 
VII. 1). 
Alkaline Phosphatase in the Callus 
Alkaline phosphatase activity was very low in 
the undifferentiated loose granulation tissue, being 
2.3 units of MIE at 5 days, 13 units at 8 days and 
3.3 units at 12 days post-fracture (Table VII. 1). 
The activity was considerably higher in the cellular 
granulation tissue, giving values of 43 units at 5 days 
and rising to a fairly constant value (around 70 - 80 
units) at 8 and 12 days post-fracture (Table VII. O. 
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Table VII. 1 The activity (mean integrated extinction x 100) of 
glucose 6-phosphate dehydrogenase (G6PD) and alkaline 
phosphatase (Alk. P) in five different cell types at 
different times during the maturation of the fracture 
callus. 
Day after Enzyme Osteoblasts Chondrocytes Granulation tissue 
fracture Mature Calcified Cellular Loose 
5* G6PD 9 ± 7 39 ± 13 28 ± 5 16 + 4 
AlkP 60 ± 13 53 ± 18 43 + 9 2.3 + 2 
8* G6PD 21 ± 8.4 41 ± 4.5 10 ± 3 38 3.5 15 
AlkP 130 ± 6.6 103 ± 7 43 ± 6 83 10 13 3.3 
12** G6PD 37 ± 3.7 28 ± 2 11 ± 1.2 51 6 Is 1.7 
AlkP 140 ± 7.3 107 ± 6.3 53 ± 8.3 70 6.7 3 2.2 
19 G6PD 22 0 0 nm nm 
AlkP 100 75 0 nm 0 
33 G6PD 13 0 - - 
AlkP 112 96 
42*** G6PD - - 
AlkP 129 
n=3 mean SD 
n= 10 mean S. E. M. 
n2 mean value 
Single values: one animal 
nm = not measured 
-= no representative cells present 
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In the mature chondrocytes the activity was 53 units 
at 5 days post-fracture and rose to an appreciably high 
and constant value (around 103 - 107 units: Table VII-1) 
at 8 days and 12 days post-fracture. Calcification 
occurred at around 8 days post-fracture, and the alkaline 
phosphatase activity in the calcified chondrocytes decreased 
to about half that found in the mature chondrocytes 
(Table VII. 1). The osteoblasts lining the trabeculae 
of the new bone showed the highest alkaline phosphatage 
activity, namely 60 units at 5 days post-fracture, rising 
to 130 units at 8 days and 140 units at 12 days post- 
fracture (Table VII. 1). 
Alkaline phosphatase remained extremely active 
in the later fractures, in the mature chondrocytes and 
osteoblasts. However by 42 days there was no detectable 
alkaline phosphatase activity in the adult bone formed 
from the remodelled woven bone. 
Discussion 
The closed fracture of the metatarsal of the 
Sprague-Dawley rat forms a useful and reproducible model 
for studying fracture-healing. It compares very closely, 
both histologically and metabolically, with the Wistar 
rat model, except for the faster time course in the 
Sprague-Dawley. 
As found in work done by Sheddon and colleagues 
(1976,1977. ), alkaline phosphatase appeared to 
be associated with calcification, and glucose 6-phosphate 
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dehydrogenase with cellular proliferation and ossification. 
Thus this model should prove useful in studying the 
effects of dicoumarol, a vitamin K., antagonist, on 
ossification (Chapter VIII). 
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CHAPTER VIII 
EFFECTS ON FRACTURE-HEALING OF AN 
ANTAGONIST OF THE VITAMIN K-CYCLE 
Introduction 
A peptide that is relatively rich in Y-carboxy- 
glutamate residues (osteocalcin; bone Gla-protein) is 
an abundant non-collagenous protein of mammalian bone; 
its synthesis depends on the vitamin K-cycle (Hauschka 
et al, 1975). A detailed discussion of osteocalcin and 
of the vitamin K cycle and its possible role in calcific- 
ation is given in Chapter III. Briefly, the production 
of the calcium-binding Y-carboxyglutamate residues 
is effected by a microsomal mixed-function oxidation- 
reduction in which vitamin Kl, or a similar naphthoquin- 
one substituted at the 3-position (Olsen et al, 1978), 
is reduced by NAD(P)H (Stenflow and Suttie, 1977; 
Suttie et al, 1978). The reoxidation of the quinol 
is required for the process in which a proton is abstracted 
from the Y-methylene of a glutamate residue (Stenflo 
and Suttie, 1977); the resulting carbanion fixes carbon 
dioxide to form the y-carboxyglutamate residue (Hauschka 
et al, 1978; Olsen et al, 1978; Fig. 111.2) 
The anticoagulant, dicoumarol (chemically related 
to Warfarin) antagonises the effect of vitamin K1 in 
the vitamin K-cycle. Some evidence suggests 
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that dicoumarol blocks the reversible conversion of 
vitamin K to the vitamin K epoxide (Whilton et al, 1978). 
The work reported in this chapter was designed to invest- 
igate the effects of dicoumarol on ossification by feeding 
it to rats (Sprague-Dawley) in which a closed fracture 
of the metatarsal had been induced. A detailed metabolic 
and histological study was made in the periosteum and 
in the callus up to 6 weeks post-fracture, by which 
time the fracture was fully united in control rats 
(Chapter VII). 
Previous studies on cellular metabolic activities 
in healing fractures in rats (Dunham et al, 1977 and 
ChapterVII) had shown that there was a marked increase 
in periosteal glucose 6-phosphate dehydrogenase (G6PD) 
activity at the site at which new bone was formed -on the 
shaft. This activity preceded the first signs of new 
bone. The simple assumption would be that the NADPH, - 
generated by this stimulated G6PD activity at this site, 
would be used in the vitamin K cycle for ossification. 
Materials and Methods 
Most of the materials and methods have been described 
in Chapter VII. Those rats that were treated with 
dicoumarol were given it in the drinking water as soon 
as they revived following the induction of the fracture. 
A standard dose was achieved by giving each rat, daily, 
25 ml of drinking water containing 0.125 mg bis-hydroxy- 
coumarin (Sigma); once this had been drunk, the water 
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bottle was replenished with ordinary water. To obtain 
a "solution" of dicoumarol, 25 mg of dicoumarol were 
dissolved initially in 10 ml of 1M sodium hydroxide, 
with the pH decreased to pH 10 with 5M HC1; this solution 
was diluted 1: 500 with tap water, giving it a final 
pH of between 8 and 9. The control rats were given 
ordinary water only. 
Clotting Times. The clotting time of normal rats 
was 2.0 minutes; in the dicoumarol-treated rats it 
became prolonged from day 4, to reach 7.5 minutes on 
day 10 and 9 minutes on day 12. 
Cytochemical Reactions. Three enzymes were studied: 
glucose 6-phosphate dehydrogenase activity, alkaline 
phosphatase activity and hydroxyacyl-coenzyme A 
dehydrogenase activity. The procedures for demonstrating 
the first two enzymes are described in Chapter VII. 
For demonstrating hydroxyacyl-coenzyme A dehydrogenase 
activity (Chambers et al, 1982) the medium contained 
DL-S-ý-hydroxybutyryl-N-acetyl cysteamine (Sigma; 37 mMs 
or 5 mM cysteamine, as control), NAD 
+ (2mM), menadione 
(3mM), sodium nitroprusside (5mM) and 0.6% OOmM) of 
purified neotetrazolium chloride in a 0.05 M glycYl 
glycine buffer containing 30% of the polyvinyl alcohol 
with a final pH of 8.5. (Details are given in Chapter VI). 
For histological', examination, sections were 
selected that passed through approximately the mid-axis 
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of the endosteal space. To confirm that this gave 
a good representation of the various cellular components, 
one bone was sectioned serially from side to side, and 
the relative size of each component was ascertained 
at different levels. The image of the selected sections 
was thrown on to a screen; the enlarged image was traced 
on to tracing paper, and the areas of the'selected 
tissue-components were measured by planimetry. 
Histological Results 
In all cases, the callus on the dorsal side of 
the fracture was considerably 
plantar side (Table VIII. O. 
in the dorsal and plantar reg 
found in both the control and 
fractures. However, up to 5 
histological structure of the 
larger than that on the 
This difference in size 
ions of the callus was 
the dicoumarol-treated 
days post-fracture, the 
calluses did not appear 
to be appreciably influenced by the administration of 
dicoumarol to the drinking water except that, in the 
controls (even as early as 3 days post-fracture) there 
were signs of bone-formation that were never seen in 
the calluses of treated rats (Fig. VIII. 1). In 
contrast, major changes were seen in the calluses in 
the later fractures (12 days onwards). All the plani- 
metry measurements were made on specimens 12 days post- 
fracture (Table VIII. 1). The total projected areas 
of the dorsal callus in the treated and control animals 
were very similar. However, the callus in the di- 
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Table VIII. 1 Total area and area of new bone formation (mean ± SEM) 
of dorsal and plantar callus in sections through the 
greatest diameter (midshaft) of fractured rat metatarsals 
12 days post-fracture. 
control (n=16) Dicoumarol treated (n=13) 
Dorsal Plantar Dorsal Plantar 
Area (mm 
2x 16) 29 ± 3.33 6±1.02 25 ± 2.57 9±1.71 
New bone 15 ± 1.53 4±o. 77 10 ± 1.14 3±o. 86 
New bone % 56 ± 3.58 45 ± 2.56 39 ± 1.43 
30 ± 1.71 
*p < 0.001 as compared with dicoumarol treated: Student's 
t test. 
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Fig. VIII. I Cryostat section of a five-day fracture in a rat 
treated with dicoumarol. The amount of new bone 
formed on the shaft (a) is much less than that seen 
in the control fractures (b) (and Fig. VII. 
Toluidine blue; x 20 
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coumarol-treated rats appeared to be less advanced in 
terms of the degree of differentiation that it achieved 
(Fig. VIII. 2). As a test of this suggestion, the area 
occupied by new bone was expressed as a percentage of 
the total area of the callus. When expressed in this 
way (Table VIII. 1), in these specimens taken 12 days 
after fracture, the proportion of the callus occupied 
by new bone was significantly higher (p < 0.001) in 
the control rats (e. g. 56% ± 10; mean ± S. D. ) than in 
those treated with dicoumarol (38% ± 6). In the controls, 
the centre of the callus around the fracture site (Fig. 
VIII. 2) was occupied by fibrocartilage-like material, 
differentiating into mature cartilage further from the 
fracture. In the rats treated with dicoumarol, the 
region which should have contained fibrocartilage-like 
material contained effete, fibrous material with few 
cells. At 6 weeks, the fracture in the control rats 
was fully united, but union was still incomplete in 
those given dicoumarol (Fig. VIII. 3). 
Cytochemical Results 
Glucose 6-phosphate Dehydrogenase Activity 
in the Periosteum. The activity was measured in 
individual periosteal cells at -measured distances (0.2 mm) 
from the fracture up to 2.2 mm away from the fracture 
site. Measurements were made 3 and 5 days post-fracture. 
In 3 control rats, 3 days post-fracture, there 
was considerable activity close to the fracture, reaching 
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Fig. VIII. 2 The degree of differentiation in the callus formed 
at 12 days in a rat treated with dicoumarol (a) is 
less advanced than that seen at this time in the 
control rats (b) . 
Toluidine blue; x 20. 
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Fig. VIII. 3 At six weeks post fracture in a dicoumarol treated rat 
union is still incomplete in that there is soft 
callus between the fracture ends whereas in control 
rats, union is complete (b). 
Toluidine blue; X 24. 
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a mean extinction value of 22 units at 0.4 mm from the 
fracture, and rising to 27 units 1.2 mm from the 
fracture (Fig. VIII. 4). In contrast, the G6PD 
activity in the dicoumarol-treated rats declined over 
this region of the perosteum (Fig. VIII. 4). Each 
different symbol in Fig. VIII. 4, closed and opened, 
represents a different animal. 
In the periosteum of the fractured bones from 
15 untreated and 14 dicoumarol-treated rats taken 5 
days after fracture, the mean activity was depressed 
in the latter. This was found even though there were 
wide individual variations (Fig. VIII. 5). The differ- 
ences at 0,0.2, and 0.4 mm from the fracture site 
were significant at the level of p<0.02; at 0.6 mm 
the difference was significant at p=0.03. 
The precise location of the peaks of G6PD activity 
varied slightly in the different animals. Consequently, 
the mean results did not adequately represent the changes 
in activity either along the periosteum of'any one animal, 
or the differences induced by dicoumarol treatment. 
In general, all the bones from the control rats, and 
most of the bones from the treated rats, showed two 
regions of elevated G6PD activity, an example of which 
is shown in Fig. VIII. 6. The region closest to the 
fracture had relatively low activity, with higher 
activities over part or all of the first 0.8 mm from 
the fracture-. Particularly in the controls, another 
peak of activity occurred in the region of 1.0 - 1.8 mm 
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Fig. VIII. 4 Glucose 6-phosphate dehydrogenase activity (G6PD; 
M. I. E. x 100) in the periosteal cells of three-day 
old fractures. Each symbol represents a different 
animal; closed symbols: dicoumarol-treated rats; open 
symbols: control rats. In the dicoumarol-treated 
rats there is no peak of G6PD activity at the site 
where new bone formation begins (about 1.2mm away 
from the fracture). The dotted line just above the 
x-axis represents the activity in unfractured bone 
from either group. 
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Fig. VIII. 5 Combined results of glucose 6-phosphate dehydrogenase 
activity (M. I. E. X 100 ± SEM) in the periosteal cells 
from 14 dicoumarol-treated rats (closed circles) and 
15 control rats (open circles) 5 days after fracture. 
Up to 1.2 mm, 'the activity is less in the dicoumarol 
treated rats. 
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Fig. VIII. 6 Glucose 6-phosphate dehydrogenase activity (G6PD; 
M. I. E. x 100) in the periosteal cells of 5-day 
fractures in a control and a dicoumarol-treated rat. 
In both there are two peaks of G6PD activity but the 
exact height and location of the peaks varies between 
individuals so that the peaks cannot be distinguished 
when the results are combined. (Fig. VIII. 5) The 
vertical lines and shaded areas define the second peak. 
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from the fracture. The precise location of these 
elevated activities varied from one rat to the next. 
Thus the overall mean values (Fig. VIII. 5) did not 
clearly show these variations. To express the first 
of these activities numerically, the activity in each 
section was plotted against the distance from the fracture, 
as in Fig. VIII. 6, and the area under the graph up to 
the beginning of the second peak was measured by plani- 
metry. 
The results are shown in Table VIII. 2. There 
was a barely significant depression of G6PD activity 
over this region of the periosteum in the dorsal callus 
of the rats treated with dicoumarol (0.05 >p >0.02). 
A similar device was used to achieve a numerical repres- 
entation of how the treatment influenced the second peak 
of activity in the region of 0.8 - 1.8 mm from the 
fracture. For this purpose, an increase from one measure- 
ment to the next (a distance of 0.2 mm) of more than 
5 units of mean integrated extinction xlOO*(corresponding 
to 0.05 of absolute extinction) was defined as a "peak". 
The area of such peaks was marked on the graphs (as 
in Fig. VIII. 6) and were measured by planimetry. 
The results (Table VIII. 2) showed that treatment with 
dicoumarol had markedly suppressed this second peak 
(p<0.001 ). 
155 
Table VIIi. 2 Glucose 6-phosphate dehydrogenase activity (mean t SEM) 
in periosteal cells of fractured rat metatarsals 5 days 
post-fracture. 
Control Dicoumarol 
(n = 15) (n = 15) 
Area of first region 25 ± 2.8 
t 
17.7 ± 1.7 
of activity from the 
fracture 
Area of second peak* 16 ± 2.7 
tt 3 0.98 
of activity 
. 
*A peak was defined as a change in activity of greater than 5 units 
MIE x 100/0.2mm. 
tO. 05 >p>0.02 and tt p<0.001 as compared with dicoumarol-treated 
rats: Student t test. 
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Alkaline Phosphatase Activity in the Periosteum.. 
In a control rat, 3 days after fracture, there was very 
low activity up to 0.8 mm from the fracture site, becoming 
markedly elevated thereafter to values exceeding those 
found uniformly throughout this region in intact 
metatarsal bones of this strain of rat (38 ± 0.8; mean 
± SEM; n= 4i Fig. VIII. 7). This loss of activity, 
close to the fracture site, was very much less marked 
in the dicoumarol-treated rats (Fig. VIII. 7). This 
pattern was found in 14 control and 16 dicoumarol-treated 
rats 5 days after fracture (Fig. VIII. 8). At all points 
in the periosteum, up to and including 0.6 mm from the 
fracture, the alkaline phosphatase activity was very 
significantly lower in the control rats than in those 
treated with dicoumarol (P < 0.0004); it was significantly 
lower also at 0.8 mm from the fracture (P = 0.01) but 
the activities thereafter were not significantly different. 
HOAD Activity in the Periosteum. This enzymatic activity 
was measured in the periosteum from the fractures of 10 
control rats and of 11 rats that had been treated with 
dicoumarol. Because inspection of the graphs of activity 
against distance for individual bones disclosed no obvious 
patterns, the results from all the specimens were plotted 
(Fig. VIII. 9). There was no difference in activity 
as a consequence of treatment with dicoumarol. 
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Fig. VIII. 7 Alkaline phosphatase activity (MIE x 100) in the 
periosteal cells of a control and a dicoumarol- 
treated rat, three days post-fracture. The character- 
istic depression of alkaline phosphatase activity 
close to the fracture is less marked in the dicoumarol- 
treated rat. The bars next to the y-axis indicate 
alkaline phosphatase activity in unfractured 
periosteum (mean t SEM; n=4 rats). 
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Fig. VIII. 8 Combined results (mean ± SEM) of alkaline phosphatase 
activity (MIE x 100) in the periosteal cells of 16 
dicoumarol-treated rats (closed circles) and 14-control 
rats (open circles) five days after fracture. The 
activity close to the fracture in the dicoumarol- 
treated rats is less depressed and more approximates 
to the activity found in unfractured bone (bars close 
to the y-axis) than that of the control fractures. 
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Fig. VIII. 9 Combined results of Hydroxyacyl dehydrogenase activity 
(M. I. E. x 100 t SEM) in the periosteal cells of 11 
dico=arol-treated and 10 control rats, five days post- 
fracture. The actývity in the two groups is 
relatively constant and similar. 
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Enzymatic Activity in the Cells of the Callus. 
Most of the metabolic studies involved in investigating 
the effects of dicoumarol were done on material of the 
12 day post-fracture, when the different cell types 
are easily defined. The enzyme activities were measured 
in 5 specified cell types in the callus; mature 
chondrocytes, chondrocytes in calcified cartilage, 
cellular granulation tissue, loose granulation tissue 
and osteoblasts (as described in Chapter VII). 
Measurements were made in earlier fractures (5 days 
and 8 days post-fracture) but it was difficult to define 
accurately the different cell types and there was also 
wide variation within each group. However the same 
pattern of results was observed as in the 12 day post- 
fractures. In the later fractures (19 days, 33 days 
and 42 days post-fracture) the control rats and 
dicoumarol-treated rats were at different stages of 
maturation. Therefore only the results from the 12 
day post-fracture are shown (Table VIII. 3). 
Glucose 6-phosphate dehydrogenase activity was 
measured generally in 5 specified cell types in the 
callus of the fractures of 10 control, and 8 dicoumarol- 
treated rats, 12 days post-fracture. Only in the cells 
of the mature cartilage (Table VIII. 3) was the activity 
in the dicoumarol-treated rats significantly lower 
P=0.01 ;n= 19) than in the controls. No differences 
were found in the activities of either alkaline phos- 
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Table VIII. 3 Enzyme activities (MIE x 100/10 min) on the various cell 
types of the callus 12 days post-fracture. 
Cell Type Enzyme: 
G6PD HOAD ALK PHOS 
Control: 28 t 2 5.3 ± 0.5 107 ± 6.3 
Mature chondrocytes 
Dicoumarol: 20 ± 2 5.5 ± 0.4 100 ± 8.3 
Chondrocytes in Control: 11 ± 1.2 2.5 ± 0.2 53 ± 8.3 
calcified cartil- 
age Dicoumarol: 10 ± 1.0 3.0 ± o. 2 53 ± 6.0 
Cellular granulat- 
ion tissue Control: 51 ± 6.0 7 ± 1.2 70 ± 6.7 
Dicoumarol: 32 7.0 7 ± 1.0 73 ± 7.0 
Loose granulation 
tissue Control: 18 1.7 3.0 ± 0.4 3.3 ± 2.2 
Dicoumarol: 14 1.5 3.0 ± o. 3 3.3 ± 3.2 
Osteoblasts Control: 37 3.7 9.0 ± 0.8 140 ± 7.3 
Dicoumarol: 20 3.0 9.0 ± 0.9 123 ± 12 
G6PD: glucose 6-phosphate dehydrogenase 
HOAD: hydrozyacyl dehydrogenase 
Alk. Phos: alkaline phosphatase 
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phatase or HOAD in any of these cell types 12 days post- 
fracture. 
DISCUSSION 
The histological results showed that the effect 
of dicoumarol treatment on fracture healing (Table VIII. 
1) had no effect on the total size of callus that developed, 
but markedly delayed maturation so that at 12 days posýt- 
fracture, whereas 56% of the area of the callus of the 
controls was occupied by bone, only 38% was occupied 
by bone in the treated rats. Moreover, the latter 
showed large regions of cartilagenous material (Fig. 
VIII. 2) and effete, fibrous material. These results 
are in accord with those of Stinchfield et al (1956), 
who found fibrous tissue and immature bone in the 
healing fractures of rabbits and a dog given dicoumarol 
at the rate of 2 mg/kg body weight each day. However' 
the results reported here seemto be at variance with 
the results of Price and Williamson (1981), who detected 
no abnormality in the repair of fractures in rats fed 
with %rfarin.. However, these workers studied young 
rats, in which the radius was fractured at 17 days of 
age. Because the amount of Vbrfarin given was 
apparently toxic, vitamin KI was also administered 
simultaneously. Thus the conditions were very differ- 
ent from those used in the present study. Also, 
evidence of repair was obtained radiologically and not 
histologically, thus allowing for the possibility that 
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an outer cuff of bone, overlying a region of unossified 
cartilage (as found in this study), could have confused 
the radiological evidence. In the literature there 
are further reports of delayed fracture healing in 
experimental animals after administration of derivat- 
ives of dicoumarol; this work has been reviewed by 
Hahnel et al (1976) and includes studies by Rokkanen 
and Slatis (1964), Blum (1964) and Knoth and Markgraf 
(1976). All seem to stress the anticoagulant properties 
of dicoumarol-: like substances as opposed to their possible 
antagonism of the vitamin KI cycle. 
Over the first 15 days after fracture of metatarsal 
bones, G6PD activity has been shown to be elevated in 
the region near the fracture and also in a region about 
1.2 mm behind the fracture (Dunham et al, 1977, and 
Chapter VII). The first peak of activity was apparently 
associated with the proliferation required to form the. 
callus, since this enzyme is the regulatory enzyme of 
the pentose shunt which is required for growth (Krebs 
and Eggleston, 1974). The second peak of activity 
was seen to be associated with the region at which bone 
first formed on the shaft of the fractured bone (Dunham 
et al, 1977 and Chapter VII). The biochemical function 
of the second peak of G6PD may be related to the fact 
that this enzymatic activity is a major source of cyto- 
solic NADPH which may be used in the vitamin K, cycle 
(Suttie et al, 1978). 
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The results in the present study indicated that 
treatment with dicoumarol only slightly depressed G6PD 
activity in the first region of the periosteum (Table 
VIII. 2 ), but virtually obliterated the second 
peak. There was also depressed G6PD activity in the 
cells of the mature cartilage (Table VIII. 3). Thus, 
not only could it be acting as an antagonist of the 
vitamin K cycle, blocking the conversion of the epoxide 
to the naphthoquinone, but it also depressed the amount 
of reducing equivalents, from NADPH, available for the 
cycle at these points of ossification. 
This action of dicoumarol was not a universal 
effect in that it had no influence on the G6PD activity 
of the other cells of the callus (and therefore on the 
proliferative capacity of the callus or its ultimate 
size); nor did it influence fatty acid oxidation, as 
shown by the hydroxyacyl dehydrogenase activity (Table 
VIII. 3). Furthermore, it enhanced periosteal alkaline 
phosphatase activity(Fig. VIII. 8) and left that of the 
various cells of the callus unaltered (Table VIII. 3). 
Thus it would seem, from the histological results, that 
dicoumarol. treatment retarded the ossification of the 
callus. This is consistent with it having an antagonistic 
effect against vitamin K1 in the vitamin K cycle. In 
addition, dicoumarol decreased the amount of reducing 
equivalents for this cycle selectively at points at 
which ossification should have occurred. 
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CHAPTER IX 
THE EFFECT OF VITAMIN B6 DEFICIENCY 
ON FRACTURE HEALING 
Introduction 
Interest in G6PD Activity 
Studies on the cellular metabolic activities 
in early healing fractures in rats showed a striking 
increase in periosteal glucose 6-phosphate dehydrogen- 
ase (G6PD) activity, at the fracture-site (associated 
with cell growth in the callus) and at the site 
at which new bone forms on the shaft (Dunham et 
al, 1977; Dodds et al, 1984). G6PD is the first and 
rate-limiting step in the pentose shunt and is important 
for supplying NADPH, to be used in many reductive bio- 
synthetic reactions, and in producing ribose phosphate 
for nucleic acid synthesis. Thus the fracture involves 
both active proliferation and biosynthesis. The increased 
periosteal G6PD activity at the site at which new bone 
forms on the shaft precedes the first signs of new 
bone. As described in Chapter VIII it may also be 
that the NADPH, generated by this stimulated G6PD activity, 
would be used in the vitamin KI cycle for ossification. 
It was therefore of interest to investigate the 
chemical mediator of G6PD activation. Investigations 
into the various forms of G6PD have shown that it can 
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aggregate to an active form, or dissociate into inactive 
units and that NADP by binding to the enzyme at a non- 
catalytic site can hold the enzyme in the active state 
(as reviewed by Bonsignore and de Flora, 1972; Chayen 
and Bitensky, 1982). This allows for a rapid response 
to stimuli in that the cell would not necessarily have 
to synthesize more enzyme during rapid changes in activa- 
tion (Chayen and Bitensky, 1982). In the liver, the 
active form of G6PD is a tetramer which can be dissociated 
into two active dimeric units. The enzyme can be 
further dissociated into inactive monomers if it is 
incubated in the presence of free fatty acids. NADP 
specifically antagonizes the inactivating effect exerted 
by fatty acids (Bonsignore and de Flora, 1972). 
Inhibitory Effects of Fatty Acid-CoA 
on Isolated G6PD 
It has also been demonstrated that long chain 
fatty acyl-CoA thioesters, such as palmitoyl-CoA 
inhibit yeast and liver, G6PD activity in vitro, (Taketa 
and Pogell, 1966). However the physiological signifi- 
cance of this finding was excluded (Taketa and Pogell, 
1966) on the basis of a complete lack of specificity, 
in that palmitoyl-CoA also inhibited several other 
enzymes. Taketa and Pogell (1966) suggested that 
the detergent-like properties of the long chain acyl- 
CoA esters produce conformational changes in the various 
enzymes studied, that may or may not alter the enzyme 
activity. It may be remarked that all these studies 
were done on isolated enzymes in solution. 
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Mita and Yasamasu (1979,1983) demonstrated that 
the polyamines spermine and spermidine, but not putrescine, 
released the inhibitory effects of palmitoyl-CoA on 
yeast and bovine adrenal G6PD activity, in vitro. 
Polyamines and their metabolism are discussed in detail 
in Chapter IV. Despite the fact that the precise 
function of polyamines has not been resolved, it is 
generally accepted that they play an important role 
in the growth and differentiation of most cell types. 
In the study by Mita and Yasumasu (1978) on iso- 
lated G6PD, spermine enhanced G6PD activity, whereas 
spermidine and putrescine had no activating effect. 
However, they concluded that the reversal effects of 
polyamines on the inhibition of G6PD by palmitoyl-CoA 
was not a result of the activation of the enzyme (Mita 
and Yasumasu, 1978). These authors postulated that 
the positively charged polyamines neutralize the 
negative charge of the palmitoyl-CoA, and this is supported 
by the fact that a polyamine with a large number of 
amino groups was more effective on the palmitoyl-CoA 
inhibition. They also showed that substitution of 
the terminal amino groups in polyamines by carboxyl 
or hydroxyl groups reduced the reversal effects. 
Finally Mita and Yasumasu reported that polyamines 
are able to bind to palmitoyl CoA. 
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Possible Linkage Between G6PD Activity and Putrescine 
As has been discussed (above), the activity of G6PD 
can be markedly changed, rapidly, by NADP added to the 
enzyme but at non-catalytic sites. Several studies have 
been made in this Laboratory on possible mediators that 
can affect this activity in life. One possibility was 
that, in life, a polyamine might take the place of NADP+ 
at non-catalytic sites. In studies on smooth muscle 
(Naomi Chayen, 1984) it was shown that 5-hydroxytryptamine 
(e. g. at 10- 
4M 
or 10- 
5 M) caused an increase in G6PD 
activity within 1 minute of its application to strips of 
rat gastric fundus muscle, and that this increase was 
related to an influx of extracellular calcium. Quantit- 
atively similar changes were produced by putrescine. 
It therefore seemed possible that the 5-hydroxytryptamine 
was activating ODC; preliminary investigations with the 
new cytochemical method for measuring ODC activity 
(Dodds and Chayen, 1984) supported this view. It therefore 
seemed reasonable to examine whether the inc . reased peri- 
osteal G6PD activity, observed early in fracture-healing 
(Chapter VII) could be inhibited by inhibiting ODC activity, 
or by decreasing tissue-levels of polyamines, and whether 
such inhibition altered the course of fracture-healing. 
Inhibition of Polyamine Synthesis 
The rate-limiting steps of polyamine synthesis in 
mammalian tissues are catalysed by two decarboxylases 
M ornithine decarboxylase (ODC), which shows an absolute 
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requirement for pyridoxal phosphate, and (ii) putrescine- 
activated S-adenosyl methionine decarboxylase (SAMD) 
(Raina and Janne, 1975). Exceptionally, SAMD has 
no requirement for pyridoxal phosphate (Eloranta et al, 
1976; Pegg, 1976). Eloranta et al (1976) and Pegg (1976) 
studied the effects of pyridoxine. (vitamin B6) deficiency 
on these two decarboylases and on the concentraion of the 
polyamines putrescine, spermidine and spermine, in various 
tissues in the rat. Briefly, 40g rats (male/female Wistar) 
fed a pyridoxine-deficient diet for 3-6 weeks had a lower 
concentration of putrescine and spermidine in their tissues 
than the appropriate controls; spermine levels remained 
fairly constant. Thus this may indicate that the effective 
ornithine decarboxylase activity in vivo was decreased 
due to the decreased amounts of the cofactor. In the 
study by Pegg (1976) ODC activity was decreased by B6 
deficiency when assayed in tissue extracts without pyridoxal 
phosphate being present, and increased when the cofactor 
was present in the assay-system. Pegg (1976) suggested 
that the cell may try to compensate for the decreased 
activity of ODC in pyridoxal phosphate-deficiency by 
increasing the concentration of the enzyme. SAMD was not 
decreased in the tissues from the B6 deficient rats. 
The conclusions from the studies by Eloranta et al 
(1976) and Pegg (1976) were that pyridoxal phosphate is 
not a cofactor for SAMD, and that although the concen- 
trations of putrescine and spermidine were decreased in 
B 6-deficient rats, the ODC and SAMD activities, measured 
'10 
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under optimal conditions in vitro, in no way correlated 
with the concentration of polyamines in vivo. Neverthe- 
less, pyridoxine deficiency seemed to be a useful tool 
in studying the metabolic effects associated with 
fracture-healing in the rat, especially the stimulation 
6r of periosteal glucose 6-phosphate dehydrogenase, discused 
/_Y 
at the beginning of this chapter. Consequently, a detailed 
metabolic and histological study has been made of the effects 
of vitamin B 6- deficiency in the fracture-healing response 
in male Wistar rats. 
Materials and Methods 
Most of the materials and methods have been described 
in Chapter VII. Male Wistar rats weighing 40 - 60 g were 
divided into two groups, one fed on a pyridoxine deficient 
diet (25g/daily: see appendix III) for 24 days before 
induction of the fracture, the other control group receiving 
the same diet supplemented with pyridoxine. The diet 
in both groups was changed daily, aAd care was taken to 
avoid contamination of the food by the excreta of the rats. 
After fractures were imposed by digital pressure on two 
metatarsals on one hind limb, the rats were retained on 
their respective diets. At various times after fracture, 
up to 9 weeks, the rats were killed and the bones removed 
and chilled (as described in Chapter VII). 
Body Weights of Pats 
The weights of the B6 deficient and control rats 
were recorded at set times after fracture. Up to 54 days 
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on the diet there was no significant difference in the 
weights. By the 80th day the control rats weighed 
an average of 346 g whereas the B6 deficient rats weighed 
316 
Cytochemical Reactions: The bones were sectioned (10 Um) 
on a Jung 1130 rotary microtome set in a Bright's 
cryostat (Johnstone et al, 1972; Johnstone, 1979; and 
discussed in Chapter V). Six enzymes were studied: 
glucose 6-phosphate dehydrogenase (G6PD) activity; 
glyceraldehyde 3-phosphate dehydrogenase (GAPD) activity; 
succinate dehydrogenase (SDH) activity; lactate dehydrogen- 
ase (LDH) activity; hydroxyacyl dehydrogenase (HOAD) 
activity; and alkaline phosphatase (Alk Phos) activity. 
Corrections had to be made for the time of reaction. 
The procedures for demonstrating these enzyme activities 
are described in Chapters VI and VII. The cytochemical 
reactions were measured at discrete sites in the peri- 
osteum, and in hist8logically defined cell types in the 
developing callus. The coloured reaction product of 
these cytochemical reactions was measured by means of 
a Vickers M85 scanning and integrating microdensitometer, 
with a x40 objective, spot size 1 (equivalent to 0.4 um.. 
in the plane of the specimen) as described in Chapters 
VI and VII . 
Serial sections were stained with toluidine blue 
for histological study (Chayen et al, 1973). At 12 
days post-fracture the image of selected sections was 
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thrown on to a screen, and the enlarged image traced. 
The areas of the selected tissue-components were measured 
by planimetry (as described in Chapter VIII). 
Histological Results 
A detailed histological study is still in progress 
and further experiments are under way, so only a brief 
discussion of the results will be given. 
As described in Chapter VII, the sequence of events 
in the healing process of fractured metatarsals in the 
Wistar rat differs in many ways from that of the Sprague- 
Dawley. In general, the resulting fractures are very 
angulated in the Wistar rat. The callus on the dorsal 
side of the fracture was in most cases larger than the 
plantar side, but not to the same extent as that found 
in the Sprague-Dawley rats (as described in Chapter VII). 
The Wistar rats in this study were very young at the 
time that their bones were fractured (e. g. 180 g instead 
of 250 g as in the study of Shedden et al, 1976); it 
was therefore not surprising that the fractures in the 
control animals healed rapidly. being fully united in 
all 8specimens studied between 26 and 30 days post- 
fracture. In contrast in the B6 deficient rats union 
was delayed so that in all 8 rats studied, there was 
still an extensive callus 26 days post-fracture; by 
9 weeks, all the fractures were united. 
This delay in union was reflected by many, quite 
bizarre, changes earlier in fracture healing. In the 
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fractures in the B 6- deficient rats, up to 5 days post- 
fracture, although there was considerable proliferation 
and thickening of the periosteum, much of the tissue 
surrounding the fracture ends was acellular, except for 
sparse inflammatory cells and macrophages (Fig. IX. 1).. 
There was extensive invasion of the ppriosteum into the 
old bone, all along the shaft, but predominantly at the 
metaphyseal end (Fig. IX. 2). Occasionally, even as 
early as two days post-fracture, it was noted that whaý 
appeared to be thickened periosteum was,, in fact, 'altered' 
old bone (as seen under crossed polars: Fig. IX. 3), cont- 
aining some undefinable cell-like material. 
At all the times investigated, the metaphyseal 
trabeculae in the B 6- deficient group were strikingly 
narrowed (Fig. IX. 4). Turther from the metaphysis, 
this narrowing became accentuated so that the solid bone 
was converted into small, isolated fragments of what 
seemed to be trabeculae surrounded by bone marrow (Fig. 
IX. 5). Since trabecular bone, in its normal sense, 
does not occur normally in rat metatarsals, this effect 
has never been seen previously in this laboratory. 
Complex changes also occurred in the main shaft. 
In the B 6- deficient rats, and beginning predominantly 
but not exclusively close to the metaphyseal end, from 
5 days onwards there was parti al replacement of cortical 
bone by woven bone. This seemed to occur in areas which, 
earlier, had the appearance of'altered'bone. This woven 
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Fig. IX. 1 Cryostat sections of ! )-day old fractures of the 
metatarsal in (a) a Wistar rat fed on a diet deficient 
in vitamin B6 and (b) a rat fed on the same diet 
supplemented with the vitamin. Particularly in (a) 
the overlap at the fracture-site that occurs with this 
fracture in this strain of rat, is noticeable. Despite 
periosteal thickening, the soft callus surrounding the 
fracture ends is larger, more obviously cellular and more 
advanced in (b) than in the vitamin B6 deficient animal 
(a). 
TOluidine blue; (a) X 24; (b) X 15. 
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Fig. IX. 2 Cryostat section of metaphyseal end of a 5-day old 
fractured metatarsal in a vitamin B6 deficient rat. 
There is invasion of the shaft of the bone by proliferat- 
ing periosteum seen as an irregular edge to the shaft, 
particularly on the upper surface. 
Toluidine blue; X38. 
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Fig. IX. 3 Cryostat section of the shaft close to the fracture Of 
a2 day old metatarsal fracture in a vitamin B6 deficient 
rat. On the dorsal surface the shaft is invaded by what 
appears to be thickened periosteum. This material 
represents 'altered' bone. 
Toluidine blue; X38 
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Fig. ix. 4 Comparison of the metaphyseal end of the metatarsal from 
vitamin B6 deficient rat and a rat fed on the supplemented 
diet. The bone trabeculae are narrowed and distorted in 
the B6 deficient metaphysis. 
Toluidine blue; X220. 
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Fig. Ix. 5 In the metaphyseal end of the metatarsal shaft of a 
5 day old fracture in a vitamin B6 deficient rat, the 
bone is split up into small isolated fraqments surround- 
ed by bone marrow. 
Toluidine blue: X 38 
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bone within the shaft apparently merged with the newly 
formed woven bone on the outside of the shaft as a normal 
consequence of fracture (Fig. IX. 6). This gave an exagger- 
ated impression of the content of new bone formation. 
There was also a striking increase in the size of the 
vascular spaces, many of which appeared to be lined with 
osteoid and some of which were lined by cells which, 
in some instances, resembled osteoclasts whereas in others 
they had the appearance of osteoblasts (Fig. IX. 7). 
At 8- 12 days post-fracture, the shaft in the 
bone in the B 6- deficient rats was virtually replaced 
by large lacy spaces so that the bone was fragmented 
into small regions resembling trabecular bone (Fig. IX. 8). 
The replacement occurred both from the periosteum and 
endosteum. 
Analysis of 12-day Fracture 
Attention has been concentrated on the 12 day callus 
in rats fed with the B deficient diet, or with' the same 6- 
diet supplemented with vitamin B 6* The images of the 
fractures in eight control and nine B 6- deficient specimens 
were projected through a photographic enlarger to attempt 
to quantify the areas occupied by such components as 
could be measured. 
The callus in the B 6- deficient rats often appeared 
to be flattened. Thus the mean (± SD ) width and length 
of the dorsal callus in 8 control rats was 2.0 Cm 
ý 0.4 
and 8.6 cm ± 1.1 respectively whereas that of 9B 6- defic- 
ient rats was 1.3 cm ± 0.4 (p < 0.001) and 8.6 cm ± 0.8 
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Fig IX. 
m. 
-. 
a. 
Cryostat section of the shaft of a8 day old fracture 
in a vitamin B6 deficient rat. The shaft is extensively 
replaced by woven bone which merges with the woven bone 
on the outer side of the shaft. 
Toluidine blue; X 30. 
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Fig. Ix. 7 Cryostat section of the shaft of a5 day old fracture 
in a vitamin B6 deficient rat. The vascular spaces are 
enlarged and many are lined with osteoid; some are 
lined by flattened cells while in others the cells appear 
multinucleate. 
Toluidine blue; X220. 
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Fig. IX. 8 Cryostat section of the shaft of a5 day old fracture in 
a vitamin B6 deficient rat. The bone appears fragmented 
into small pieces surrounded by interlacing spaces. 
Toluidine blue; X 220. 
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respectively. The plantar callus showed the same pattern. 
The total width of the callus (including shaft) was 
3.7 cm ± 0.6 in 8 control rats and 2.7 cm ± 0.5 in 9 
B 6- defici. ent rats (Table IX. 1). There were also diminished 
areas of calcifying cartilage (Fig. IX. 9). In the controls, 
there were clearly defined areas of dense granulation 
tissue, cartilage and calcifying cartilage, very much 
as described in Chapter VII for both Sprague-Dawley and 
Wistar rats fed on a normal pellet diet. In contrast, 
the callus in the B 6- deficient rats still contained very 
undifferentiated cells and often had large areas which 
were largely acellular. 
The width of the shaft, measured from the endosteum 
to the periosteum (inclusive) confirmed the impression 
that, in the B 6- deficient rats, the shaft was being eroded 
and replaced by woven bone. Thus the mean (± SD ) thick- 
ness (as defined above) in 5B 6- deficient animals (46 
measurements) was 0.31 cm ± 0.9 whereas that of five 
control animals (44 measurements) was 0.37 cm ± 1.3 
(0-05 >p>0.02) (Table IX. 1). As shown in Table IX. 2 
(also Fig. IX. 10) the size of the total callus in the 
B 6- deficient rats was smaller than in the controls 
(0.05 >p>0.02). Initial measurements showed that 
although there was less new bone (p = 0.05) formed in 
the B 6- deficient rats (Fig. IX. 11) the proportion of 
callus occupied by new bone was the same (41%) in both 
groups. However, this apparent discrepancy is almost 
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Table IX. 1. Analysis of the 12 day Fracture. 
Length of metotorsols tmm) 
(neon 1 SEID 
Control B6 - deficient 
14.7 1 0.11 14.6 i 0.32 
Length M and hommum VIM (W) of Callus (m) 
Control B6 - deficient 
Dorsal Plantor Dorsal Plontor 
8.6 t 0.4 L 7.6 0.59 8.6 0.28 L 6.9 0.5 
and 
2i0.15*. **W 1.1 0.39 1.3 0.14 VI 0.76 O. OG 
Totol maximun width of collus (m) 
Control B6 - deficient 
3.7 1 0.2 2.7 1 0.17 
0** 
p, O. uO2 
Controls: n 8; D6 - deficient :n=9 
All results mean :! SEII 
Thickness ot shoft 
Control 
(n - 46) 
0.37 1 0.019 
E6 - defIclent 
(n = Li5) 
0.31 i 0.013 
0 02 
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Table IX. 2. Measurements of the area of the callus and the area 
occupied by new bone in 12 day old fractures of the 
metatarsals from vitamin B6 deficient and supplemented 
rats. 
I 
n=8n=9 
Control B6- defJclent 
Total area of colluS 21 t 2.2 15±1.67 
(M2 - mean t SUD 
Area of New Bone 8.6 ± 1.09 6,2 - 0.6 
(mrr, 2 i mean ± SEM) 
p<0.05 
p<0 -02 
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Fig. IX. 9 Cryostat sections through the mid-shaft of the fractured 
metatarsal, 12 days post-fracture in (a) a rat deficient 
in vitamin B6 and (b) a rat supplemented with the vitamin. 
The callus in the vitamin B6 deficient animal is flattened 
and less well differentiated; the area of calcifying 
cartilage is diminished. 
Toluidine blue, X 20. 
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Fig. Ix. 10 Scattergram of the total area (mm2) of the callus in 
sections through the mid-line of the shaft of 12-day 
fractured metatarsals (a) in 8 control rats fed with a 
supplemented diet and (b) in 9 vitamin B6 deficient rats. 
188 
mm 2 
15 
10 
5 
Fig. IX. 11 Scattergram of the area of the fracture callus occupied 
by new bone in 12-day fractured metatarsals (a) in 8 
control rats fed with a supplemented diet and (b) in 
9 vitamin B6 deficient rats. 
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certainly due to over-estimating the area occupied by 
new bone in the B 6- deficient rats by including some of 
the remodelled old shaft within this estimate, and within 
the estimate of the size of the callus. 
Cytochemical Results 
Glucose 6-phosphate Dehydrogenase Activity 
in the Periosteum. The activity was measured in ind. ividual 
periosteal cells at set distances (0.2 mm) from the fracture 
site up to 2.6 mm. from the fracture site, 3 and 5 days 
post-fracture. G6PD activity was negligible in periosteal 
cells from unfractured metatarsals. 
No obvious differences were observed between 3 
control rats, and 2B 6- deficient rats, 3 days post-fracture 
(Fig. IX. 12). However larger numbers of rats will have 
to be examined. There was considerable activity close 
to the fracture site, values ranging from 14 to 20 units 
of mean extinction in both groups up to 0.4 mm away from 
the fracture site. In two control rats there was a 
peak of C6PD activity I mm away from the fracture site; 
in the two B 6- deficient specimens and in one control 
the periosteal activity declined in the region after 
0.4 mm. 
In the periosteum of the fractured bones from 3 
control and 5B 6- deficient rats taken 5 days after fracture, 
there was no difference in activity between the two groups 
close to the fracture-site, values reaching as high as 
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Fig. IX. 12 Glucose 6-phosphate dehydrogenase activity (MIE x 100) 
in the periosteal cells of 3 day-old fractures. Each 
symbol represents a different rat; open symbols: control 
rats fed with the supplemented diet; closed symbols: 
vitamin B6 deficient rats. The dotted line close to 
the x-axis represents this activity in the periosteum 
in unfractured bone. 
02 04 0-6 08 1-0 1-2 1-4 1-6 1-8 2-0 2-2 .' 2-4 Distance from fracture ( mm ) 
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40 units of mean extinction in both groups. In contrast, 
whereas there was a large second peak of G6PD activity 
in the control rats, 1.4 to 1.6 mm away from the fracture 
site, (as fully described by Dunham et al, 1977, and 
in the Introduction to the present Chapter), the activity 
declined over this region of the periosteum in the B 6- 
deficient rats (Fig. IX. 13). The peaks of activity 
ranged from 56 to 80 units of mean extinction in the 
control rats, and between 15 and 37 units of mean extinction 
in the B 6- deficient rats. 
Alkaline Phosphatase Activity in the Periosteum. 
In 3 control rats, and 2 B6- deficient rats, 3 days 
after fracture, there was low Alk Phos activity up to 
0.6 mm from the fracture site (Fig. IX. 14). The activity 
thereafter became more elevated in both groups. In 
the control rats this activity exceeded those values 
found uniformly in the periosteum Of intact metatarsal 
bones of this strain of rat (29 ± 3.8; mean ± SEM; n=3). 
This increase in Alk Phos was much less marked in the 
B 6-deficient rats: mean value of 29 units of mean extinc- 
tion compared to a mean value of 38 units of mean extinc- 
tion in the control rats. However as stated previously, 
a larger number of rats will be required to establish 
this finding. 
The same general pattern was found 5 days post- 
fracture in 3 control rats and 5B 6- deficient rats 
(Fig. IX. 15). However there was no difference in activity 
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Fig. IX. 13 Glucose 6-phosphate dehydrogenase activiey (MIE x 100) 
in the periosteal cells of 5 day-old fractures. Each 
symbol represents measurements made in a different rat; 
open symbols: control rats fed with the supplemented 
diet; closed symbols: vitamin B6 deficient rats. The 
high activity, in the periosteum. about 1.5mm distal to 
the fracture, that is evident in the control rats, is 
not present in the 5 vitamin B6 deficient rats. The 
dotted line just above the x-axis represents the activity 
in the periosteum of normal bone. 
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Fig. IX. 14 Alkaline phosphatase activitY (MIE x 100) in the 
periosteal cells in 3 day old fractures of three control 
rats (open symbols) and two vitamin B6 deficient rats 
(closed symbols). The bars near the y-axis represent 
the mean (t SEM) activity in the periosteum from 
unfractured metatarsal. 
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Fig. IX. 15 Alkaline phosphatase activity (MIE x 100) in the 
periosteal cells in 5-day old fractures in 3 control 
rats fed with the supplemented diet (open symbols) and 
5 vitamin B6 deficient rats (closed Symbols). The bars 
near the y-axis represent the mean (t SEM) activity 
of the periosteum in unfractured metatarsals. 
0-2 04 0-6 ob to 1-2 1-4 16 1B 20 2-2 24 
Distance from fracture (mm) 
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after 0.6 mm and onwards in these rats (mean value of 
28 units of mean extinction in the control rats and 30 
units of mean extinction in the B 6- deficient rats). 
HOAD Activity in the Periosteum.. HOAD activity was 
measured in the periosteum from the fractures of 3 control 
rats and of 2B 6- deficient rats 
3 days after fracture, 
and in 3 control and 5 B6- deficient rats 5 days after 
fracture. In both cases there was no difference in 
activity as a consequence of B6- deficiency (Fig. IX. 16, 
17). 
( 
Enzymatic Activity in the Cells of the Callus 
Metabolic studies on the cells of the callus were 
done on material of the 12 day post-fracture. As explained 
in Chapters VI and VIII the different cell-types are 
easily de. f ined in this mature callus. The enzyme activ- 
ities were measured in 5 specified cell-types of the 
callus from 8 control and 9B6 -deficient rats: mature 
chondrocytes; chondrocytes in calcified cartilage; 
cellular granulation tissue; loose granulation 
tissue; and osteoblasts (as described in Chapter 
The results for all the enzyme activities are shown in 
Table IX. 3. In all cell-types, except the chondrocytes 
in the calcified cartilage, G6PD activity was significantly 
decreased in the B6- deficient rats. Either no, or 
relatively small differences were found in the activities 
of LDH, GAPD, HOAD, SDH or Alk Phos activities, in any 
of these cell-types 12 days after fracture. It was 
of interest to note that, whereas G6PD activity was 33% 
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Fig. IX. 16 Hydroxyacyl dehydrogenase activity (MIE x 100) in the 
periosteum of 3 day old fractures in 2 vitamin B6 
deficient rats (closed symbols) and 3 control rats fed 
with the supplemented diet. 
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Fig. 1X. 17 Hydroxyacyl dehydrogenase activity (MIE X 100) in the 
periosteum of 5-day old fractures in 5 vitamin B6 deficient 
rats (closed symbols) and 3 control rats fed with the 
supplemented diet (open symbols). 
G2 04 06 O-B 1.0 1.2 1-4 1-6 1-8 2-0 2-2 2.2 
Distance from fracture (mm) 
198, 
Table IX. 3 The activity (mean integrated extinction x 100) of various 
enzymes in different cell types in the callus of 12 day 
old fractures of the metatarsals from vitamin B6 
deficient (b 
6 
d) and supplemented (c) rats. (Values 
corrected to 20 min incubation; mean ± SEM). 
ENZYME ACTIVITIES IN VARIOUS CELL TYPES OF 
12 - day fracture callus 
EU= Osteoblosts ClIondrocytes Granula tion tissu 
riature CalcifyIng Loose Cellulor 
G6PDlc 45 2.8*6* 56 3.2*** 14 1 22 22 80 - 6.6 
bGd 31 2.6 27 2.5 11 0.7 15 t 1.4 
47 z'3.5 
LDH'C 50 3.2 106 3.2*** 32 1.6 32 % 2.2 69 z 6.6 
b6d 47 1.96 71 3.6 25 1.4 30 : 1.4 53 s 3.4 
GAPD'c 11 2 22 1.8 6 0.5 at0.8 39 2 
10 
b6d 10 z1 22 2.0 7 0.3 
9: 0.3 34 z6 
'IOADI c 14 0.5 10 0.75 5 0.39 5 0.5 9 1.4 
b6d 15 0.8 11 1.1 4 0.19 5 0.39 9 1.2 
SDH2 c 22 1.0 -0 -0 5 0.25 10 0.5 
b6d 22 2.2 -0 -0 6 0.8 
14 1.2 
Al k. PhOS. I 
c 166 25.5 173 10.5* 63 t 9.5 24 4 99 4.5 
b6d 189 14 169 11 73 t C. 5 33 4 90 6.5 
I. Control n - 8; B def nw9 6 
2. Control n - 4; B6 def n-5 
*0w0.02 
:0D10.01 
. *D'0.001 
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lower in the osteoblasts and 52% lower in the mature 
chondrocytes, it was less decreased in the loose granu- 
lation tissue (30% decrease), and in the cellular granu- 
lation tissue (39% decrease). 
Discussion 
As has been shown in this thesis (Chapters VI, 
VII) and in previous studies (Dunham et al, 1977), 
one of the remarkable biochemical responses to fracture 
is the striking elevation of periosteal G6PD activity. 
It was suggested that this activity plays a major role 
both in the periosteal proliferation to form the callus 
and in the process of new bone formation. This increase 
in G6PD activity is therefore so fundamental to the 
process of fracture healing that it seemed important 
to try to define the mechanism by which it is brought 
about. One possibility was that it is stimulated 
by the formation of putrescine from ornithine decarboxy- 
lase (ODC) activity. This activity is readily stimulated 
by many hormones acting on their target cells (Bachrach, 
1980) and it was not inconceivable that the trauma 
of fracture might act similarly. ODC activity depends 
on pyridoxal phosphate (vitamin B 6) , and it has been 
shown (Eloranta et al, 1976; Pegg, 1976) that young 
rats can be made deficient in polyamines if fed on 
a particular diet. Consequently it seemed possible 
to test whether the stimulation of G6PD, in fracture- 
healing, could be modified by depleting the rats of 
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vitamin B 
The results of these studies were in conformity 
with the view that ODC activity might regulate G6PD 
activity. Thus of all the enzymes tested only G6PD 
activity was markedly decreased in the B6 -deficient 
callus (Table IX. 3). For example, the HOAD activity 
was totally unaffected. It was of interest that the 
decreased G6PD activity was most marked in bone-forming 
regions of the periosteum (Figs. IX. 12,13) and in 
the osteoblasts and mature chondrocytes of the callus 
(Table IX. 3). Thus although there was significant 
decrease in G6PD activity available for proliferation, 
there was even less available for the formation of 
new bone. 
Thus although it is appreciated that deficiency 
of vitamin B6 can influence many enzymes, these results 
support the suggestion that this deficiency would be 
reflected in decreased G6PD activity. 
The decreased G6PD activity, for proliýeration 
and for bone-formation, was also reflected in the histo- 
logical changes found in the B 6- deficient fractures. 
These included a flattened callus of diminished width 
and a decrease in the area occupied by new bone. What 
was totally unexpected were the bizarre histological 
changes found in the shaft of the bone and which, as 
discussed above, led to an under-estimate of the size 
of callus and extent of new bone . These changes were remark- 
ably-similar to the appearance found in human osteoporosis. 
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This requires much more investigation: if they are 
fully substantiated they would indicate that here we 
may have a much needed animal model of osteoporosis. 
I 
The results suggest that the deficiency of vitamin B6 
may have lead to an uncoupling of the normal turnover 
of bone, with decreased anabolic activity (possibly ' 
related to G6PD activity). However, this is for the 
future. 
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CHAPTER X 
CHANGES IN CRYSTAL SIZE AND ORIENTATION OF 
GLYCOSAMINOGLYCANS AT THE FRACTURE SITE 
IN FRACTURED NECKS OF FEMUR. 
I nt rod uction 
The aim of this study was to try to elucidate 
the increased susceptibility of the neck of femur to 
fracture. The incidence of this condition rises 
exponentially after the age of 50 years (Knowelden 
et al, 1964) and the fractures are usually the result 
of only relatively minor trauma. An estimated 40,000 
such fractures occur in the United Kingdom each year 
(Lewis, 1981) and represent, therefore, a significant 
social and medical problem in terms of treatment and 
rehabilitation (Lewinnek et al, 1980). The rate of 
fracture of the femur rises with age, generally more 
steeply in women than in men(Alffram, 1964; knowelden 
et-al, 1964 Fig. X-1). 
It is apparent from the reported studies on 
the aetiology of fractures of the femoral neck that 
there is no single cause of the fracture but rather 
it is associated with a combination of factors such 
as age, sex, nature and type of fall, and changes in 
bone fragility (Elsasser et al, 1980; Cook et al, 
1982). 
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Fig. X. I Cumulative incidence of fracture of the neck of femur with 
age. 
(from Alffram, 1964) 
I 
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The structural changes that occur in the femoral 
neck prior to fracture are not understood. They may 
be a result of several sequential or concurrent changes 
such as osteoporosis or osteomalacia, or in the tensile 
strength of the bone matrix (Wall et al, 1979; Cook 
et al, 1982). Cook et al (1982) found that osteoporosis 
is of major importance in the aetiology of fractured 
neck of femur. However there was a trend towards 
an inverse relationship between osteoporosis and osted 1* 
malacia in that patients who suffer these fractures 
and who do not have osteoporosis seem more likely to 
have osteomalacia. Wall et al (1979) showed that 
both the density and the intrinsic strength of bone 
increase up to about the fourth decade of life and 
then decrease with age. However the decrease in tensile 
strength of bone with age progresses at a greater rate 
than the decrease in bone density. This fact indicated 
that a change in structure of the bone or in the inter- 
action between the organic matrix and the mineral phase 
could explain the increased liability of the femoral 
neck to fracture. Changes in the mechanical properties 
of machined pieces of the femoral shaft, from such 
fractures, compared with similar pieces prepared from 
normal subjects, have been found (Dickenson. et al, 
1981). The bone specimens tested under tension from 
patients who had femoral neck fractures had less stiffness 
and strength compared with normal bone and these changes 
were correlated with the degree of osteoporosis. 
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These bones also had considerably reduced energy absorption 
before failure and this was not related to changes 
in mineral content of the bone or to the degree of 
Osteoporosis. Thus this bone has a much greater tendency 
to fracture during the sudden stress of a fall when 
the work done on the bone is too great to be elastic- 
ally absorbed. 
The three-dimensional structure of bone, especially 
the morphology of bone mineral, has been studied with 
techniques such as polarised light microscopy (von Ebner, 
1894; von Schmidt, 1938), x-ray diffraction (Carlstrom, 
1955; Engstr6m, 1972; Chatterji et al, 1981), electron- 
microscopy (Robinson, 1952; Bernard, 1969; Bocciarelli, 
1970; Voegel and Frank, 1977) and scanning electron 
microscopy (Jackson et al, 1978). There is some dis- 
agreement as to the shape of the apatite crystals 
(needle-like or plate-like crystals) and of the orienta- 
tion of the crystallite c-axis with regard to the long 
axis of the collagen fibre (parallel or perpendicular). 
There is however good agreement that the apatite crystals 
must be small in size (50 nanometres or less in the 
long axis). Chatterji et al (1981), using x-ray 
diffraction techniques, measured the orientation and 
size of crystals in human femoral cortical bone taken 
from subjects within the ages of 13 to 97 years. 
After the age of 60, there was a marked change in the 
distribution of crystallites so that older bones had 
a greater proportion of large crystallites (over 600 nm). 
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They showed that ultimate tensile strength and mineral 
particle size correlated closely with respect to age. 
They discussed the fundamental basis for this correl- 
ation: The bond between apatite and collagen matrix 
is strong (Swanson, 1971 as cited by Chatterji et al, 
1981), so that with a decreasing percentage of small 
particles, the specific surface area available for 
bonding decreases and so decreases the tensile strength 
of bone. This would occur irrespective of bone dens'ity. 
In the present study, quantitative polarised 
light microscopy has been used to identify changes 
in the microstructure of some of the components of 
bone at the site of fracture that could explain the 
increased fragility of the bone in these patients. 
Materials and Mýthods 
The femoral heads were obtained from Northwick 
Park Hospital over an eleven month period, 
. 
from patients 
undergoing total hip replacement for severe osteoarthritis 
or Thompson replacement for subcapital femoral neck 
fractures; others were obtained at necropsy from 
patients whose death was'not related to any bone disease. 
Small blocks of trabecular bone (about 2x1x3 
cm) were sawn from the femoral head to include the 
fracture site or from an equivalent position at the 
epiphysial region of the osteoarthritic and cadaveric 
bones (Fig. X. 2 ). Pieces of bone were also collected 
at operation from three patients who had suffered traumatic 
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Fig. X. 2 Diagrammatic representation of the femoral head and neck to 
show the site of sampling. 
post mortem fractured neck 
of femur 
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fractures of the tibial or femoral shaft or the neck of 
humerus. The small blocks were immersed in 5% (w/v) 
polyvinyl alcohol (G04/140 Polyviol; Wacker Chemicals) 
before being chilled to -70' C in n-hexane. Cryostat 
sections(10 microns thick) of the unfixed, undemineral- 
ised bone were prepared as described in Chapter V. 
These sections were cut from the blocks orientated in 
such a way that one side of the section was at the 
fracture surface or the equivalent surface from the 
osteoarthritic or cadaveric specimens. All sections 
were dried overnight at 370 C. 
Crystal Study. For the study on crystals, 19 osteo- 
arthritic samples (7 male, and 12 female; mean age 
and standard deviation, 67.6 ± 11.5 years), 16 cadaveric 
samples (5 male, 11 female; mean age and standard 
deviation, 73.7 ± 8.2 years) and 21 samples of fractured 
necks of femur (I male; mean age and standard deviation 
76.7 ± 12.6 years) and 3 samples of traumatic fracture 
were investigated (Table X. 1). 
Birefringence_Study. For the study on the birefringence 
of collagen and of the glycosaminoglycans (GAGs), the number 
of specimens and the ages of the subjects were 8 osteo- 
arthritic (62.1 ± 14.7 years), 8 cadaveric samples 
(72.3 ± 5.1 years) and 11 samples of fractured necks 
of femur (80.4 ± 12.0 years) (Table X . 2).. 
The sections were then inspected, under crossed 
polars, either unstained or after staining with Alcian 
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Table X. 1 Crystal study : age and sex of patients. 
Osteoarthritic Cadaveric 
No. studied 
sex 
age 
mean ± SD 
19 
7M 12F 
67.6 11.5 
16 
5M 11F 
73.7 8.2 
Fractured 
neck of femur 
21 
1M 20F 
76.7 12.6 
Table x. 2 Collagen and GAG birefringence : age of patients. 
osteoarthritic Cadaveric Fractured 
neck of femur 
No. studied 88 11 
Age 62.1 ± 14.7 72.3 ± 5.1 8o. 4 ± 12 
mean ± SD 
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blue, by the critical electrolyte concentration method 
of Scott and Dorling (1965) as described by Chayen, 
Bitensky and Butcher (1973) (see later). 
All the microscopic exainations and birefringence 
measurements were done using a Brace-Mler X/30 
compensator on a Zeiss universal microscope equipped 
with a range of polarising objectives (16X, 0.32 NA; 
40X, 0.85 NA; 63X, 0.9 NA). 
Polarised Light Microscopy 
Polarised light microscopy is used for the 
detection and measurement of matter that has crystalline 
or crystalline-like properties. Light has electro- 
magnetic properties and is therefore influenced by 
the electromagnetic properties of the material through 
which it passes. Thus all matter will retard light 
to a greater or lesser extent.. The degree of 
retardation is given by the term 'refracti. ve index' 
(RI): 
RI = velocity of 
light in air 
velocity of light in the material 
In general, crystals, and crystal-like material, 
have three optical axes, corresponding to the length, 
breadth and depth of the material. For non-crystalline, 
or isotropic, material, the refractive index along 
all three axes is the same. In contrast, the RI along 
the length of most crystalline-like, or anisotropic, 
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material is different from that along one or other 
(or both) of the other axes. Such anisotropic 
material shows the property of birefringence, which 
is defined as the difference between the refractive 
index measured with light parallel to the long axis 
(nil) and with light vibrating perpendicular to the 
long axis (n that is nil n The polar- 
ising microscope actually measures the optical path 
difference in our material, that is the interaction 
of both refractive indices that causes a change in 
the velocity of the light. This is influenced by 
the thickness of the specimen. Thus 
optical path difference birefringence 
thiC'kness 
Consequently a thicker crystal appears brighter than 
a thinner crystal of the same material. 
The Mechanism. The theory of polarised light micros- 
copy is very complex but can be explained very simply 
by the use of vectors (Fig. X. 3). 
ANALYSER 
e"OB 
J EC T 
W< 
POLARISER 
Fig. X. 3 Diagrammatic representation of the theory of polarized light 
microscopy. (from Chayen, 1983) 
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The polariser is situated below the condenser 
and can be rotated to give plane-polarised light vibrating 
solely in the east - west (E - W) direction. Consequently 
it has vectors in the 45* p. ositions. It has no vectors 
in the N-S direction and thus will not pass the rotatable 
analyser, set to the N-S position. The analyser 
is set between the objective and the eyepiece. The 
analyser is apolar and transmits light that vibrates, 
in one direction only. Positioned in the N -'S position 
the field will appear black. 
When a birefringent object, in which light vibrates 
more rapidly (or more slowly) along its long axis than 
its short axis, is placed in the field in a 45* position 
it will be maximally bright. This is because one of 
the 45* vectors of the E-W light will be moving along 
this long (fast) axis, the other 45* vector being retarded. 
The vibration of the resultant light will be 
turned towards the N-S axis, the object having turned 
the plane of polarisation. This resultant vibration 
now has a vector that is in the N-S position and will 
pass through the analyser (set to N-S position). 
The object will appear bright with the background remaining 
black. 
The theory of polarised light microscopy involves 
the interference between the two vectors of the light 
which, moving slightly out of phase with one another, 
will give the resultant light. 
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Types of Birefringence. 
of birefringence. 
There are two main types 
1. Crystalline (intrinsic). This is determined 
by the chemical structure of the material. 
2. Form (textural). Structures such as collagen 
fibres which contain orientated elongated submicro- 
scopic particles show form birefringence. 
Crystalline birefringence depends directly on 
the electromagnetic characteristics of the material 
and thus is not dependent on the refractive index of 
the mounting medium. Form birefringence 
depends on 
the different velocity of light in the array of 
particles (or fibrils) and the velocity in the material 
in which they are mounted. 
Measurement of Birefringen 
This subject has been fully reviewed by 
Hartshorne 
I 
and Stuart (1970). In practice, since the measurement 
of birefringence requires that the thickness of the 
object has been determined (see above), it is preferable 
to record the optical path difference (opd). This 
can be measured accurately by the use of various 
compensators. In the present study, a Brace-KO"hler 
X /30 rotatable compensator has been used with a Zeiss 
universal microscope (Fig. X. 4). It is inserted 
at the 450 position, above the objective and below 
the analyser; it is rotated, about its own axis, until 
the retardation imposed by it compensates for the 
retardation caused by the birefringent object. For 
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Fig. X. 4 A. Zeiss Brace-Kbhler X/30 compensator. 
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precision, it is advisable to use monochromatic light. 
Procedure. The polariser and analyser are crossed 
and the compensator is set to extinction (that is, 
with its vibration directions parallel to those of 
the polariser and analyser). The crystal or fibre(s) 
is turned into either of its 45* positions. The 
compensator is then rotated until extinction is obtained. 
Birefringence is expressed as nanometres of optical 
path difference (R obj 
) after conversion of the angle 
of rotation of the compensator (Q according to the 
equation 
R 
obj ýR comp s 
in 2 q) comp 
where R comp 
is the optical path difference imposed 
by the compensator (Chayen and Denby, 1968). 
Orientation of GAGs and Related Compounds 
Collagen fibres naturally show form birefringence. 
In contrast, the other major organic component of bone- 
matrix, namely GAGs, cannot be detected by polarised 
light microscopy. This may be due to various causes. 
They may be totally unorganized, so that they would 
show no overall birefringence even if they were capable 
of showing form-birefringence; or their form-birefringence 
could be so low that, even if they were highly oriented, 
they would be undetectable. Yet it is of some importance 
to know if they are oriented in normal bone, and if 
that orientation were to become altered in pathological 
conditions. 
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To examine this question in detail, we have developed 
a procedure involving 'induced birefringence', along 
the lines indicated by Modis (1974). In this procedure 
we stain the bone with a planar dye, Alcian blue, which 
is highly birefringent either in the dry, semi-crystalline 
state, or when caused to become oriented, namely when 
a solution is drawn out into thin lines and allowed 
to dry. I found that the GAGs of normal bone-matrix, 
stained with this dye, showed strong birefringence (hence 
the term 'induced birefringence'). The staining was 
done by the critical electrolytic method of Scott and 
Dorling (1965), as described by Chayen et al (1973). 
Alcian Blue Staining: concept of the critical 
electrolyte concentration. The theory states that 
the intense negatively charged field of a polyanion 
attracts positively charged coloured dyes, such as Alcian 
. blue, producing a coloured 
bound stain. Addition of 
an uncoloured cation leads to competition between the 
dye and the electrolyte. Although all the glycosamino- 
glycans are negatively charged and bind Alcian blue, 
they vary in their ability to compete with increasing 
concentrations of magnesium ions (magnesium chloride). 
Ten micron sections were stained with an 0.05% 
solution of Alcian blue in 0.25M sodium acetate buffer 
at pH 5.8. To this solution was added magnesium chloride 
at the appropriate molarity: 
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0.025M to stain all GAGs and acidic moieties that 
remain ionized at this pH 
0.5M to stain only chondroitin sulphate and keratan 
sulphate (and suppresses sialic acid residues). 
The use, therefore, of the potential birefringent 
properties of Alcian blue allows the study of the 
orientation of glycosaminoglycans on sections of bone. 
. 
Demonstration of Crystals.. Sections were inspected 
either dry or in benzaldehyde (R. I. 1.544) under crossed 
polars. Crystals were examined to determine their 
sign of birefringence, extinction angles, general habit 
and refractive index. 
Sign of birefringence. This defines whether the optically 
slow axis is along the long or short geometric axis 
of the crystal. This is determined by orientating the 
crystal along its long axis at the 45* position that 
intersects the N-E angle. The crystal will appear maxi- 
mally bright on a black background. A quartz-red plate is 
then inserted into the slot in the microscope tube. 
The quartz red plate is cut in such a way that the vectors 
(or rays) interfere with one another to give first order 
red light in Newton's scale. The field now appears red. 
Then if the slow axis of the retardation plate is parallel 
to the slow axis of the crystal, and since 
R=R+R the crystal will appear total , plate specimen' 
blue (increased resultant interference wavelength). 
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Such a crystal is called a positive crystal. If the 
slow axis of the plate is parallel to the fast axis 
of the crystal then 
R 
total =R plate 
R 
specimen 
and the crystal will appear yellow on a red background 
(decreased resultant interference wavelength). Such 
a crystal is called a negative crystal. (R total etc. 
refers to the retardation of the plate or specimen). 
, 
Extinction angle. Crystals that appear blackest when 
set to the N-S or E-W position (but bright at intermediate 
positions) show straight extinction. Some crystals 
do not become darkest at exactly the N-S position, but 
at some angle to this direction. This may be related 
to whether the three axes of the unit crystal are at 
right angles or not. The extinction angle is very 
useful in defining the crystalline material, e. g. 
crystals of apatite show straight extinction. 
Refractive index. The refractive index of crystals 
was determined by the method described by Watts et al 
(1971). Briefly, crystals were chosen and individually 
orientated to the position that made them maximally 
bright: the microscope stage was locked and the amount 
of birefringence (actually, optical path difference) 
was measusred by Brace-K; ýhler compensation as described 
earlier, The measurement of birefringence was repeated 
with the section mounted in media of differing refractive 
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index, keeping the chosen crystal in the centre of the 
field. The refractive indices of the fluids were then 
plotted against their retardation values. The refractive 
index which gave the lowest birefringence was taken 
as the refractive index of the crystal. 
Results 
Appearance of sections under crossed polars. All seqtions 
from all 35 osteoarthritic or cadaveric specimens, mounted 
either in air or in benzaldehyde (RI = 1.545), showed 
highly birefringent lamellae of collagen. Haversian 
systems were often in the plane of the section. Between 
these arrays of collagen, the section appeared to be 
as black as the background. This indicated an apparent 
lack of suitably orientated birefringent material in 
between the circular or linear arrays of collagen 
(Fig. X-5 and 6). Such sections, which were fully 
mineralised, were indistinguishable from sections of 
bone that has been chemicaly fixed, decalcified, embedded 
in paraffin and sectioned in a routine histological 
laboratory. An exactly similar image was obtained when 
the sections of undemineralised bone were treated with 
EDTA (0-1M) at pH 7 for 16 hours to remove the mineral 
component. These results implied that the crystals 
of mineral, in the undecalcified sections, were too 
small, and too disorientated, to be detected in this 
microscopic system. 
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Fig. X. 5 An example of a cryostat section of fresh human unde- 
mineralized bone from the femoral epiphysis viewed under 
crossed polars showing the Haversian arrays of collagen. 
The spaces in between the birefringent collagen bundles 
show no birefringent material and appear black.. X 220. 
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Fig. X. 6A section of trabecular fragment from a human femoral 
epiphyseal region viewed under crossed polars. As in 
Fig. X. 5, the spaces between the bright birefringent 
linear arrays of coliagen appear black. X 220. 
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In marked contrast, in all 21 samples of fractured 
necks of femur, discrete crystalline material was found, 
particularly close to the site of fracture, in between 
the collagen lamellae (Figs. X. 7. and 8). The incidence 
of crystals apparently decreased-with distance (up to 
3 cm) from the site of fracture. 
Characteristics of the crystals. These crystals showed 
true crystalline birefringence in that their birefringence 
was relatively unaffected by the refractive index of 
the medium in which the sections were mounted. They 
showed straight extinction, positive birefringence and 
appeared to be hexagonal (Figs. X. 7 and 8). Although 
many of the crystals were small, about 0.5 um long, 
many were 2.5 by 0.5 um. The optical path difference 
through these large crystals was only 19 nm; if the 
thickness of these crystals is taken to be 0.5 um, 
this indicates a birefringence of 3.8 x 10- The 
refractive index was greater than 1.545 (the RI of ben- 
zaldehyde). Thus in all features, these crystals 
corresponded to crystals of apatite. 
Birefringence of collagen and of GAGs. Untreated 
sections were examined by polarised light microscopy. 
The optical path difference measured in the collagen 
lamellae was the same in all three types of specimen 
(Table X. 3 and Fig. X. 9). 
Sections stained with Alcian blue, in the presence 
of either 0.025M or 0.5M magnesium chloride, (Fig. X 
10 (a) and 11 (a)) were examined by polarised light 
microscopy. They showed blue birefringent matter 
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Fig. X7 and 8 
Low and high power photomicrographs of a section from the 
sub-capital fracture site of a human femur. In contrast 
to Figs. 5 and 6, scattered between the bright 
birefringent collagen bundles are bright birefringent 
crystals. Fig. 7X 220; Fig. 8x 343 
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Table X. 3 Birefringence (optical path difference) of collagen and 
sections of bone stained with Alcian blue, measured in 
nanometres of retardation (mean t SEM). 
Osteo- Fractured 
arthritic Cadaveric neck of femur 
Treatment (n = 8) (n = 8) (n= 11) 
Unstained 17.4 + 0.5 17.2 ± 0.6 16.7 + 0.2 
collagen 
Alcian bluc 20.3 + 0.4 
+ 0.025m- 
MgC12 
20.2 ± 0.3 H. 2 + 0.4* 
Alcian blue 15.2 + 0.6 
+ 0.5m- 
M9Cl2 
15.8 ± 0.6 7.8 + 0.5 * 
Traumatic 
fractures 
(n =2 or 3) 
14.7,16.9 
19.1,21.0 
17.3,15.8, 
15.1 
*Significantly different (P<0.001) from ostcoarthritic and cadaveri, 
groups; Student's mest 
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Fig. X. 9 Scattergram of the values of optical path difference (opd) 
measured in unstained sections (collagen) and sections 
stained with Alcian blue in the presence of either 0.025M 
or O. SM MgCl 2 of samples of human femoral epiphyseal 
region taken from ostecarthritis (OA), cadaveric (PM), 
and subcapital fractures (FNF). Three examples of 
traumatic fractures are also shown. The horizontal bars 
indicate the mean for each group. 
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Fig. X. 10 and 11 
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B 
Two examples of sections of samples of the human femoral 
epiphyseal region stained with Alcian blue viewed (a) by 
ordinary light microscopy and (b) under crossed polars. 
The blue 'induced' birefringence is superimposed on the 
__1.! S.. __  ''" 
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apparently coincident with the collagen lamellae, which 
largely obscured the white biref ring ence of the collagen 
lamellae (Fig. 
. 
X. 10 (b) and 11 Sb))-. The optical 
path difference induced by this blue birefringence in 
sections of osteoarthritic and cadaveric samples, 
stained by Alcian blue in the presence of 0.025M 
MgC1 
2 was identical. However it was markedly depressed 
in sections from the fractured necks of femur (Table 
X'.. 3): it was least when close to the site of fracture 
and rose to high values up to 15 mm from the fracture 
(Fig. X. 12), although even at this distance from the 
fracture, the values were well below normal levels. 
However, it may be noted that the induced birefringence 
was considerably greater than the natural birefringence 
of the collagen. 
The higher concentration of magnesim chloride 
(0-5 1ý decreased the amount of Alcian blue birefringence 
but essentially similar results were observed (Table X . 3; 
Figs-X . 9,11 and 12). 
Content of GAGs. In a few sections, 'the amount of 
Alcian blue stain present was measured by direct photo- 
metry in the same regions as had been selected for 
birefringence measurements. . 
The results are shown 
in Fig. X . 13. They show that the content of GAGs 
through the thickness of the section was equivalent 
in all three types of specimen even though the amount 
Of birefringence in the individual lamellae in sections 
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Fig. X. 12 The mean optical path difference measured in sections 
from five different cases of subcapital femoral fracture 
(mean t SEM) with distance from the fracture site. The 
collagen birefringence (squares) in unstained sections 
remains constant whereas the 'induced' Alcian blue 
birefringence (low MgC1 2: circles; 
high MgC1 2: triangles) 
increases with distance from the fracture site but does 
not reach normal values. 
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Fig. X. 13 The optical path difference (opd), measured under crossed 
polars, plotted against the absorption produced by the 
Alcian blue stain (concentration) in the same region of 
the same sections of samples of (a) sub-capital 
fractures (circles) and the equivalent epiphyseal region 
from (b) cadaveric (triangles) and (c) osteoarthritic 
(squares) femoral heads. The amount of Alcian blue 
staining in all three groups is similar but the induced 
OPd is depressed only in the fracture group. 
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from the fractured necks of femur was decreased by about 
45%. 
Results from traumatic fractures. No crystals were 
found in several serial sections taken from these fractures. 
The optical path difference measured in the native collagen 
and the Alcian blue birefringence in sections stained 
at both concentrations of magnesium chloride agreed 
closely with the values found in the non-fractured spetimens 
(Table X 
.3 and 
Fig. X. 9). 
Reproducibility of measurements of birefringence. 
On six occasions, the birefringence (optical path difference) 
was measured 5 times by myself and by Dr. N. Kent. The 
overall coefficient of variance was 9.5%. 
Discussion 
Dickenson et al (1981) investigated the relation-ý 
ship between applied tensile load and resultant strain 
in normal and osteoporotic bone; they showed that the 
elastic component (presumably related to the collagen) 
was virtually identical in both. However they showed 
that osteoporotic bone will break at lower load than 
normal bone, and this is probably related to the proper- 
ties of the mineral component. The results from the 
present study are in agreement with those of Dickenson et al 
(1981). The degree of orientation of the collagen 
lamallae was the same in the specimens of fractured 
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neck of femur as in the osteoarthritic and cadaveric 
samples. The mineral phase was found to be different 
in that, close to the site of fracture, some of the 
mineral phase occured in the form of crystals of the 
size that could readily be resolved by normal, polarised 
light microscopy. The crystals observed in sections. 
from fractured necks of femur were not seen in the few 
traumatic fractures that were available for study. 
This last point shows that the crystals seen in fractured 
necks of femur were unlikely to be due simply to the 
fracture process. 
The use of the potential birefringent properties 
of Alcian blue allowed studies to be made on the orien- 
tation of glycosaminoglycans (GAGs). As defined by 
Scott and Dorling (1965) and described by Chayen et al 
(1973) Alcian blue in the presence of 0.025M MgCl2 
will stain all GAGs and other acidic molecules, such 
as hyaluronic acid and acidic proteins. These acidic 
molecules may not be birefringent, even when orientated; 
however, when Alcian blue becomes bound to such orientated 
molecules, the complex with the dye does exhibit bire- 
fringence (Modis, 1974). Alcian blue in the presence 
of 0.5M MgC12 will only bind to highly sulphated, 
long-chain moieties, mainly chondroitin and keratan 
sulphates (Scott and Dorling, 1965; Scott, 1973). 
Thus it is possible to distinguish between the orientation 
of acidic, long-chain molecules generally and that of 
chondroitin and keratan sulphates.. 
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The total content of GAGs was the same in all 
samples tested in this study. However, the degree 
of orientation of all long-chain acidic molecules (stained 
in the presence of 0.025M MgCl2) and of the chondroitin 
and keratan sulphate-like moieties, was found to be 
about 45% less in the bone from the fractured necks 
of femur than in the osteoarthritic or cadaveric specimens. 
This decreased orientation was largest close to the 
site of fracture and tended towards more normal values7 
further from the fracture. However even 15 mm from 
the site of fracture the birefringence was somewhat 
abnormal (Fig. . X. 12). 
This effect was unlikely to 
be the result of fracture since the orientation of Alcian 
blue-stained material in the lamellae of traumatic 
fractures was the same as in the "control" specimens 
(Table X. 3 and Fig. . X. 9). 
This study showed that close to the fracture site, 
relatively large crystals exist, that have the optical 
properties of apatite. This was seen in all 21 cases 
of fractured necks of femur and in none of the 35 other 
"control" specimens or in the three traumatic fractures. 
This finding was in keeping with the observations of 
Wall et al (1979) and Chatterji et al (1981), that, with 
advancing age, some microstructural change occurs in bone 
and that the density of the bone is not the sole determin- 
ing factor in its resistance to fracture. The develop- 
ment of crystals, of the size found in the present study, 
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would be in keeping with a microstructural change that 
could predispose the bone to fracture. The presence 
of such crystals in otherwise microcrystalline metals 
can be a source of structural failure or fracture 
(Forsyth, 1969; Engel and Klingele, 1981). 
The finding that the orientation of ordered 
components of the non-collagenous ground substance was 
also decreased in the fractured necks of femur could 
indicate a cause for the development of such anomalously 
large crystals of apatite in the microcrystalline 
mineral phase. This arises from the fact that the 
crystallisation of apatite can be modulated by GAGs 
(Boskey, 1981). The fact that these changes, and the 
appearance of crystals, occur only at a specific locus 
may be related to the fact that this region is the site 
of greatest shear. It is certainly the site of greatest 
tension, as shown by Singh et al (1970). 
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CHAPTER XI 
DEVELOPMENT OF A METHOD FOR MEASUREMENT 
OF SODIUM POTASSIUM ATPase 
Introduction 
Relation of G6PD and Na+-K +- ATPase 
Much of the work in this thesis has been concerned 
with changes in glucose 6-phosphate dehydrogenase (G6PD) 
activity. It has been suggested that this activity* 
is central to cellular activity, particularly in fracture- 
healing, both because it controls pentose-shunt activity 
(and therefore the production of ribose sugars) and 
because it is a major source of cytosolic NADPH. The 
latter is implicated in many cellular physiological 
functions, some of which have been discussed earlier. 
However there is also evidence (Dikstein, 1971) that 
there may be a relationship between G6PD activity, or 
the generation of NADPH, and the activity of sodium- 
potassium-dependent adenosine triphosphatase (Na+-K+- 
ATPase). Because this enzymatic activity is vital to 
the life of cells, and may play a major role in cellular 
oedema, as in fracture-healing, it was considered 
necessary to investigate this enzymatic activity. 
Background to Na+-K +- ATPase 
As reviewed by Baker (1972) the' energy-requiring 
cellular process of active transport of sodium and 
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potassium plays a major role in the maintenance of cell 
volume; in absorption processes in kidney and intestine; 
and in the propagation of action-potentials in excitable 
and contractile tissue. The active transport of sugars 
and amino acids is also possibly dependent on the distrib- 
ution of sodium and potassium ions (Hokin and Dahl, 
1972; Katz et al, 1979). The energy dependent intra- 
cellular control of sodium and potassium ions apparently 
depends on sodium-potassium-ATPase activity as a "pump" 
(Baker, 1972). The important feature of this pump 
is that ATP appears to be the energy source for this 
transport. It is now established that the sodium-potassium 
dependent, magnesium - stimulated adenosine triphosphatase 
(Na +-K+- ATPase) of cell plasma membranes provides 
the catalytic machinery for the coupling of the energy 
released by the hydrolysis of ATP allowing the exchange 
of Na 
+ for K+ across plasmalemmal surfaces against their 
respective concentration gradients (Perez-Gonzalez de 
la Manna et al, 1980). 
Because of the critical importance of this ATPase 
in cellular physiology, several workers have sought 
a cytochemical procedure for demonstrating its activity- 
A great deal of this work has been done on the kidney. 
This is an ideal test material for the following reasons: 
M The Na+ -K+- ATPase activity, measured biochemic- 
ally, is high in the renal cortex; 
(ii) The relative activities of this enzyme, in different 
regions of the nephron, have been investigated in detail 
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by microdissection studies with radio-labelled ATP; and 
(iii) The activity of the enzyme is likely to be under 
hormonal control (as will be discussed later), so that 
changes in the activity (in different regions of the 
nephron) induced by physiological conditions or hormonal 
influence should be reflected by changes measured cyto- 
chemically. 
One of the major problems of the earlier cyto- 
chemical methods for demonstrating Na +-K+- ATPase 
activity was the inability to demonstrate activity in 
proximal tubules, in which this enzymatic activity appears 
to fulfil major physiological functions, namely the 
transport of glucose and of calcium (Kinne et al, 1978). 
This disadvantage, along with many others, in the earlier 
methods will be discussed briefly. 
Earlier Histochemistry of the Enzyme. 
The initial 'attempts to localize Na+ -K 
+_ ATPase 
cytochemically centred about the Wachstein and Meisel 
(1957) techniques. The methods employed lead ions 
to trap the phosphate liberated by the ATPase activity. 
However these methods fell into disrepute because the 
lead ions themselves caused a non-enzymic , hydrolysis 
of the ATP that was used as substrate, and also because 
free lead ions strongly inhibit Na +-K+- ATPase activity 
(as reviewed by Ernst and Hootman, 1981; Ernst, 1972(a); 
Beeuwkes and Rosen, 1975,1980). Moreover, ouabain, 
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the specific inhibitor of Na +-K+- ATPase, had no 
effect on the activity. Omission of Na + or K+ had 
little effect either (Novikoff, 1961; Farquhar and Palade, 
1966; Tormey, 1966). 
In an attempt to overcome these problems, Ernst 
(1972 (a), (b)) introduced the use of the substrate 
p-nitrophenyl phosphate (PNPP) for demonstrating the 
ouabain sensitive, potassium-dependent phosphatase activity 
which is now believed to function as part of the Na + -K 
+ 
ATPase activity (Ernst, 1972 (a); Hokin and Dahl, 1972). 
Hydrolysis of the phosphate bond of p-nitrophenylphosphate 
(PNPP) yields inorganic phosphate which can be precipitated 
by heavy metal capture ions. Strontium was used as the 
trapping agent because its inhibitory effect on activity 
was less than that of lead at equivalent concentrations 
However this still left an unsatisfactory degree of inhib- 
ition and left untouched the related problem of the require- 
ment of an alkaline pH for efficient precipitation of the 
phosphate. This alkaline pH is sub-optimal for enzymatic 
activity(Ernst, 1972 (a)). Furthermore, PNPP is readily 
hydrolysed by alkaline phosphatase at pH values above 8. 
Thus for most tissues it becomes essential to add a 
sufficient concentration of an appropriate inhibitor of 
alkaline phosphatase activity to the reaction medium 
if the reaction for K+NPPase activity is to be valid. 
However it is fortunate that alkaline phosphatase and 
K+-PNPPase activities are localized in different plasma- 
lemmal surfaces in the kidney cortical tubules. This 
method has apparently been found to be unsatisfactory 
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so that Guth and Albers (1974) modified it in two ways: 
first, by adding dimethyl sulphoxide to the medium, 
which at 30% concentration, changes the optimal pH to 
9.0 (Beeuwkes and Rosen, 1980), and inhibits alkaline 
phosphatase activity(Ernst et al, 1980) ; and secondly, 
by leaving out the strontium, relying on the phosphate 
being captured by the magnesium and potassium ions 
endogenous to the tissue (Beeuwkes and Rosen, 1975; 
Ernst et al, 1980). The precipitated phosphate was 
converted to cobalt phosphate, by immersion in a solution 
of cobalt chloride, and thence to cobalt sulphide. 
So, although the phosphates of both potassium and magnesium 
are appreciably soluble, and although this method depends 
on the presence of sufficient concentrations of these 
ions in the tissue, it is hoped that phosphate, hydrolysed 
during_ the reaction, remains within reactive cells 
without the need of a heavy metal capture-ion. This 
method was used by Beeuwkes and Rosen (1975,1980) who 
used electron-probe analysis to quantify the reaction- 
products. In the kidney, Beeuwkes and Rosen (1975) 
showed highest activity in the thick ascending limbs 
of the loop of Henle, and in the distal convoluted 
tubules. They reported no PNPPase activity in the 
proximal tubules, even though the ATPase activity, 
recorded in these tubules by the microchemical, micro- 
dissection studies of Schmidt and Dubach (1969), of 
Schmidt et al (1974) and of Katz et al (1979) showed 
that the activity in these tubules was one third that 
239 
of the distal tubules. Beeuwkes and Rosen (1975) 
concluded that their inability to record activity in 
proximal tubules might have been due to the relative 
insensitivity of their method. Morphological preser- 
vation is poor in this method and the nature of the 
phosphate precipitation process precludes subcellular 
definition of the distribution of the reaction product 
(Ernst and Hootman, 1981). 
Mayahara et al (1980) presented a modification 
of the PNPPase procedure. Lead citrate was substituted 
for strontium as the trapping agent. A study by Mayahara 
and Ogawa (1980), using this method, demonstrated K+- 
dependent activity in the rat kidney that paralleled 
the distribution obtained with the original method, 
as used by Firth (1974) and by Ernst (1975). The 
advantage of this technique is that it is methodologically 
simple. 
Thus until recently, this important enzyme, 
Na+ - K+ - ATPase, has been examined cytochemically 
only by an indirect method that has a number of disad- 
vantages. Most importantly, as far as studies on the 
kidney are concerned, the methods described do not demon- 
strate activity in proximal tubules. Yet, the Na +- 
K+- ATPase activity in the proximal tubules may be 
about half that found in the strongly active distal 
tubules (Katz et al, 1979). Secondly, although there 
seems little doubt that the K +- dependent phosphatase, 
demonstrable by the PNPP-method, is associated with 
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the Na +_ K+-ATPase, there are several discrepancies, 
as reviewed by Hokin and Dahl (1972). It is of interest, 
for instance, that differences between Na+-K +_ ATPase 
and PNPPase in sensitivities to certain ions and inhibit- 
ors become less significant when the phosphatase assay 
conditions are made similar to the usual assay conditions 
for the Na+-K+-ATPase i. e. assayed in presence of Na+ and 
ATP (Yoshida et al, 1969). 
It would therefore be preferable to have a cyto--* 
chemical procedure that can demonstrate Na 
+_ K +_ ATPase 
activity directly by its response to its normal substrate 
(ATP) and in relation to the ions that are known to 
influence such activity. The method should be signif- 
icantly inhibited by ouabain or other cardiac glycosides 
that are established inhibitors of Na +_ K+-ATPase activity. 
The original, direct method of Washstein and 
Meisel (1957) failed because lead ions hydrolyse ATP 
in solution and inhibit the enzyme. Furthermore few, 
if any, lead salts are readily soluble at the pH at 
which the reaction should be done for maximum Na +_ K 
ATPase activity. It was therefore decided to complex 
the lead with weak acid moieties which should sequester 
the lead from the ATP and from the-active site of the 
enzyme, but which would be displaced by the eleettoo- 
Chemically more active phosphate ions when these were 
liberated by the action of the ATPase on ATP. Consequently, 
a mixture of lead salts was prepared (by Mr. G. T. B. 
Frost, of Sigma, London) which, when dissolved in water 
with the addition of a dilute solution of ammonia, would 
give a buffered solution of lead ammonium citrate acetate. 
241 
This lead ammonium citrate acetate material contained 
approximately 10% lead in a bound form; it is readily 
soluble at pH values from 7 to 8; and it does not 
hydrolyse solutions of ATP although it forms a rapid 
and dense precipitation when free phosphate is present. 
This chapter records the use of lead ammonium citrate, 
as a capture reagent in a method for Na+- K+-ATPase 
activity. 
Development of the Method 
In the development of a cytochemical method 
for assaying magnesium-activated Na +_ K+- ATPase activity 
in the kidney the following technique was used. 
Segments (about 5x5x3 mm) were cut from 
the kidneys of Wistar rats (of either sex) or of guinea- 
pigs (Hartley strain, either sex) that had been killed 
by asphyxiation in nitrogen and chilled to -70* C in 
n-hexane (BDH; free from aromatic hydrocarbons, boiling 
range 67 - 700 C). The tissue was stored in cold tubes, 
at -70* C and used within 2 days because the activity 
alters markedly after this time, as assessed biochemically 
(Perez-Gonzalez de la Manna et al, 1980). The tissue was 
sectioned at 10 Um (Chapter V) and picked off the knife 
on to glass slides. To economize on the relatively 
costly components of the reaction-medium, the reactions 
were done by placing a small Perspex ring around each 
section and pouring the medium into the ring (Chayen 
et al, 1973). 
The method for assaying the Na+-K +_ ATPase 
activity was derived from the biochemical procedure 
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of Schwartz et al (1971). The reaction medium contained 
the substrate ATP (disodium adenosine 5' triphosphate), 
sodium chloride, potassium chloride, magnesium chloride 
and lead ammonium citrate acetate. Despite the fact 
Na+- K+-ATPase is a membrane-bound enzyme, no activity 
was found unless a stabilizer was used in the reaction 
medium: in this case a 40% solution of Polypep 5115 
in the reaction medium gave optimum results. To over- 
come the lower diffusibility in this viscous polypep- 
tide medium, all the reactants were used at four times 
the concentrations used by Schwartz et al (1971). The 
40% solution of Polypep was prepared in 0.2M Tris buffer 
at pH 7.4 containing sodium acetate (1 mM for sections 
of rat kidney and 2 mM for the more delicate guinea 
pig tissue). Then the following concentrations of 
reactants were dissolved sequentially in this medium 
sodium chloride (24 mg/ml; 410 mM), magnesium chloride 
(4 mg/ml; 20 mM), potassium chloride (2.8 mg/ml; 37.5 
MM). The lead ammonium citrate acetate complex (Sigma) 
was. dissolved, with constant shaking, in the smallest 
volume of dilute ammonia (5 drops of 0.88 ammonia per 
ml) to give a final concentration of 32 mg/ml. The 
final pH used initially was 7.5 adjusted by the addition 
of either of a mixture of sodium and potassium hydrox- 
ides (10: 1 on a molar basis; 2.5 mM) or of 0.1 M hydro- 
chloric acid. 
The first experiment was to use different concen- 
trations of ATP based on four times the concentration 
used by Schwartz et al (1971), to obtain the optimum 
243 
concentration for this reaction. It was also essential 
to show that the reaction was ouabain-sensitive. Serial 
sections were treated with the same medium containing 
0.4 mM (0.3 mg/ml) ouabain (ouabain octahydrate; Sigma). 
The different concentrations of ATP used were 0,5, 
10,15,20 mg/ml. The reaction was done at 370 C and 
it was found that a time of 15 minutes was required 
to give sufficient reaction-product for accurate quantif- 
ication. The sections are then rinsed in Coplin jarsf 
in several changes of 0.2 M Tris buffer, pH 7.4, at 
37* C to remove all the Polypep. They were then immersed, 
at room temperature, in water that had been saturated 
with hydrogen sulphide (1 -2 min). They were then 
rinsed several times in distilled water and allowed 
to dry. They were mounted in the Z5 medium that is 
based on polyvinyl alcohol (Zaman and Chayen, 1981). 
The reaction-product is assumably lead sulphide 
and was measured by means of a Vickers M85 microdensit- 
ometer, with a x40 objective, at 585 nm (since this gave 
best discrimination from the background), and with a 
flying-spot of 0.4 m diameter in the plane of the section. 
The size of the mask allowed measurement of the reaction- 
product in one cell. By suitable calibration (Chayen 
1978 (a), (b); Bitensky, 1980) the microdensitometric 
readings were expressed as the mean ± SEM of the inte- 
grated extinction. In general, duplicate sections-srs 
were measured, with 10 or 20 cells from different regions 
of the nephron being measured in each section. L-p- 
244 
bromotetramisole oxalate (Aldrich; 0.4 mM) was included 
in both reaction mediums i. e. with and without ouabain, 
to prevent interference by alkaline phosphatase activity. 
The reaction-product was found on the contralumenal 
boundary of the tubule cells and was decreased when 
ouabain was included in the reaction-medium. 
Optimal concentration of ATP. This was examined in 
the thick ascending limbs (TAL) of the loop of Henle. 
With the full reaction-medium, the optimal concentration 
for total activity was 10 mg/ml (Fig. XI. 1). The activity 
of the ouabain-insensitive activity was increased by 
5 mg/ml but was unchanged by higher concentrations. 
Subtraction of the results for these two activities 
gave the activity of the ouabain-sensitive ATPase, i. e. 
the Na+- K+-ATPase. Such subtraction indicated that 
the optimal concentration of ATP for this enzyme was 
10mg/ml (17 mM). Conditions for optimal pH are shown in Fig. XI 
Specificity. Very low activity was found when ATP 
was replced, at approximately equimolar concentrations 
(10 mg/ml), by either adenosine diphosphate or tri- 
sodium guanosine 5'-triphosphate (Fig. XI. 3). When 
the sodium and potassium chloride were excluded from 
the reaction-medium, the total activity and the ouabain- 
sensitive activity were depressed, with the ouabain- 
insensitive activity being unaffected. It is probable 
that the residual ouabain-sensitive activity was due 
to the sodium/potassium hydroxide used to establish 
the final pH, and to endogenous ions within the section. 
The addition of L-p-bromotetramisole oxalate (0.4 mM; 
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Fig. Xl. 1 The effect of increasing concentrations of ATP on the 
activity of (MIE x 100; mean ± SEM) of total ATPase 
(triangles) and ATPase in the presence of ouabain 
(squares) measured in the cells of the thick ascending 
limb of the loop of Henle (TAL). r1be Na -K 
+ 
-ATPase 
activity (calculated by subtraction) is shown by the 
solid line. 
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Fig. XI. 2 The effect of pH on the activity (MIE x 100; mean t SEM) 
of total (triangles) and ouabaih-insensitive (squares) 
ATPase activity in TAL; Na+-K+-ATPase activity is shown 
by the solid line. 
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Fig. XI. 3 Histograms of the activity MIE x 100; mean ± SEM) in TAL 
of total (hatched columns), ouabain - insensitive (open- 
columns) and Na+-K 
+ 
-ATPase activity in the presence of 
adenosine triphosphate (ATP); guanosine triphosphate (GTP); 
adenosine diphosphate (ADP); ATP without added Na 
+ 
or K; 
and ATP but in the presence of bromotetramizole. 
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0.15 mg/ml), to inhibit alkaline phosphatase, did not 
affect the measured Na+- K+- ATPase activities in this 
region of the nephron. 
Linearity of response. The activities, in the same 
region of the nephron, measured in serial sections, 
were linear with, thickness of the sections from 5- 
20 Um (Fig. XI. 4) and with time, for at least 20 minutes. 
Activities in other regions of the nephron. As discussed 
previously, earlier methods did not demonstrate Na 
+- K 
ATPase activity in proximal tubules. Using this new 
technique, in both the rat and the guinea pig, total 
and ouabain-sensitive Na +_ K+-ATPase activity was found 
on the contra-lumenal boundary of the cells of proximal 
convoluted tubules (characterized by the lumenal alkaline 
phosphatase activity). Activity was also found on the 
contra-lumenal boundary of the cells of the distal 
convoluted tubules and in the cells of tubules that 
were grouped in clusters at the cortico-medullary boundary 
and extended into the medulla (Fig. XI. 5) Following 
Beeuwkes and Rosen (1975), these-last tubules were taken 
to be the thick ascending limbs (TAL) of the loop of 
Henle. 
Comparison of results with other assays. Measurements 
were made of the total and the ouabain-sensitive Na 
+_ K 
ATPase activities, at various times, in cells in these 
three regions, in seven guinea-pigs (part of this work was 
done by J. Pitchfork). The total activity (15 minutes 
reaction time; mean integrated eXLinction xIOO; mean ±SEM) 
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Fig. XI. 4 The effect of time or thickness on the activity (MIE X 100; 
mean ± SEM) in TAL of total (triangles) and ouabain- 
insensitive (squares) ATPase activity; Na -K -ATPase 
activity is indicated by the solid line. 
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Fig. XI. 5 Photomicrograph of total ATPase activity in a cryostat 
section of rat kidney showing strong activity in small 
clusters of distal convoluted tubules in the cortex and 
moderately strong activity in the tubules at the cortico- 
medullary junction (TAL) X 21. 
- 
\; 
(q 
251 
in the proximal convoluted tubules was 12.4 ± 1.1. 
In the distal convoluted tubules and in the TAL, the 
total activity was 29.5 ± 4.2 and 33.8 ± 2.8 respectively 
(Table XI. 1). The ouabain-insensitive activity, measured 
in duplicate sections that were reacted with the same 
reaction medium with added ouabain, gave activities 
of : proximal convoluted tubules 7. T 1. Z; distal 
convoluted tubules 13. X A-1 and TAL 15. cl ± 2.3. 
The percentage of the total activity that was represen 
ted by the ouabain-sensitive Na 
+- K +- ATPase was then 
calculated. The activities were 41%, 58% and 54% 
respectively. 
To compare this study with that done by Katz 
et al (1979), the concentration of ouabain was increased 
from 0.4 mM to'l mM. The results for total activity 
(mean integrated extinction x100; mean ± SEM), in the 
presence of bromotetramizole were as follows: proximal 
convoluted tubules, 9.2 ± 1.2; distal convoluted tubules 
25.4 ± 2.8; and TAL 16.9 ± 2.2. The percentage of 
the total activity that was due to ouabain-sensitive 
Na+- K +- ATPase activity was calculated as 38%, 60% 
and 64% (Table XI. 1). in the proximal convoluted tubules, 
the distal convoluted tubules and'in the TAL respectively. 
Background problems. In all these studies using 
this method for assaying Na+- K+- ATPase there was always 
a strong background colouration on the section. Under 
the microscope this background colouration appeared 
to sit above the section, making the measurement, at 
times, very difficult. It was envisaged that the "fuzz" 
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Table XI. The activity (mean integrated extinction) of total 
ATPase, ouabain-insensitive and -sensitive ATPase in 
three regions of the guinea-pig and rat nephron. 
Total Ouabain Ouabain % 
insensitive sensitive 
Prox 12.4 ± 1.06 7.5 ± 1.18 4.9 0.59 41% ± 5.8 
Dist 29.46 ± 4.24 13.15 ± 2.65 16.3 2.49 58% ± 5.9 
T. A. L. 33.8 ± 2.8 15.94 ± 2.28 17.9 1.79 34% ± 4.8 
n=7 guinea pigs :I ouabain) 0.4mM 
Prox 9.2 ± 1.2 5.7 3.5 38% 
Dist 25.4 ± 2.8 10.16 15.24 60% 
T. A. L. 16.9 ± 2.2 6.08 10.82 64% 
n=1 rat : [ouabain] lmM 
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might have been due to deleterious effects produced 
by the last three stages of the reaction, namely (i) 
the rinse in 0.2M Tris buffer at pH 7.4 used to remove 
the reaction-medium; (ii) the immersion in distilled 
water that had been saturated with H2S to blacken the 
lead deposit; and (iii) the final rinse in distilled 
water. Many variants of these Vere tested (Fig. XI. 6) 
but all were unsuccessful. Consequently attention 
was focussed on the earlier stages of the procedure 
and it was realized that the "background" colouration 
might be caused by free phosphates that were being retained 
in, or close to, the sections by the stabilizer. Thus 
the next step was to rinse the sections before actually 
pouring the reaction medium onto the section. A 40% 
solution of Polypep 5115 containing 1 mM potassium 
acetate in 0.2 M Tris buffer at pH 7.4, was poured onto 
each section (potassium phosphate being very soluble). 
This medium was sucked-off after 5 minutes. A little 
of the full reaction-medium was added to each section, 
and then sucked off again to ensure adequate replacement 
of the initial Polypep medium. Then the full reaction- 
medium was added. After the reaction, the sections 
were immersed in distilled water saturated with H2S 
and the final rinse was done with distilled water. 
This pre-rinse in Polypep proved very successful and 
is now done routinely. The background colouration 
was almost completely removed and the artifact that 
was observed i. e. the colouration sitting above the 
section disappeared. The relative activities were 
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unaltered by the rinsing procedure. 
Discussion 
The enzymes which hydrolyze ATP are 
able importance in normal cell-function. 
include the mitochondrial ATPases, myosin 
of muscle, and the various ATPases-of the 
Initially it might have been hoped that t 
of Wachstein and Meisel (1957) could have 
of consider- 
These 
ATPase activity 
cell surface. 
he procedure 
been used 
to demonstrate all these enzymes. However, the free 
lead ions used in this method inhibited the enzymes 
and hydrolyzed, non-enzymatically, the ATP used as sub- 
strate. A huge controversy grew up over the validity 
of the procedure (as reviewed by Ernst, 1972a; Ernst 
et al, 1980). As regards the Na+- K 
+_ ATPase activity 
that is associated with cell membranes, and to avoid 
the disputed arguments over the validity of the use 
of lead ions as trapping agents, Ernst (1972a, b) and 
Guth and Albers (1974) turned to methods for demonstrating 
the K+-dependent phosphatase activity. This is related 
to Na+- K+-ATPase activity in that the hydrolysis of 
ATP by the Na+- K+-ATPase is believed to proceed in 
at least two steps involving a sodium-dependent phosphory- 
lation (Hokin and Dahl, 1972). However, there is con- 
siderable evidence that the K +_ dependent phosphatase, 
responsible for the phosphorylation, is not specific 
to the phosphorylated intermediate but can act on a 
variety of phosphate esters (as reviewed by Ernst, 1972a). 
Beeuwkes and Rosen (1975,1980) used a modified form 
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of Ernst's (1972a, b) paranitrophenyl phosphate (PNPP) 
method ; following Guth and Albers (1974) they relied 
on the rather inefficient (Ernst et al, 1980) capture 
of the liberated phosphate by magnesium and potassium 
ions. They did, however, show clear differences in 
activities in the various parts of the nephron, both 
by visual inspection and by the use of electron probe 
analysis to quantify the amount of reaction-product 
produced in each region. They found high activities 
in the distal convoluted tubules and in tubules which 
they considered to be the thick ascending limbs (TAL) 
of the loop of Henle. These activities were in agreement 
with microchemical results done after microdissection 
of the nephron (e. g. Schmidt and Dubach, 1969). 
The disadvantages of the PNPP method were: (i) 
it was indirect, measuring the K+-dependent phosphatase 
activity that was generally, but not necessarily, related 
to the Na+- K+-ATPase activity; it was of concern that 
the K+-dependent phosphatase was not specific for the 
phosphorylated intermediate generated by Na+- K +- ATPase 
activity; (ii) it did not demonstrate the Na +- K +- ATPase 
activity that was known, from biochemical studies, to 
be present in the proximal convoluted tubules; thus 
it was unlikelytO be of value in the study of less active 
ATPases in cells in which this activity was not as great 
as it is in the distal convoluted tubules and TAL. 
The new method has reverted back to the Wachstein 
and Meisel method but has overcome its deficiencies by 
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ensuring that there are no free lead ions in the reaction- 
medium. In the lead ammonium citrate/acetate complex, 
the lead is hidden (and so made soluble in neutral and 
alkaline solutions) by ammonium citrate. Thus when 
it is added to a solution of ATP, the solution remains 
crystal-clear. However free phosphate, generated by 
enzymatic hydrolysis, successfully competes with the 
ammonium citrate moieties and precipitates lead phosphate, 
which can be converted to the brown-black lead sulphidd. 
With this trapping agent, the enzymatic activity was 
linear with thickness (amount of enzyme) and with time. 
The activity increased with increasing concentration 
of the lead ammonium citrate/acetate up to the concen- 
tration used in the present method. There was no in- 
hibition of activity with higher concentrations. The 
PH optimum was PH 7.6. This is close to that reported 
for 'microsomal preparations' that include the cell 
membrane (Perez-Gonzdlez de la Manna et al, 1980). 
The reaction was also specific for ATP and was not influ- 
enced by the potent inhibitor (Borgers and Thone, 1975) 
of alkaline phosphatase, bromotetramizole. 
The reaction-product was precipitated along the 
contra-lumenal boundary of the cells. This is the 
expected location of the enzyme (Beeuwkes and Rosen, 
1975,1980; Perez-Gonzalez de la Manna et al, 1980; 
Ernst et al, 1980). In the guinea-pig and the rat 
it was found in greatest concentration in the TAL and 
in the distal convoluted tubules. It was appreciably 
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less in the proximal convoluted tubules. These 
findings agree with those of Katz et al (1979) who 
assayed ATPase activities microchemically in regions 
of the nephron of the rat, mouse and rabbit. However, 
the results of Katz et al (1979) were expressed in terms 
of picomoles of ATP hydrolyzed per millimetre length 
of the region of the nephron per hour and cannot be 
directly related to these cytochemical measurements 
which give the concentration of the activity per cell., * 
Nonetheless the proportion of the total activity that 
was due to the specific, ouabain-sensitive, Na +- K +- 
ATPase activity should be similar, whether measured 
microchemically or cytochemically. In the rat, Katz 
et al (1979) found that the proportion of the total 
activity that was due to Na +- K ATPase activity was 
51% (proximal convoluted), 76 78% (TAL) and 65% 
(distal convoluted tubules). The results with the 
new method were 38%, 64% and 60% respectively. The 
relative values of the total activity in the. three regions 
were also similar: taking the total ATPase activity 
of the distal convoluted tubules as 100, the activity 
in the proximal convoluted tubules, found by Katz et 
al, was 44 (in comparison with 36 in the present study), 
and that in the TAL was 59 (as against 66 in the present 
study). Therefore, these results indicate that the 
present method, based on a hidden-lead trapping agent, 
can measure ouabain-sensitive ATPase activity, with 
relative values in different regions of the nephron 
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that generally conform with results obtained by micro- 
chemical methods. The advantages of this presentmethod 
are that it affords a direct measurement of ATPase 
activity, rather than depending on the related, or 
associated, K+-dependent phosphatase activity. It 
also seems to be more sensitive than previous methods, 
as shown by the measurement of activity in the proximal 
convoluted tubules. It should be possible to adapt 
this present method to the measurement of a wide range-' 
of ATPase activities, such as calcium-dependent ATPase, 
mitochondrial ATPases and possibly even adenyl cyclase 
activity. 
Recent studies using the new method. 
(a) A new bioassay of arginine vasopressin, 
namely the antidiuretic hormone, has been developed 
(Bayliss et al, 1980) using the method described in 
this chapter. It depends on the finding that the 
Na +_ K +_ ATPase activity, measured in the TAL of the 
loop of Henle in rat renal tissue mainta ' 
ined in vitro, 
res ponded to increasing concentrations of synthetic 
arginine vasopressin in a log-dose related fashion. 
(b) There is a lot of evidence (e. g. Dikstein, 
1971), that inhibition of Na +_ K 
+_ ATPase is associated 
with the stimulation of glucose 6-phosphate dehydrogenase, 
the rate-limiting enzyme in the pentose phosphate pathway. 
Work done by Fenton et al (1981) has developed a highly 
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sensitive cytochemical assay that shows the capacity 
of biological fluids to stimulate renal glucose 6- 
phosphate dehydrogenase activity in vitro as a marker 
of their ability to inhibit Na+-K+-ATPase activity. 
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CHAPTER XII 
GENERAL DISCUSSION 
Problems Concerning-the Oxidative Metabolism 
of Bone. 
Although the electrical and biochemical properties 
of bone have been studied extensively, relatively little 
work has been done on its biochemistry and general 
metabolism. This is due largely to the physical natýre 
of bone which is relatively difficult to examine by 
the procedures of conventional biochemistry. However 
it was shown, in this laboratory, that thin (e. g. 10 pm) 
sections of fresh, undemineralized adult bone could 
be cut with a heavy duty microtone set in a cryostat 
and equipped with a tungsten-carbide tipped knife 
(Johnstone et al, 1972; Johnstone, 1976). Consequently 
bone could now be examined for metabolic and other 
biochemical features by virtually the same methods 
of cytochemical analysis as have been used previously 
for soft tissues. 
Studies on the oxidative metabolism of bone were 
facilitated by the development (by Dr. G. T. B. Frost, 
for this laboratory) of a new substrate for assaying 
hydroxyacyl dehydrogenase (HOAD) activity. This enzyme 
is involved in the a-oxidation of fatty acids and 
so made possible, cytochemically, the investigation 
of fatty acid oxidation (Chapter VI). Thus for the 
first time it was possible to show that bone is-capable 
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of this type of oxidation, with the implication that 
fatty acids may constitute a considerable source of 
energy for bone cells. This may have much wider impli- 
cationsin bone pathology. However, the immediate 
consequence of this finding was that it became possible 
to suggest the mechanism of the apparent paradox of 
'aerobic glycolysis' in bone. Thus by assaying maximal 
activities of certain key-enzymes, it was apparent 
that such fatty acid oxidation could supply the needs 
of the Krebs' cycle and direct the conversion of pyruvate 
to lactate, even at high oxygen tensions (Chapter VI). 
In studying the general oxidative metabolism 
of bone, in particular in fracture-healing, increased 
activity of glucose 6-phosphate dehydrogenase was a 
prominent feature. There is considerable evidence 
(discussed in Chapter XI) of an inverse relationship 
between this activity and that of Naý-K+-ATPase. There 
were many reasons why the latter could not be investigated 
cytochemically. Yet this is such an impor*tant enzyme 
for the normal function ofcells that it was worthwile 
trying to overcome the obstacles to its assay. This 
was done by the development (by Dr. G. T. B. Frost) of 
a 'hidden-capture' reagent (as described in Chapter XI). 
The drawback to the use of this method on sections of 
bone has been the propensity of the 'hidden' lead to 
react with the free phosphate of bone. It is likely 
that this can be overcome by reacting the sections 
first with material that will bind to these phosphates, 
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but that is a problem for the future. 
Fracture-healing and the Vitamin K 1- cycle 
The earlier studies on the metabolism of fracture- 
healing by Dunham et al (1977) demonstrated that the 
closed fracture of the metatarsal of the Wistar rat 
formed a useful and remarkably reproducible model for 
studying the major changes that occur during fracture- 
healing. The response to fracture involves both active 
cell proliferation and biosynthesis of extra-cellular 
material. 
Subsequent to these earlier studies on fracture- 
healing, it was found (Hauschka et al, 1978) that miner- 
alization might involve the y-carboxylation of glutamate 
residues in existing proteins. This y-carboxylation 
is produced by the vitamin K1 cycle, with NADH or NADPH 
as the reductant, and results in calcium-binding y- 
carboxyglutamate (Gla) residues (Fig. 111.2). 
Although much attention has been focussed on 
osteocalcin, or on the bone Gla-protein, and although 
such studies have generated considerable controversy 
(as discussed in Chapter III), there seems little doubt 
that the formation of Gla-residues, by the action of 
the vitamin K I- cycle, plays an essential role in the 
formation of new bone. It is fortunate that the function 
of this cycle can be demonstrated by feeding animals 
with the anticoagulant Warfarin, or related substances, 
which inhibit the conversion of the vitamin K epoxide back 
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to the naphthoquinone, so breaking the cycle (Whitlon 
et al, 1978). However, such experiments have yielded 
confusing results due largely to the various experi- 
mental designs used by the different workers (and as 
discussed in Chapter III). Thus it seemed advisable 
to re-examine the effect of such compounds, and so 
the significance of the vitamin K 1- cycle, in a well 
studied system (Chapter VIII). For this, I used the 
closed fracture of the metatarsal in the rat, as had 
e* 
been investigated in some detail by Shedden et al (1976) 
and by Dunham et al (1977). Since it seems to be 
virtually impossible to deplete rats of vitamin Kl, 
I used dicoumarol to inhibit the vitamin K 1- cycle. 
The immediate difficulty in using this model 
was the finding that the Wistar rats used in the model 
described by Shedden et al, 1976, proved too sensitive 
to dicoumarol. Consequently, for these studies, male 
Sprague-Dawley rats were used as they were found to 
be more resistant to the anticoagulant eff'ect. However, 
t'his entailed investigating fracture-healing in this 
rat to ensure that it was equally reproducible. 
Chapter VII describes the fracture-healing process and 
the associated metabolic changes, in the Sprague-Dawley 
rat, comparing it directly to the. earlier work done 
on the Wistar rat by Shedden et al (1976) and Dunham 
et al (1977). It compared very closely, both histo- 
logically and metabolically, with the Wistar rat model 
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except that the bones healed considerably faster in the 
Sprague-Dawley and in all cases the callus was larger 
on the dorsal side than that on the plantar side in 
the Sprague-Dawley rats. As in the study by Dunham 
and colleagues (1977) interest was centred on the activity 
of glucose 6-phosphate dehydrogenase (G6PD). G6PD 
is important for supplying NADPH, to be used as the 
source of reducing equivalents in many biosynthetic 
reactions, and in producing ribose phosphate for nucleic 
acid synthesis. As in the study by Dunham et al (1977) 
there was a striking elevation of periosteal G6PD activity 
in response to the fracture both at the site of periosteal 
proliferation and, later, at the site of formation 
of new bone, suggesting that NADPH plays a role both 
in the periosteal proliferation to form the callus 
and in the process of new bone formation on the shaft 
of the bone. 
When dicoumarol was fed to the Sprague-Dawley 
rats (immediately after fracture) the ossification 
of the callus was severely retarded. Dicoumarol also 
decreased G6PD activity selectively at points at which 
ossification occurred. Thus, not only could dicoumarol 
be acting as an antagonist of the vitamin K cycle but 
it also depressed the amount of reducing equivalents, 
from NADPH, available for the cycle at these points 
Of ossification. 
a 
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Possible Mechanism of G6PD Activation 
The increase in G6PD activity therefore seemed 
to be fundamental to the process of fracture-healing. 
Thus it seemed important to investigate the mechanism 
by which this increase is brought about. From other 
studies in progress in this laboratory, it seemed possible, 
that G6PD activity may be stimulated by the formation 
of the polyamine precurser, putrescine, from ornithine 
decarboxylase (ODC) activity (fully described in Chapter 
IV). ODC activity is readily stimulated by many hormones 
acting on their target cells (Bachrach, 1980) so it 
is possible that the trauma of fracture might act similar- 
ly. G6PD can exist in an active aggregated form or 
it may dissociate into inactive units: by binding to 
the enzyme at non-catalytic sites, NADP+ can hold the 
enzyme in this active state (as reviewed by Bonsignore 
and de Flora, 1972; Chayen and Bitensky, 1982), allowing 
for a rapid response to stimuli. So it was possible 
that a positively charged polyamine (such as putrescine) 
might take the place of NADP + at these non-catalytic 
sites. Consequently, a study was made to investigate 
whether the increased periosteal G6PD activity, observed 
early in fracture-healing, could be inhibited by inhibiting 
ODC activity and thus decrease the tissue levels of 
Polyamines(Chapter IX). ODC activity is dependent 
on the co-enzyme pyridoxal phosphate (vitamin BO 
and it has been demonstrated (Eloranta et al, 1976; 
Pegg, 1976) that young Wistar rats can be made deficient 
266 
in polyamines if fed on aB 6- deficient diet (described 
in Appendix 3). Thus male Wistar rats (50 g) were 
fed on aB 6- deficient diet (control rats were fed a 
similar diet supplemented with BO before and after 
their metatarsals were fractured. A detailed histological 
and metabolic investigation was made (Chapter IX). 
The results of these studies conformed with the view 
that ODC activity might regulate G6PD activity. Thus,, 
of all the enzymes tested only G6PD activity was markedly 
decreased in the various cell types of the forming 
callus. This decreased G6PD activity, necessary for 
proliferation and for bone formation, was also reflected 
in bizarre histological changes found in the B 6- deficient 
fractures. The callus appeared flattened and there 
was a decrease in new bone formation. There was also 
massive invasion of the periosteum and endosteum into 
the shaft of the bone and partial replacement of cortical 
bone by woven bone, producing bone tha. t was remark ably 
similar t6 that found in hun-an, osteoporosis. 
Studies on Osteoporotic Fractures 
Osteoporotic fracture of the hip in the elderly 
is a significant social and medical problem. The 
fractures are often induced by minimal trauma in osteo- 
porotic patients, and the aim of the study in Chapter X 
was to try to elucidate the increased susceptibility of 
the neck of femur to fracture in these osteoporotic 
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subjects. Inspection of the sections taken from the 
fracture-site showed the appearance of unexpectedly 
large crystals, apparently of apatite. The presence 
of such large crystals, much larger than have been 
reported from the many cryostallographic studies in 
normal bone, could account for the increased tendency 
to fracture: in this respect, these osteoporotic 
fractures of the neck of femur might resemble the fatiSue 
fractures of metals. However the fundamental question 
was what caused the growth of such large crystals. 
Previous enquiries had focussed on possible roles 
for the collagen matrix. This was readily examined 
because the collagen fibres show form birefringence. 
However it was shown (Chapter X. ) that the orientation 
(as measured by the birefringence) of the collagen 
was unchanged in the fractures. At the time this 
work was started, there was only scanty information 
as regards the orientation of the glycosaminoglycans 
(GAGs) which do not show form-birefringence. However, 
by making use of the potentially birefringent properties 
of Alcian blue, a method of 'induced birefringence' 
was developed. The results showed firstly that the 
GAGs of normal bone were closely orientated to the 
collagen, and secondly that, although the total content 
of GAGs was unaltered, they were relatively disorientated 
in the osteoporotic bone, even at a considerable distance 
from the fracture (Chapter X). 
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Appendix 1 
Methods for Determining 
Enzyme Activity 
1. Glucose 6-phosphate dehydrogenase 
The reaction medium contained NADP (3 mM; 2.5 mg/ml); 
glucose 6-phosphate (5 mM; 1-5 mg/ml); chloroform- 
purified neotetrazolium chloride (5 mM; 0.3%; 0.6% 
in Chapter VI) in a 30% (w/v) solution of polyvinyl 
alcohol (grade G04/140) in 0.05M glycylglycine buffer. - 
(PH 8.0). The final reaction medium was adjusted to 
PH 8.0 and saturated with nitrogen before and during use. 
Phenazine methosulphate (0.7 mM; 0.2 mg/ml) was added to 
this medium just before use and the sections incubated 
at 37*C. Perspex rings surrounding the sections were 
used to contain the reaction medium and the slides were 
placed in an incubation chamber. The reacted sections 
were rinsed well with distilled water and mounted in 
Farrants' medium prior to measurement. 
Lactate dehydrogenase 
The reaction medium contained NAD (2.5 mM; 1.75 mg/ 
ml); sodium lactate (60 mM); chloroform purified 
neotetrazolium chloride (5 mM; 0.3%; 0.6% in Chapter VI) 
in a 30% (w/v) solution of polyvinyl alcohol (grade G04/ 
140) in 0.05 M glycylglycine buffer (pH 8.0). The pH. of 
the final reaction medium was adjusted to pH 8.0 and 
saturated with nitrogen before and during use. 
Phenazine methosulphate (0.7 mM; 0.2 mg/ml) was added to 
this medium just before use and the sections incubated at 
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37"C. The reacted sections were rinsed in distilled water 
and mounted in Farrants' medium. 
3. Glyceraldehyde 3-phosphate dehydrogenase 
The reaction medium contained NAD (1.5 mM; 1 mg/ml); 
aldolase (10 units per ml); fructose 1-6-diphosphate, 
trisodium salt (5 mM; 3 mg/ml); chloroform-purified 
neotetrazolium chloride (5 mM; 0.3%; 0.6% in Chapter VI) 
in a 30% (w/v) solution of polyvinyl alcohol (grade 
G04/140) in 0.05 M glycylglycine buffer (pH 8.0). The 
pH of the final reaction medium was adjusted to pH 8.5 
and saturated with nitrogen before and during use. 
Phenazine methosulphate (0.7 mM; 0.2 mg/ml) was added to 
this. medium just before use and the sections incubated 
at 37*C. The reacted sections were rinsed in distilled 
water and mounted in Farrants' medium. 
4. Succinate dehydrogenase 
For demonstrating succinate dehydrogenase activity, 
which is tightly bound within the mitochondria, the 
reaction medium contained chloroform-purified neotetraz- 
olium chloride (0.6%) in a 0.1 M phosphate buffer, 
pH 7.8. Sodium succinate (50 mM; 13.6 mg/ml) was added 
and the solution saturated with nitrogen before and 
during use. Phenazine methosulphate (0.7 mM; 0.2 mg/ml) 
was added to the medium and the sections incubated in 
a Coplin jar at 37*C. The sections were rinsed in 
distilled water and mounted in Farrants' medium. 
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5. Alkaline phosphatase: The Naphthol-phosphate Method. 
The reaction medium contained a 10% solution of 
magnesium chloride, MgCl2 6H 20 
(0.2ml); a naphthol acid 
phosphate sodium salt (2 mg) in a 2% solution of 5,5 
diethylbarbiturate (50 ml). The pH of the medium 
was adjusted to pH 9.2 and Fast blue RR salt (50 mg) 
added just prior to use. The reaction was done at 
room temperature (25*C) in a Coplin jar. 
6. a -Hydroxy acyl CoA dehydrogenase 
7. Na+K+-ATPase 
The methods for determining these enzyme activities 
are described fully in Chapters VI and XI respectively. 
Appendix II 
Cytochemical Demonstration of Ornithine 
Decarboxylase 
It has proved considerably difficult to demonstrate 
the products of ornithine decarboxylase (ODd) activity 
cyt'ochemically. This is because it is unlikely that 
a way will be found of specifically precipitating the 
decarboxylated substrate (putrescine), and it is not 
easy to precipitate the other product of the reaction 
(CO 
2) at the pH at which the enzyme works optimally 
(about pH 7.1). Consequently histochemical procedures 
have concentrated on localizing the site of the enzyme 
itself. Two types of method have been suggested: 
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1. Use of a labelled suicidal enzyme inhibitor, 
namely a-difluoromethylornithine (Gilad and Gilad, 
1981; Pegg et al, 1982a). 
2. Immunohistochemistry (Persson et al, 1982). 
Both methods are reviewed by Dodds and Chayen (1984'). 
Preliminary studies towards a quantitative 
cytochemical method 
Neither method mentioned gives quantitative resu lts 
and are not likely to be able to define changes in ODC 
activity. Consequently there is a real need for a 
quantitative cytochemical demonstration for ODC. 
In normal cytochemistry, the activity of an enzyme 
such as a phosphatase or decarboxylase would be measured 
by precipitating the smaller moiety released, namely either 
phosphate or, in this case, carbon dioxide. With metal 
capture reactions, where the metallic ion may be inhibitory 
to the enzyme, care has to be taken to ensure that the 
precipitating ion should be sequestered from the active 
site of the enzyme (Chayen et al, 1981). It was found 
by Dr. G. T. B. Frost (personal communication) that lead, 
in the form of lead hydroxyisobutyrate, is stLfficiently 
chelated not to inhibit the enzyme, but can be precip- 
itated, apparently as lead carbonate, by CO 2 at neutral 
pH. All the solutions have to be prepared in CO 2- 
free water and care must be taken not to introduce other 
ions that might compete successfully against the hydroxy- 
isobutyrate . 
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At present, the provisional method, outlined below, 
seems to yield a quantitative estimation of ODC activity 
in the mouse kidney. 
Reaction - medium 
All solutions have to be prepared in CO 2- free 
water. To three volumes of 0.2 M triethanolamine buffer, 
pH 8.0, containing-40% G04/140 grade of polyvinyl alcohol 
(PVA) (Wacker Chemicals, Mount Felix, Bridge Street, 
Walton-on-Thames, KT12 1AS, UK) is added 1 volume of 
the solution of lead hydroxyisobutyrate (17.85% Pb); 
L-ornithine, 3.4 mg/ml; pyridoxal phosphate, 0.62 mg/ml; 
D, L-dithiothreitol, 0.08 mg/ml; L-p-bromotetramizole, 
0.15 mg/ml (to inhibit alkaline phosphaýase acting on 
the pyridoxal phosphate). The final pH should be adjusted, 
if necessary, to pH 7.1. Before incubating the sections 
in this reaction-medium, a pre-rinse is required to 
remove 'background' colouration, possibly caused by 
free phosphates retained in, or close to, the sections, 
by the stabilizer (as discussed in Chapter XI). The 
pre-rinse consists of 0.2 M triethanolamine buffer, 
pH 8.0, containing 20% G04/140 PVA. The final pH is 
7.1. This medium is poured into Perspex rings 
surrounding the sections and left for 10 minutes at 
37*C after which time it is sucked off and replaced 
by the reaction-medium. 
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Procedure 
1. Incubate in the full reaction-medium at 
37*C (sections of unfixed mouse kidney may require 
10 - 30 min). 
2. Wash in CO 2- free water. 
3. Immerse in 0.5% aqueous solution of 
ammonium sulphide (I min). 
4. Rinse in distilled water. 
Mount in Farrants' medium. 
Measurement 
The reaction-product is measured by microdensitometry 
at 580 nm, with a x40 objective and a flying spot that 
had a diameter of 0.4 pm in the plane of the section. 
Results 
At present, the provisional method, outlined above, 
has several drawbacks. With prolonged reaction-times, 
the nature and intracellular localization of the 
reaction-product changes. This may be due to the format- 
ion of a complex lead precipitate containing the more 
soluble lead bicarbonate. For all that, measurements 
of total activity per cell increased (in mouse kidney) 
linearly with time, irrespective of the localization 
of the lead precipitate (Fig. A. 1). For the optimi- 
zation of all the reactants, a time of 30 minutes was 
chosen. Figures A. 2,3 and 4 show the optimizations 
of substrate (L-ornithine), co-factor (pyridoxal 
phosphate) and pH. The reactions were always done 
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Fig. A. 1 The effect of time of incubation on the activity (MIE x 
100; mean ± SEM) of ornithine decarboxylase activity in 
the proximal convoluted tubules of mouse kidney. 
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Fig. A. 2 The effect of different concentrations of substrate on the 
activity (MIE x 100; mean ± SEM) of ornithine decarboxylase. 
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Fig. A. 3 The effect of increasing concentrations of pyridoxal 
phosphate on ornithine decarboxylase activity (MIE x 100; 
mean ± SEM) . 
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Fig. A. 4 The effect of pH on the activity (MIE x 100; mean ± SEM) 
of ornithine decarboxylase. 
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with and without an inhibitor of alkaline phosphatase 
(L-p-bromotetramizole). 
Extensive studies were done to choose the correct 
grade and concentration of PVA, the amount of lead 
reagent, and the type of buffer used. Lower concen- 
trations ( <40%) of PVA produced extensive nuclear 
staining. Polypeptide (grade P5115) caused immediate 
precipitation in the reaction medium. 
Specificity 
30 mM a-difluoromethyl ornithine (DFMO; gift 
from Merrill International, Strasbourg) caused up to 
42% inhibition of activity in sections of mouse kidney 
reacted for 30 minutes. 
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Appendix III 
The formula of the B6 deficient diet 
Vitamin/Fat Free Casein 20.0% 
Corn Oil 5.0% 
Cellulose Powder 5.0% 
Cornflour Starch 35.0% 
Sugar 30.0% 
Premix 5.0% 
The premix contributes the following per kilogramme of diet: - 
Vitamin A 10000 i. u. /kg Choline 400 mg/kg 
it D3 2000 it Iron 50.0 
it E 100 mg/kg Cobalt 0.5 
it B2 10 it Manganese 50.0 
to K 10 Copper 10.0 
Nicotinic Acid 20 Zinc 20.0 
Calcium Pantothena te 20 Iodine 0.5 
Folic Acid 1.0 Magnesium 100 
Vitamin B 10.0 Chlorine 3.0 g/kg 
Biotin 40.0 mcg/kg Sodium 2.0 
Vitamin B- 12 10.0 
it Phosphoros - 5.0 
Inositol 500 mg/kg Calcium 8.0 
pAminobenzoic Acid 100 Potassium 5.0 
Vitamin C 50.0 Selenium 0.05mg/kg 
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Summary. The original lead-trapping method for demonstrating Na '-K '- 
ATPase activity was discredited because of the effect that lead ions can 
have on the substrate and on the enzyme. Current methods, that measure 
this activity by the related K' -dependent phosphatase activity, 
do not appear 
to measure activity that is known, from microchemistry, to occur in proximal 
convoluted tubules. The disadvantages of using lead appear to have been 
overcome by the use of a new reagent in which the lead is complexed 
with ammonium citrate ions; phosphate, liberated enzymatically, successfully 
competes with these ions. The activities of total ATPase and of the ouabaýn 
sensitive Na' - K'-ATPase have been measured in three regions of the neph- 
ron in the guinea-pig and in the rat. The relative activities found, by this 
method, in the different regions of the latter, appear to be comparable 
with results found by others, using microchernical methods applied to isolated 
regions of the nephron. 
Introduction 
There seems little doubt that the sodium-potassium dependent, magnesium-stimu- 
lated adenosine triphosphatase (Na' - K'-ATPase) of cell plasma membranes 
(P6rez-Gonzdlez de la Manna et al. 1980), equated with the sodium-potassium 
exchange pump (e. g. Hokin and Dahl 1972; Katz ct al. 1979), plays a major 
role in maintaining the normal ionic concentration and cell volume (Baker 
1972) and possibly even in the transport of sugars and amino acids (Hokin 
and Dahl 1972). Because of the critical importance of this ATPase in cellular 
physiology, several workers have sought a cytochemical procedure for demon- 
strating its activity. The earlier methods, based on that of Wachstein and Meisel 
(1957) which employed lead ions to trap the phosphate liberated by ATPase 
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activity, fell into disrepute because the lead ions themselves caused a non- 
enzymatic hydrolysis of the ATP that was used as a substrate, and also because 
free lead ions strongly inhibit Na '-K '-ATPase activity (as reviewed by Ernst 
1972a; Beeuwkes and Rosen 1975,1980). Ernst (1972a, b) introduced the use 
of the substrate p-nitrophenyl phosphate (PNPP) for demonstrating the potassi- 
um-dependent phosphatase activity which is now believed to function as part 
of the Na'-K'-ATPase activity (Ernst 1972a-, Hokin and Dahl 1972); he 
used strontium as the trapping agent and this strongly inhibits the enzymatic 
activity (Ernst 1972a; Ernst et al. 1980). Guth and Albers (1974) modified 
this technique in two ways: first, by adding dimethyl sulphoxide to the medium, 
which, at 30% concentration, changes the optimal pH to 9.0 (Beeuwkes and 
Rosen 1980), and inhibits alkaline phosphatase activity (Ernst et al. 1980); and 
secondly, by leaving out the strontium, relying on the phosphate being captured, 
albeit rather inefficiently, by the magnesium and potassium ions (Beeuwkes 
and Rosen 1975; Ernst et al. 1980). The precipitated phosphate was converted 
to cobalt phosphate, by immersion in a solution of cobalt chloride, and thence 
to cobalt sulphide. This method was used by Beeuwkes and Rosen (1975,1980) 
who used electron-probe analysis to quantify the re action- products. In the kid- 
ney, Beeuwkes and Rosen (1975) showed highest activity in the thick ascending 
limbs of the loop of Henle, and in the distal convoluted tubules, but reported 
that no PNPPase activity could be discerned in the proximal tubules, even 
though ATPase activity has been recorded in these tubules by the microchemical, 
microdissection studies of Schmidt and Dubach (1969) and Schmidt et al. (1974) 
and of Katz et al. (1979). Beeuwkes and Rosen (1975) considered that their 
inability to record activity in proximal tubules might have been due to the 
relative insensitivity of their method. 
Thus until recently, this important enzyme, Na'-K+-ATPase, has been 
examined cytochemically only by an indirect method that has a number of 
disadvantages. Firstly, it does not demonstrate activity in proximal tubules, 
in which this enzymatic activity appears to fulfil major physiological functions 
(Kinne et al. 1978) and may be about half that found in the strongly active 
distal convoluted tubules (Katz et al. 1979). Secondly, although there seems 
little doubt that the K'-dependent phosphatase, demonstrable by the PNPP- 
method, is associated with the Na '-K -'-ATPase, there are several discrepan- 
cies, as reviewed by Hokin and Dahl (1972), that imply that the relationship 
may not always hold. It would therefore be preferable to have a cytochemical 
procedure that can demonstrate Na +-K' -ATPase activity directly, by its re- 
sponse to its normal substrate (ATP) and in relation to the ions that are known 
to influence such activity. 
The original, direct method of Wachstein and Meisel (1957) failed because 
lead ions hydrolyze ATP in solution and inhibit the enzyme. Furthermore few, 
if any, lead salts are readily soluble at the pH at which the reaction should 
be done for maximal Na '-K '-ATPase activity. It was therefore decided to 
complex the lead with weak acidic moieties which should sequester the lead 
from the ATP and from the active site of the enzyme, but which would be 
displaced by the electrochemically more active phosphate ions when these were 
liberated by the action of the ATPase on ATP. Consequently, a mixture of 
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lead salts was prepared which, when dissolved in water with the addition of 
a dilute solution of amnionia. would give a buffered solution of lead ammonium 
citrate. This lead ammonium citrate/acetate material contained approximately 
10% lead in a bound form. This new stable lead ammonium citrate/acetate 
cornplex (Sigma) is readily soluble at pH values from 7 to 8 and does not 
hydrolyze solutions of ATP although it forms a rapid and dense precipitate 
when free phosphate is present. This communication records its use as the 
capture-reagent in a method for Na '-K '-ATPase activity. 
Msiterials and Methods 
Segments (about 5x5x3 min) cut from the kidneys of Wistar rats (of either sex) or of guinea-pigs 
(Hartley strainý either sex) that had been killed by asphyxiation with nitrogen, were chilled to 
- 70* C in n-hexane (BDI 1: free from aromatic hydrocarbons, boiling range 67-70' 
Q. The tissue 
was stored in cold drv tubes. at - 70' C for up to 2 days. As has been found in biochemical 
studies on Na K '-ATPasc acti% to, (Percz-Gonzýlcz de la Manna et al. 1980), the activity alters 
with prolonged storage. For most purposes the tissue was sectioned at 10 pm in a Bright's cryostat, 
with an automatic cutting de% ice to ensure constancy of thickness (Chayen 1980), with the cabinet 
temperature between - 25 and - 30' C and with the knife cooled with solid carbon dioxide. The 
sections were picked off' the knife on it) glass slides (Chayen et al. 1973,1975). 
The method for assaý ing magnesium-activated, Na *-K '-ATPase activity was derived from 
the biochemical procedure of' Schwartz et al. (1971) except that all reactants were used at four 
times the concentrations in order to overcome the lower diffusibility in the viscous polypepticle 
medium. Thus the final reaction-medium was made as follows: A 40% solution (w/v) of Polypep 
: 5115 (Sigma) wits prepared in 0.2 M Tris buffer at pH 7.4 containing sodium acetate (I mM 
for sections of rat kidney and 2 mM for the more delicate guinea-pig tissue). Then the following 
were added sequentially: sodium chloride (24mg/mlý 410mM), magnesium chloride (4mg/ml; 
20 MM). potassium chloride (2.8 ing/ml: 37.5 mM) and ATP (disodium adenosine 5' triphosphate, 
]30ehringer: 10 mg/ml: 16.5 mM). The lead ammonium citrate/acetate complex (Sigma) was dis- 
solved, with constant shaking. in the smallest volume of dilute ammonia (5 drops of 0.88 ammonia 
per ml) to give a final concentration of 32 mg/ml. The final pH was adjusted to pH 7.5 by 
the addition either of a mixture of sodium and potassium hydroxides (10: 1 on a molar basis; 
2.5 MM) or ol'O. ] M hydrochloric acid. 
To economize on the relatively costly components of the reaction-medium, the reactions were 
done by placing a small Perspex ring around each section and pouring the medium into the 
ring (Chaycn ct al. 1973). 
in the final method, but not in some earlier studies, the sections were first immersed for 
5 Min in a 40% solution of Polypep 5115 in the Tris buffer, pH 7.5, containing 0.1 M potassium 
acetate. The purpose of this procedure was to remove free phosphate that otherwise produced 
a strong 'background' colouration. This medium was sucked-off; a little of the full medium was 
added to each section, and then sucked-off again, to ensure adequate replacement of the initial 
polypep medium. Then the full rcaction-medium was added to each section to a depth of 2-3 mm. 
The medium, and the sections, were at 37' C before these procedures were begun. At 37' C, 
15 min were required for reactions that could readily be quantified. The sections were then rinsed, 
in Coplin jars, in several changes of a 0.2 M Tris buffer, pH 7.4, at 37' C to remove all the 
polypep. They were then immersed. at room temperature, in water that had been saturated with 
hydrogen sulphicle (1 2 min). Subsequently they were rinsed several times in distilled water and 
allo, ed to 
dry. They were mounted in the Z5 medium that is based on polyvinyl alcohol (Zaman 
and Chayen 
1981). This contains 12% polyvinyl alcohol (G]8/140 grade from Wacker Chemical 
Ccp. ); 20% glycerine; 20% lactic acid in a 0.4 M sodium acetate: acetic acid buffer, with the final 
PI-I of 6.5. 
The reaction- product. assurnably of lead sulphide, was measured by means of a Vickers M85 
mic rodensito meter, with ax 40 objective, at 585 nm, and with a flying-spot of 0.5 Prn diameter 
in the plane of the section. The size of the mask allowed measurement of the react ion- product 
in onecell. By suitable calibration (Chayen 1978a, b; Bitensky 1980) the microdensitometric readings 
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were expressed as the mean+SEM of the integrated extinction. In general, duplicate sections 
were measured, with 10 or 20 cells from different tubules from each region of the nephron being 
measured in each section. The reaction measured in sections exposed to the full medium gave 
the total Na '-K' -ATPase activity. Serial sections were treated with the same medium containing 
0.4 mM (0.3 mg/ml) ouabain (ouabain octahydrate ý Sigma). Measurements made in these sections 
recorded the activity of the ouabain-insensitive enzyme or enzymes. Subtraction of this activity 
from the first (i. e. the total Na K' -ATPase activity) gave the activity of the specific, ouabain- 
sensitive, Na' -K '-ATPase. 
For some studies, where alkaline phosphatase activity was likely to interfere with the measure- 
merits, the specific inhibitor (Borgers and Thon& 1975), L-p-bromotetramisole oxalate (Aldrich: 
0.4 mM), was included in both reaction-media. 
Results 
Optimal Concenlration of'Reactants and Spe(#icity 
The optimal pH for the specifically ouabain-sensitive reaction, in the thick 
ascending limbs (TAL) of the loop of Henle in sections of rat kidney, was 
pH 7.65 (Fig. 1). The use of different concentrations (0,5,10,15,20 mg/ml) 
of ATP in the full reaction-medium (with and without ouabain) used on sections 
of rat kidney showed that, in this region of the nephron, the optimal concentra- 
tion was 10 mg/ml for the ouabain-sensitive Na '-K '-ATPase activity (Fig. 2). 
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Fig. 1. The effect of pH on the activities of total 
ATPase (triangles: top graph), ouabain-insensitive 
ATPase (squares; middle graph) and of the 
ouabain-sensitive ATPase (by subtraction: circles; 
bottom graph) in the thick ascending limb of the 
loop of Henle in the rat. Activity is recorded as 
mean integrated extinction per unit field per unit 
time 
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Fig. 2. The effect of the concentration of ATP on the 
activities (mean integrated extinction x 100) of total 
ATPase (top), ouabain-insensitive ATPase (middle) and 
of the ouabain-sensitive ATPase (bottom graph; derived 
by subtraction of the previous graphs) in the thick 
ascending limb of the loop of Henle in the rat 
0 10 20 IATPI mg/mi 
Na' -K' -ATPase Activity 
Fig. 3. Specificity of the reaction. Serial 
sections were tested for activity against 'x 
ATR GTP and ADP: others were tested C) 
against ATP either with no sodium or 
P i 
potassium added to the reaction-medium, tlý 
or with bromotetramisole oxalate (BTAO) 
to inhibit alkaline phosphatase activity. For 
each treatment, the specific ouabain- 
sensitive ATPase activity (stippled columns) Uj 
was derived by subtracting the ouabain- 
insensitive activity (clear columns) from the 
z 
iý 
total ATPase activity (crossed columns); I 
bars represent the SEM of the readings 
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Very low specific activity was found when ATP was replaced by trisodiurn 
guanosine 5'-phosphate (10 mg/ml: 17 mM), or by adenosine diphosphate at 
equimolar concentration (Fig. 3). When the sodium and potassium chlorides 
were excluded from the reaction-medium, the total activity and the ouabain- 
sensitive activity were depressed, with the ouaba in- insensitive activity being 
unaffected (Fig. 3). It is probable that the residual ouabain-sensitive activity 
was due to the sodium/potassium hydroxide used to establish the final pH, 
and to those ions that were endogcnous within the section. The addition of 
L -p-bromotetramisole oxalate (0.4 mM; 0.15 mg/ml), to inhibit alkaline phos- 
phatase activity, did not affect the measured Na'-K'-ATPase activities in 
this region of the nephron (Fig. 3). In this region of the nephron, the activity 
was linear with thickness over the range of thickness tested (5-20 Pm); it was 
linear with time for at least 20 min, 
Total and Ouabain- Sensitive Na' - K'-A TPase Activities 
in Dý11ýrent Regions o *the Nephron 
In both the rat and the guinea-pig, total and ouabain-sensitive Na'-K'- 
ATPase activity was found on the contra-lumenal boundary of the cells of 
proximal convoluted tubules (characterized by the lumenal alkaline phosphatase 
activity), of the distal convoluted tubules and in the cells of tubules that were 
grouped in clusters at the co rtico -medullary boundary and extended into the 
medulla (Fig. 4). Following Beeuwkes and Rosen (1975), these last tubules were 
taken to be the thick ascending limbs (TAL) of the loop of Henle. 
The total and the ouabain-sensitive Na+ - K+-ATPase activities were mea- 
sured, at various times, in cells in these three regions in seven guinea-pigs. 
The total activity (mean integrated extinction x 100, mean ± SEM) in the proxi- 
mal convoluted, distal convoluted tubules and in the TAL, were 12.4 + 1.1, 
29.5 ± 4.2, and 33.8 + 2.8, respectively. The percentage of the total activity that 
was represented by the ouabain-sensitive Na +-K +-ATPase activity was 41 + 
5.8,58 + 5.9 and 54 + 4.8, respectively. 
In sections of rat kidney, and with the concentration of ouabain increased 
to I mM for comparison with the studies of Katz et al. (1979), the results 
ATP GTP ADP ATP ATP 
-Na/K -STAO 
S38 
(.. * 4t. 
"" 
. 1. Clmýcll cl A, 
Fig. 4. A lo%k, -poAe,. %ie%N x -11 of' a cr)ostat section of' rat 
kidney reacted for total ATPase 
activity. The proximal tubules of the cortex can be seen by ýirtue of their weak, grey staining, 
the distal tubules being much darker. The thick ascending limbs of' the loop of' Ilenle in the 
medulla stain heavily 
for total activity (mean integrated extinction x 100; mean+ SEM), in the presence 
of bromotetrami sole, were 9.2 + 1.2,25.4 + 2.8 and 16.9 + 2.2 in the proximal 
convoluted and distal convoluted tubules and in the TAL respectively. The 
percentage of the total activity that was due to ouabain-sensitive Na +-K '- 
ATPase activity was 38%, 60% and 64%o, respectively. The addition of bromo- 
tetramisole had no effect on either the total or the Na +-K+ -ATPase activity 
in the distal convoluted tubules or in the TAL. Thus the total activity without 
bromotetramisole in these regions was 24.0 + 3.3 and 16.1 + 1.9, respectively. 
Discussion 
There seems little doubt that enzymes which hydrolyze ATP are of considerable 
importance in normal cell-function. These include the mitochondrial ATPases, 
'. tf 
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myosin ATPase activity of muscle, and the various ATPases of the cell surface. 
Initially it might have been hoped that the procedure of Wachstein and Meisel 
(1957) could have been used to demonstrate all these enzymes. However, the 
free lead ions used in this method inhibited the enzymes and hydrolyzed, non- 
enzymatically, the ATP used as substrate. A huge controversy grew up over 
the validity of the procedure (as reviewed by Ernst, 1972a). As regards the 
Na -- -K '-ATPase activity that is associated with cell membranes, and to avoid 
the contentious arguments over the validity of the use of lead ions as trapping 
agents, Ernst (1972a, b) also Guth and Albers (1974) turned to methods for 
dernonstrating the K* -dependent phosphatase activity. This is related to Na' - 
K-1--ATPase activity in that the hydrolysis of ATP by the Na'-K'-ATPase 
is believed to proceed in at least two steps involving a sodium-dependent phos- 
phorylation of the enzyme and a potassium-dependent dephosphorylation (Hok- 
in and Dahl 1972). However. there is considerable evidence that the K'-depen- 
deria phosphatase. responsible for the dephosphorylation, is not specific to the 
phosphorylated intermediate but can act on a variety of phosphate esters (as 
reviewed by Ernst 1972a). Beeuwkes and Rosen (1975,1980) used a modified 
forrn of Ernst's (1972a, b) paranitrophenyl phosphate (PNPP) method, following 
Guth and Albers (1974) they relied on the rather inefficient (Ernst et al. 1980) 
capture of the liberated phosphate by magnesium and potassium ions. For 
all that, they showed clear differences in activities in the various parts of the 
nephron, both by visual inspection and by the use of electron probe analysis 
to quantify the amount of reaction-product produced in each region. They 
were able to show high activities in the distal convoluted tubules and in tubules 
which they considered to be the thick ascending limbs (TAL) of the loop of 
Heinle. These activities were in agreement with microchernical results done after 
nlicrodissection of the nephron (e. g. Schmidt and Dubach 1969). 
The disadvantages of the PNPP method were: (i) it was indirect, measuring 
the K '-dependent phosphatase activity that was generally, but not necessarily, 
related to the Na' - K'-ATPase activity; it was of concern that the K'-depen- 
derlit phosphatase was not specific for the phosphorylated intermediate generated 
by Na' - K'-ATPase activity; (ii) it did not demonstrate the Na' - K'-ATPase 
activity that was known, from biochemical studies, to be present in the proximal 
colivoluted tubules; thus it was unlikely to be of value in the study of less 
active ATPases in cells in which this activity was not as great as 
it is in the 
distal convoluted tubules and TAL. 
We have therefore reverted to the Wachstein and Meisel method but have 
SOLIght to overcome its deficiencies by ensuring that there are no free lead 
i0irls in the react ion-med i um. In the lead ammonium citrate/acetate complex, 
the lead is hidden (and so made soluble in neutral and alkaline solutions) 
by ammonium citrate. Thus when it is added to a solution of ATP, the solution 
rernains crystal-clear. However free phosphate, either added to the solution 
or generated by enzymatic hydrolysis, successfully competes with the ammonium 
citrate moieties and precipitates lead phosphate, which can then 
be converted 
to the brown-black lead sulphide. With this trapping agent, the enzymatic activity 
is linear with thickness (amount of enzyme) and with time. The activity increased 
with increasing concentration of the lead ammonium citrate/acetate up to the 
540 J. Chayen et al. 
concentration used in the present method; higher concentrations did not appear 
to inhibit the activity. The pH optimum of 7.6 recorded with this trapping 
agent is close to that reported for 'microsomal preparations' that include the 
cell membrane (P&rez-GonzMez de la Manna et al. 1980). The reaction seems 
to be specific for ATP and is not influenced by bromotetramisole which is 
a potent inhibitor of alkaline phosphatase (Borgers and Thon& 1975). 
The re action- product is precipitated along the contra-lumenal boundary of 
the cells, which is the expected location of the enzyme (Beeuwkes and Rosen 
1975,1980; P&rez-GonzMez de la Manna et al. 1980; Ernst et al. 1980). It 
was found in greatest concentration, in the guinea-pig and the rat, in the TAL 
and in the distal convoluted tubules, and was appreciably less active in the 
proximal convoluted tubules. These findings agree with those of Katz et al. 
(1979) who assayed ATPase activities microchernically in regions of the nephron 
of the rat, mouse and rabbit. Their results were expressed in terms of picomoles 
of ATP hydrolyzed per millimetre length of the region of the nephron per 
hour and therefore cannot be directly related to cytochemical measurements 
which give the concentration of the activity per cell. Nonetheless, the proportion 
of the total activity that was due to the specific, ouabain-sensitive, Na '-K '- 
ATPase activity should be similar, whether measured microchernically or cyto- 
chemically. In the rat, Katz et al. (1979) found that the proportion of the 
total activity that was due to Na '-K' -ATPase activity was 51 % (proximal 
convoluted), 76-78% (TAL) and 65% (distal convoluted tubule). The results 
of the present method were 38%, 64% and 60% respectively. The relative 
values of the total activity in the three regions were also similar: taking the 
total ATPase activity of the distal convoluted tubules as 100, the activity in 
the proximal convoluted tubules, found by Katz et al. was 44 (in comparison 
with 36 in the present study), and that in the TAL was 59 (as against 66 
in the present study). 
The results indicate that the present method, based on a hidden-lead trapping 
agent, can measure ouabain-sensitive ATPase activity, with relative values in 
different regions of the nephron that are in general conformity with results 
obtained by microchernical methods. The advantages of the present method 
are that it affords a direct measurement of ATPase activity, rather than depend- 
ing on the related, or associated, K '-dependent phosphatase activity; it seems 
to be more sensitive than previous methods, as shown by the measurement 
of activity in the proximal convoluted tubules; and it should be possible to 
adapt it to the measurement of a wide range of ATPase activities, such as 
calcium-dependent ATPase, mitochondrial ATPases and possibly even adenyl 
cyclase activity. 
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The aim of this study was to try to elucidate the increased susceptibility of the neck of femur to fracture. 
Quantitative polarised light microscopy has been applied to fresh, undecalcified sections, of samples of bone 
taken from the site of fracture, in specimens taken at operation from patients with fractures of the femoral 
neck or osteoarthritic femoral heads or from the equivalent site from otherwise normal subjects at necropsy. 
In all 21 specimens of fractured necks of femur, but in none of the other specimens, relatively large crystals 
(up to 2.5 x 0.5 micrometres) were found close to the site of fracture; the properties of these crystals were 
compatible with their being apatite. Measurement of the natural birefringence of the collagen showed no 
difference in the orientation of the collagen in all three types of specimen. However, the orientation of acidic 
glycosaminoglycans, measured by the birefringence of alcian blue bound to these moieties, was 45 per cent 
lower in the specimens from fractured necks of femur than in the other specimens, even though the total 
content of acidic glycosaminoglycans was unchanged. Although the decreased orientation was most marked 
close to the site of fracture, it was still apparent 15 millimetres from that site. These changes were unlikely 
to be simply the sequelae of fracture since they were not found in traumatic fractures of other bones. Thus it 
is conceivable that changes in the orientation of the ground substance allow formation of relatively large 
crystals of apatite and that such crystals, in the microcrystalline mass of apatite, are the cause of the 
increased fragility of such bones. 
The incidence of fractures of the femoral neck rises 
exponentially after the age of 50 years (Knowelden, Buhr 
and Dunbar 1964) and the fractures are usually the result 
of only relatively minor trauma. An estimated 40 000 
such fractures occur in the United Kingdom each year 
(Lewis 198 1). They represent a significant social and 
medical problem in terms of treatment and rehabilitation 
(Lewinnek et al. 1980). It is apparent from the reported 
studies on the aetiology of fractures of the femoral neck 
that there is no single cause of the fracture but rather it 
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is associated with a combination of factors such as age, 
sex, nature and type of fall, and changes in bone fragility 
(Elsasser et al. 1980; Cook et al. 1982). 
The structural changes that occur in the femoral 
head before fracture are poorly understood, partly 
because they may be a result of several sequential or 
concurrent changes such as osteoporosis, osteornalacia or 
in the tensile strength of the bone matrix (Wall, Chatteýi 
and Jeffery 1979; Cook et al. 1982). Since the decrease in 
tensile strength of bone with age progresses at a greater 
rate than the decrease in bone density (Wall et al. 1979), 
a change in structure of the bone or in the interaction 
between the organic matrix and the mineral phase could 
explain the increased liability of the femoral neck to 
fracture in these individuals. In osteoporotic patients 
who have had a femoral neck fracture, changes in the 
mechanical properties of machined pieces of the femoral 
shaft compared to similar pieces prepared from normal 
subjects have been found by Dickenson, Hutton and 
Stott (1981). The bone specimens tested under tension 
from patients who had femoral neck fractures had less 
stiffness and strength compared with normal bone and 
these changes were correlated with the degree of 
osteoporosis. Moreover, these bones had considerably 
reduced energy absorption before failure and this was 
not related to changes in mineral content of the bone or 
to the degree of osteoporosis. Thus this bone has a much 
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greater tendency to fracture during the sudden stress of 
a fall when the work done on the bone is too great to be 
elastically absorbed. 
The three-dimensional structure of bone, especially 
the morphology of bone mineral, has been studied with 
techniques such as polarised light microscopy (von Ebner 
1894; von Schmidt 1938), x-ray diffraction (Carlstr6m 
1955; Engstr6rn 1972; Chattedi, Wall and Jeffery 1981), 
electron microscopy (Robinson 1952; Bernard 1969; 
Bocciarelli 1970; Voegel and Frank 1977) and scanning 
electron microscopy (Jackson, Cartwright and Lewis 
1978). Although there is some disagreement on the habit 
of the crystallites (rod- or plate-like) and the orientation 
of the crystallite c-axis with regard to the long axis of the 
collagen fibre (parallel or perpendicular) there is very 
good agreement that the crystals must be small in size (50 
nanometres or less in the long axis). Lees (1979) attempted 
to reconcile the two types of crystallite habit and 
orientation into one model for the distribution of 
hydroxyapatite crystals in bone. More recently, Chatterji 
et al. (198 1), using x-ray diffraction techniques, measured 
the orientation and size of crystals in human femoral 
cortical bone taken from individuals within the age range 
13 to 97 years. After the age of 60, there was a marked 
change in the distribution of crystallites so that older 
bones had a greater proportion of large crystallites (over 
600 nanometres). 
In the present study, we have used quantitative 
polarised light microscopy to identify changes in the 
microstructure of some of the components of bone at the 
site of fracture that could explain the increased fragility 
of the bone in patients who have suffered fracture of the 
femoral neck. Some of this study has been presented at a 
meeting of the British Orthopaedic Research Society. 
MATERIALS AND METHODS 
lFemoral heads were obtained from Northwick Park Hospital between 
pecember 1980 and October 1981 from patients undergoing total hip 
replacement for severe osteoarthritis or Thompson replacement for 
subcapital femoral neck fractures; others were obtained at necropsy 
from patients whose death was not related to any bone disease. 
For studies on crystals, 19 osteoarthritic samples (five male, and 12 
female; mean age and standard deviation, 67.6+ 11.5 years), 16 
cadaveric samples (five male, II female; mean age and standard 
deviation, 73.7 + 8.2 years) and 21 samples of fractured necks of femur 
(one male; mean age and standard deviation, 76.7 ± 12.6 years) were 
ifivestigated. For studies on the bireffingence of collagen and of the 
glycosaminoglycans, the number of specimens and the ages of the 
stjbjects were eight (62.1 + 14.7 years), eight (72.3 + 5.1 years) and II 
(8o. 4 ± 12.0 years) respectively. 
Small blocks of trabecular bone (about 2xIx3 centimetres) were 
sawn from the femoral head to include the fracture site or from an 
equivalent position at the epiphysial region of the osteoarthritic and 
cadaveric bones. Pieces of bone were also collected at operation from 
three patients who had suffered traumatic fractures of the tibia] or 
femoral shaft or the neck of humerus. After brief immersion in five per 
cent (weight/volume) polyvinyl alcohol (GO4/140 Polyviol; Wacker 
Chemicals) the blocks of bone were chilled to - 70 degrees Celsius in 
, j-hexane. Cryostat sections (10 micrometres thick) of the unfixed, undemin- 
cralised bone were prepared as previously described (Johnstone 1979). 
The sections were cut from the blocks orientated in such a way that one 
side of the section was at the fracture surface or the equivalent surface 
from the osteoarthritic or cadaveric specimens. All sections were dried 
overnight at 37 degrees Celsius. They were then inspected, under 
crossed polars, either unstained or after staining with alcian blue by the 
critical electrolyte concentration method of Scott and Dorling (1965) as 
described by Chayen, Bitensky and Butcher (1973). These methods 
depend on the fact that whereas collagen fibres naturally show form 
birefringence, the orientation of the acidic glycosaminoglycans and 
related molecules can be demonstrated only after a birefringent dye has 
been attached to them (M6dis 1974). All microscopic examinations and 
birefringence measurements, using a Brace-K6hler A130 compensator, 
were done on a Zeiss universal microscope equipped with a range of 
polarising objectives (16 x, 0.32 NA; 40 x, 0.85 NA; 63 x, 0.9 NA). 
Birefringence was expressed as nanometres of optical path difference 
(Rob) after conversion of the angle of rotation of the Brace-Uhler 
compensator (O. p) according to the equation 
R. bj = R., psin21p., p 
where R... is the optical path difference imposed by the compensator 
(Chayen and Denby 1968). The refractive index of crystals was 
determined by the method described by Watts el al. (1971). The amount 
of alcian blue staining in the areas used for birefringence measurements 
was quantified with a Zeiss photometer head fitted to the microscope; 
the optical density was determined with a standard mask-aperture with 
light from a mercury-vapour lamp. The photometer was calibrated 
with a series of neutral density filters. 
RESULTS 
Reproducibility of measurements of birefringence. On six 
occasions, the birefringence (optical path difference) was 
measured five times by each of two of us. The overall 
coefficient of variance was 9.5 per cent. 
Appearance of sections under crossed polars. All sections 
from all 35 osteoarthritic or cadaveric specimens, either 
mounted in air or in benzaldehyde (refractive index 
1.545), showed highly birefringent lamellae of collagen, 
often with the haversian systems in the plane of the 
section. In between these arrays of collagen, the section 
appeared to be as black as the background, indicating an 
apparent lack of suitably orientated birefringent material 
(Figs I and 2). Such sections, which were fully mineral- 
ised, were indistinguishable from sections of bone that 
had been chemically fixed, decalcified, embedded in 
paraffin and sectioned in a routine histological laboratory. 
An exactly similar image was obtained when the sections 
of undernineralised bone were treated with EDTA (0.1 m) 
at pH7 for 16 hours to remove the mineral component. 
These results implied that the crystals of mineral, in the 
undecalcified sections, were too small, and too disorien- 
tated, to be detected in this microscopic system. 
In marked contrast, in all 21 samples of fractured 
necks of femur, discrete crystalline material was found, 
particularly close to the site of fracture, in between the 
collagen lamellae (Figs 3 and 4). The incidence of crystals 
decreased with distance (up to three centimetres) from 
the site of fracture. These crystals showed true crystalline 
birefringence in that their birefringence was virtually 
unaffected by the refractive index of the medium in 
which the sections were mounted. They showed straight 
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extinction, positive birefringence and appeared to be 
hexagonal. Although many were small, about 0.5 micro- 
metres long, many were 2.5 by 0.5 micrometres. The 
optical path difference through such large crystals was 
only 19 nanometres; assuming a thickness of 0.5 
micrometres, this indicates a birefringence of 3.8 x 10-2. 
blue in the presence of 0.025m-MgCl, was identical. It 
was markedly less in the sections from the fractured 
necks of femur (Table 1): it was least when close to the 
site of fracture and rose to higher values up to 15 
millimetres from the fracture (Fig. 5); however, even at 
this distance from the fracture, the values did not achieve 
Fig. II igý 2 
Section of' undecalcified osteoarthritic bone, viewed between crossed polars. Figure I-The spaces between the 
birefringent collagen bundles of the haversian system arc clear of birefringcnt material (x 440). Figure 2-The space 
between the birefringent (white) collagen is devoid of crystalline material (x 1750). 
Fig. 3 Uig. 4 
Section of' undecalcified bone from the area of the fracture of a fractured neck of lemur. Even in (lie low-power 
photograph (Fig. 3: x 440), and more discretely in the higher power view (Fig. 4: x 1750), birefringent and apparently 
crystalline material can be seen in between, and on, the birefringent (white) collagen. 
The refractive index was greater than 1.545. Thus in all 
features, these crystals corresponded to crystals of apatite. 
Birefringence of collagen and acidic glycosaminoglycans. 
Untreated sections were examined by polarised light 
microscopy. The optical path difference measured in the 
collagen lamellae was the same in all three types of 
specimen (Table 1). 
Sections stained with alcian blue, in the presence of 
either concentration of magnesium chloride, and exam- 
ined by polarised light microscopy showed blue birefrin- 
gent matter apparently coincident with the collagen 
lamellae. The white birefringence of the latter was largely 
obscured by the blue birefringence. The optical path difference induced by this blue birefringence in sections 
of osteoarthritic and cadaveric samples, stained by alcian 
Table 1. Birefringence (optical path difference) of collagen and sections 
of bone stained with alcian blue, measured in nanometres of retardation 
(mean +SEM) 
Osteo- Fractured Traumatic 
arthritic Cadaveric neck of femur fractures 
Treatment (n = 8) (n = 8) (n = 11) (n ý2 or 3) 
Unstained 17.4 + 0.5 17.2 + 0.6 16.7 + 0.2 14.7,16.9 
collagen 
Alcian blue 20.3 + 0.4 20.2 + 0.3 11.2 + 0.4* 19.1,21.0 
+ 0.025m- 
mgcl, 
Alcian blue 15.2 + 0.6 15.8 + 0.6 7.8 + 0.5 17.3,15.8, 
+ 0.5m- 15.1 
MgC12 
*Significantly different (P<0.001) from ostcoarthritic and cadaveric 
groups; Student's t-test 
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normal levels. Although the higher concentration of 
rnagnesium chloride decreased the amount of alcian blue 
birefringence, essentially similar results were obtained 
(Table 1; Fig. 5). 
18 
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Fig. 5 
The amount of birefringence (optical path differ- 
ence, measured as nanometres of retardation of 
the polarised light) found in the collagen (squares), 
in the material that was stained with alcian blue 
either with the low (circles) or the high (triangles) 
concentration of magnesium chloride, at different 
distances from the fracture site. The results 
represent the mean + SEM measured in two 
sections from each of five specimens, each 
measured five times independently by two 
observers. 
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Fig. 6 
, jrhe concentration of alcian blue stain, measured by direct microscopic 
hotometry (as extinction of the dye) measured in the same microscopic 
eld as the birefringence of oriented dye (optical path difference) in 
.. Ctions of 
fractured necks of femur (circles), of cadavcric (triangles) 
apd of osteoarthritic 
(squares) specimens. Although there is a clear 
difference in the degree of orientation (optical path difference), this is 
not reflected in the total amount of dye present. 
Content of acidic glycosaminoglycans. In a few sections, 
the amount of alcian blue stain present was measured by 
direct photometry in the same regions as had been 
selected for birefringence measurements. These results 
(Fig. 6) showed that the content of acidic glycosamino- 
glycans through the thickness of the section was 
equivalent in all three types of specimen even though the 
amount of birefringence in the individual lamellae in 
sections from the fractured necks of femur was decreased 
by about 45 per cent. 
Results with traumatic fractures. No crystals were found 
in several serial sections taken from these fractures. The 
optical path difference measured in the native collagen 
and the alcian blue birefringence in sections stained at 
both concentrations of magnesium chloride agreed 
closely with the values found in the non-fractured 
specimens (Fig. 7). 
DISCUSSION 
The relationship between applied tensile load and 
resultant strain in normal and osteoporotic bone (Dick- 
enson et al. 198 1) shows the elastic component, presum- 
ably related to collagen, is virtually identical. The 
difference between these types of bone lies in the plastic 
loading region so that the latter will break at lower load; 
this region is presumably related to the properties of the 
mineral component. In agreement with these findings, 
the degree of orientation of the collagen has been the 
same in the specimens of fractured neck of femur as in 
the other two categories. However, the mineral phase 
has been found to be different in that, close to the site of 
fracture, some of the mineral phase occurred in the form 
of crystals of the size that could readily be resolved by 
normal, polarised light microscopy. Such crystals were 
not seen in the few traumatic fractures that have been 
available for study so that the crystals seen in the 
fractured necks of femur were unlikely to be due simply 
to the fracture process. 
The use of the potential birefringent properties of 
alcian blue allowed studies to be made on the orientation 
of acidic glycosaminoglycans. Under the conditions used 
in this study, as defined by Scott and Dorling (1965), in 
the presence of 0.025M-MgCI2 this dye will stain all acidic 
glycosaminoglycans and other acidic molecules, such as 
hyaluronic acid and acidic proteins. Although such acidic 
molecules may not be birefringent, even when orientated, 
the stain that is bound to such orientated molecules will 
exhibit birefringence (M6dis 1974). At the higher 
concentration of magnesium chloride, the binding of the 
dye is restricted to highly sulphated, long-chain moieties, 
mainly chondroitin and keratan sulphates (Scott and 
Dorling 1965; Scott 1973). 
The total content of acidic glycosaminoglycans was 
the same in all samples tested in this study. However, the 
degree of orientation, both of the "non-specific" acidic 
moieties (stained in the presence of the lower concentra- 
tion of magnesium chloride) and of the chondroitin and 
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Fig. 7 
Scattergram showing the degree of orientation (optical path difference) in the collagen and in the 
ground substance (stained with alcian blue with either 0.025m- or 0.5m-MgCI2) in sections from 
osteoarthritic (OA) cadaveric (PM), fractured necks of femur (FNF) and traumatic fractures 
(TF). The bar indicates the mean value for each group. (The statistical significance of these 
results is given in Table 1). 
keratan sulphate-like moieties, was about 45 per cent less 
in the bone from the fractured necks of femur than in the 
osteoarthritic or cadaveric specimens. This decreased 
orientation was maximal close to the site of fracture and 
tended towards more normal values further from the 
fracture. But it was noteworthy that the birefringence 
was subnormal even 15 millimetres from the fracture 
(Fig. 5). This effect was also unlikely to be a direct 
consequence of fracture since the orientation of alcian 
blue-stained material in the lamellae of the traumatic 
fractures was the same as in the "control" specimens 
(Fig. 7). 
Thus this study has shown that, close to the fracture, 
relatively large crystals, that appear to have the optical 
properties of apatite, have been detected in all 21 cases 
of fractured necks of femur and in none of the 35 other 
control specimens or in the three traumatic fractures. 
This finding is in keeping with the observations of Wall 
et al. (1979) and of Chatterji et al. (1981) that, with 
advancing age, some microstructural change occurs in 
bone and that the density of the bone is not the sole 
determining factor in its resistance to fracture. The 
development of crystals, of the size found in the present 
study, would be in keeping with a microstructural change 
that could predispose the bone to fracture. It is well 
known (Forsyth 1969; Engel and Klingele 198 1) that the 
presence of such crystals in otherwise microcrystalline 
metals can be a source of structural failure or fracture. 
The finding that the orientation of ordered compo- 
nents of the non-collagenous ground substance is also 
decreased in the fractured necks of femur may indicate 
a cause for the development of such anomalously large 
crystals of apatite in the microcrystalline mineral phase. 
This arises from the fact that the crystallisation of apatite 
can be modulated by glycosaminoglycans (Boskey 198 1). 
The fact that these changes, and the appearance of 
crystals, occur only at a specific locus may be related to 
the fact that this region is the site of greatest shear; it is 
the site of greatest tension, as calculated by Singh, 
Nagrath and Maini (1970). 
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The apparent paradox of aerobic glycolysis has been investigated in bone and in cartilage. 
A new cytochemical procedure for hydroxyacyl dehydrogenase (HOAD) activity showed 
that the maximal activity of this enzyme in both tissues was equivalent to the maximal 
activity ofglyceraldehyde 3 -phosphate dehydrogenase (GAPD). The sum of these activities 
gave a measure of the maximum amount of acetyl-coenzyme A that could be produced. In 
these tissues, but not in liver which does not exhibit aerobic glycolysis, this summed value 
exceeded the maximal activity of succinate dehydrogenase (SDH). Consequently, it 
suggested that where fatty acid oxidation is sufficient to supply all the acetyl-coenzyme A 
required for the Krebs' cycle, that derived from fatty acid oxidation may inhibit pyruvate 
dehydrogenase causing accumulation of pyruvate which must be converted to lactate if 
pentose-shunt activity is to be maintained. 
Keywords: Bone, aerobic glycolysis, fatty acid oxidation, cartilage 
Introduction 
Cartilage (as reviewed in Refs 1 and 2) and bone 3,4 
produce considerable amounts of lactic acid from 
glucose, indicating a dependence on glycolysis. This 
might be expected of cartilage which can be 
relatively anaerobic because of its avascular nature, 
but this argument cannot be applied to bone which 
is a highly vascular tissue. Moreover, both show the 
phenomenon of 'aerobic glycolysis' namely a high 
rate of formation of lactic acid from glucose, even 
when studied in vitro at high oxygen tensions in the 
medium. This apparent paradox of aerobic glycolysis 
has been found to occur in many cell-types, and is 
particularly marked in growing malignant cellS5. 
Both cartilage and bone are difficult to study by 
conventional biochemical procedures. Bone, in par- 
ticular, is recalcitrant to conventional biochemical 
procedures. Both contain relatively few cells per 
mass of tissue; the cells may be of different cell-types 
so that, even when they have been harvested, the 
population may be heterogeneous and each sub- 
population may have characteristic metabolic acti- 
vities. An approach to the study of the oxidative 
metabolism of bone and cartilage, that overcomes 
these difficulties is afforded by the development of 
methods for cutting serial sections of adult unfixed, 
undemineralized bone 6, '. Such sections can be 
examined by conventional methods of quantitative 
cytochemistry so that biochemical activities can be 
related to histology, so avoiding problems of tissue 
heterogeneity. 
In considering the question of lactic acid produc- 
tion by these tissues, it is obvious that the pyruvate 
dehydrogenase complex could play a crucial role 
(Figure 1). There is considerable evidence that the 
behaviour of this multi-enzyme complex is fun- 
damental in determining the fate of pyruvate 
produced by the Embden-Meyerhof pathway. It has 
been studied particularly in alloxan-diabetes where 
pyruvate oxidation is inhibited8. The activity of the 
complex is inhibited by the products of fatty acid 
oxidation (as reviewed in Ref. 8), particularly by 
acetyl co-enzyme A (Ref. 9). It therefore seemed 
appropriate to try to evaluate the oxidative metabol- 
ism of the various cellular components of bone and of 
cartilage to determine whether these tissues could 
oxidize fatty acids at such a rate that the acetyl 
coenzyme A, so produced, might become a factor in 
controlling the pyruvate dehydrogenase activity. 
This study became feasible with the synthesis of a 
new substrate for hydroxyacyl dehydrogenase 
(HOAD) activity, namely DL-S-0-hydroxybutyryl-N- 
acetyl cysteaminelo. 
Materials and methods 
Female Wistar rats weighing - 50 g were killed by 
cervical dislocation. The metatarsals were cut in 
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Figure I The main oxidative enzymes involved in the genera- 
tion of acetyl-coenzyme A for the Krebs' cycle, and in the 
production of lactic acid. 1, glucose 6-phosphate dehyd- 
rogenase; 2, glyceraldehyde 3-phosphate dehydrogenase; 3, 
the pyruvate clehydrogenase complex; 4, hydroxyacyl dehyd- 
rogenase; 5, lactate dehydrogenase (pyruvate reductase) 
half and the distal half, with the epiphyseal plate, 
was removed. Two metatarsals from each of six rats 
were used for all the enzyme studies except for the 
study of succinate dehydrogenase where three 
metatarsals from each of two rats were used. The 
bones were dipped in 5% polyvinyl alcohol before 
being chilled in n-hexane at -65 to -70'C. These 
techniques have been fully described by Chayen et 
al. " The bones were sectioned (10 jim) on a Jung 
1130 rotary microtome set in a Bright's cryostat 
(cabinet temperature -25 to -30'C with the knife 
cooled with solid carbon dioxide', "). To test the 
oxidative activity in a tissue that does not show 
taerobic glycolysis', small pieces (3 X3X3 mm) of 
the liver from three female Wistar rats (body weight 
200 9) were chilled in hexane at -65 to -70"C and 
sectioned at 10 Rm in a Bright's cryostat". The same 
reactions were carried out on these sections as on 
those from the metatarsals. 
Except for the studies on succinate dehydrogenase 
activity, all the reaction-media contained 0.6% (10 
rnm) chloroform-purified neotetrazolium chloride 
(Serva) in a 30% (w/v) solution of polyvinyl alcohol 
(grade G04/140; Wacker Chemicals Ltd, Walton-on- 
Thames, Surrey, UK) in glycyl glycine buffer (50 
nim; pH 8.0). For demonstrating the activity of 
succinate dehydrogenase, which is tightly bound 
within the mitochondria, a 0.1 m phosphate buffer, 
pH 7.8 was used. Except for the demonstration of 
hydroxyacyl dehydrogenase activity (see below), the 
rnedia contained the intermediate hydrogen- 
acceptor, phenazine methosulphate (0.7 mm added to 
the medium just before use). 
The specific reactants were as follows. Lactate 
dehydrogenase activity: sodium lactate, 60 mm; 
NAD, 2.5 mm. Glucose 6-phosphate dehydrogenase 
activity: glucose 6-phosphate, monosodium salt, 5 
rnm; NADP, 3 mm. Glyceraldehyde 3-phosphate 
dehydrogenase activity: fructose 1-6-diphosphate, 5 
rnm; aldolase, 10 units ml-'; NAD, 1.5 mm. The 
reaction medium was left for 20 min at 37*C before it 
was used in order to convert sufficient fructose 
diphosphate to glyceraldehyde 3-phosphate 13. SUC_ 
cinate dehydrogenase activity: sodium succinate, 50 
mm. P-Hydroxyacyl dehydrogenaselo: the reaction- 
medium contained NAD (2 mm); sodium nitroprus- 
side (5 mm) to inhibit the effects of any acetyl 
cysteamine liberated by non-enzymatic hydrolysis of 
the substrate; menadione (2-methyl-1,4-naphtho- 
quinone, 3 mm) as the preferred intermedi- 
ate hydrogen-acceptor for this reaction'; and either 
the substrate, DL-S-0-hydroxybutyryl-N-acetyl cys- 
teamine (50 mm) or cysteamine (P-mercapto- 
ethylamine; 5 mm) in a 0.05 m glycyl 
glycine buffer at pH 8.0. The menadione and the 
substrate were first dissolved in a small volume of 
ethanol so that, when added to the reaction medium, 
the final concentration of alcohol in the test and 
control medium was 1%. The pH of the medium was 
adjusted to pH 8.9 before the substrate, or cys- 
teamine, was added to it. After this addition, the pH 
was again checked and adjusted to pH 8.5 when 
necessary. Unless otherwise specified, all chemicals 
were obtained from Sigma, London, UK. 
All the reactions were performed at 37*C in dn 
atmosphere of nitrogen, since oxygen competes with 
neotetrazolium chloride for reducing equivalents. 
The reactions were run for 45 min except for that for 
lactate dehydrogenase activity which was run for 10 
min, the results from this being multiplied by 4.5 for 
comparison with the results from the other tests. 
Over these reaction times, the responses were linear 
with time. 
Measurement 
The coloured formazan produced in the sections 
was measured with a Vickers M85 scanning and 
integrating microdensitometer with aX 40 objective 
and a flying spot that had a diameter of 0.5 ttm in 
the, plane of the section, and at a wavelength of 585 
4 nm 4. The mask encompassed one cell of each type 
studied and the results were expressed in absolute 
units of extinction (mean integrated extinction X 
100) per cell. The cell-types measured were: chon- 
drocytes in the resting, proliferating, and hyper- 
trophic zones of the growth plate; and osteoblasts 
and osteocytes in the metaphysis. 
Results 
Validation of the HOAD reaction 
The optimal pH for osteoblasts, was pH 8.5 and for 
chondrocytes was pH 8.0 (Figure 2). The graph 
relating activity to concentration of coenzyme was 
broad, with 2 mm giving maximal activity, and little 
sign of inhibition at greater concentrations. The 
concentration of the final hydrogen-acceptor, neotet- 
razolium chloride, had a strong influence on the 
activity recorded: the activity (mean extinction for a 
reaction-time of 45 min) was 0.29 at 0.6% (10 mm); 
maximal (0.32) at 0.9% (15 mm): with some 
inhibition (0.23) at 1.2% (20 mm). To ensure fi-eedom 
from inhibitory effects, 0.6% was used in all 
subsequent studies. Nitroprusside increased activity 
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Figure 2 Variation in activity with pH of hydroxy, acyl dehyd- 
rogenase in (A) osteoblasts, and (B) chondrocytes. The activity 
is represented by the mean integrated extinction (MIE) x 100 
per cell in a 45 min reaction; the bars represent the s. e. m. of 20 
measurements 
in osteoblasts and in chondrocytes up to a concentra- 
tion of 5 mm with considerable inhibition thereafter; 
50 mm nitroprusside caused total inhibition. In- 
creasing concentrations of substrate produced typic- 
al substrate-activity graphs with a rapid initial rise 
in activity at lower concentrations (up to 5-10 mm) 
with a much slower rise in activity at higher 
concentrations, up to 100 mm. Considering the cost 
of the substrate, and the small difference found at 
higher concentrations, 50 mm was taken as an 
adequate compromise. The substrate has the poten- 
tial to become hydrolysed spontaneously, at the pH 
of the reaction, to yield free N-acetylcysteamine 
that, in the presence of menadione, could reduce the 
neotetrazolium 
5 
salt. Spectrophotometric 
determinations' of the cysteamine liberated in the 
reaction-medium, after 30 and 90 min, gave values 
equivalent to 3.1,4.0 and 2.7 mm of free cysteamine. 
When sections were reacted with various concentra- 
tions of cysteamine instead of the substrate, the 
(activity' recorded was maximal with 2.5 mm 
cysteamine, this level of activity was maintained up 
to 10 mm; higher concentrations gave less activity, 
with no reaction at 50 mm. Consequently control 
sections were reacted with 5 mm cysteamine 
replacing the substrate. This was over-cautious 
since dithionite reduction Of the neotetrazolium in 
the reaction-medium did not produce formazan 
deposits in the chondrocytes. 
Increasing the concentration of the intermediate 
hydrogen-acceptor, menadione, up to 3 mm, in- 
creased the activity with no further increase, or 
inhibition, at concentrations up to 5 mm. 
The reaction was linear with time over the first 45 
min; the activity increased less rapidly over the 
subsequent 20 min and did not increase with longer 
reaction-times. This may reflect the rate of hydroly- 
sis of the substrate. 
Sections of bone, incubated in the final reaction- 
medium for 45 min at 37'C, showed reaction-product 
in all cell-types of normal bone, including the 
osteocytes deeply embedded in adult bone. 
Oxidative activities in the various cell-types of 
the bone and cartilage 
The activities of one oxidative enzyme of each of 
the major pathways (Figure 1) were measured in the 
region of the growth plate of the metatarsals. The 
selected enzymes were as follows: Embden- 
Meyerhof pathway: glyceraidehyde 3-phosphate de- 
hydrogenase (GAPD); pentose-shunt: glucose 6- 
phosphate dehydrogenase (G6PD); the tricarboxylic 
acid cycle: succinate dehydrogenase (SDH); fatty 
acid oxidation: hydroxyacyl dehydrogenase 
(HOAD); and lactate dehydrogenase activity (LDH). 
The results (Table 1) showed first, that under the 
conditions of the tests, in all cell-types the HOAD 
activity was equivalent to that of GAPD; secondly, 
that the SDH activity was too small to accommodate 
the combined GAPD plus HOAD activities; and 
thirdly, that there was a direct correlation (r = 0.85; 
p=0.02) between the LDH activities and the value 
of (GAPD + HOAD) - SDH. The activities recorded 
when these reactions were done in the absence of the 
substrate were so low that they have not been taken 
into account. 
Oxidative activities in rat liver 
In the liver, with its stores of endogenous 
substrates, the activities recorded when the reac- 
tion-medium lacked exogenous substrate were 
appreciable (Table 2). However, whether or not 
these 'control' values were taken into account, the 
combined activities recorded for glyceraldehyde 
3-phosphate dehydrogenase and for hydroxyacyl 
dehydrogenase (GAPD + HOAD; Table 2) were far 
less than that recorded for succinate dehydrogenase 
activity. Thus the value (GAPD + HOAD) - SDH 
was negative (Table 2). 
Discussion 
The development of a new substrate and a new 
method for measuring fatty acid oxidation has 
allowed the demonstration that all the cells of the 
growth-plate, even the differentiated osteocytes, are 
capable of oxidizing fatty acids. It is recognized that 
although cells show a particular metabolic activity 
in such tests, this does not prove that the cells have 
the same activity in life, as they are not necessarily 
supplied with optimal concentrations of substrate, 
cofactor and other reactants. Equally, the activities 
of enzymes that support 'near-equilibrium' or 
'non-equilibrium' reactions cannot be taken to 
indicate the flux through the system or pathway in 
which they occur. However, the results of these tests 
can be taken as an indication of the potential 
activities of the different pathways, and of their 
maximal capacities. 
The pentose-shunt involves the oxidation of 
glucose 6-phosphate, where NADP is the obligate 
cofactor. However, for the system to remain active 
as a cycle, it must feed-back into the normal 
glycolytic (Embden-Meyerhof) pathway, supplying 
either fructose 6-phosphate or glyceraldehyde 3- 
phosphate". Thus, the maximum activity of GAPD 
must be considered to be rate-limiting both for the 
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Table I Enzymatic activities, expressed as the mean integrated extinction x 100 ± s. e. m. /cell/45 min reaction, in various cell-types of 
the bone and cartilage of the growth-plate 
EnzYmO Osteocytes Osteoblasts Chondrocytes from 
Hypertrophic Proliferating Resting 
zone zone zone 
G61PD 12.0 ± 1.0 54.2 ± 2.6 29.4 ± 0.9 21.0 ± 0.9 13.4 ± 0.6 
LDH 32.3 ± 1.0 63.2 ± 1.0 95.6 ± 1.0 81.9 ± 2.0 45.8 ± 1.0 
GAIPD 14.0 ± 1.0 24.2 ± 1.1 20.7 ± 1.3 11.6 ± 0.9 8.6 ± 2.9 
HOAD 8.9 ± 1.9 19.6 ± 1.6 19.6 ± 2.6 14.2 ± 1.5 10.1 ± 3.2 
SDH 13.0 ± 0.7 32.0 ± 2.0 9.0 ± 0.6 9.0 ± 0.5 6.0 ± 0.5 
GADP + HOAD 22.9 43.8 40.3 25.8 18.7 
(GAIPID + HOAD) - SDH 9.9 11.8 31.3 16.8 12.7 
Tgible 2 Mean (± s. e. m. ) of the oxidative activities measured in the liver of three rats 
Activity (mean integrated extinction x 100/unit field/10 min reaction) 
G6PD LDH GAPD HOAD SDH GAPD + HOAD (GAPD + HOAD) - SDH 
ActiVity (n = 3) 52+0.7 45+0.5 67+1.0 32+0.4 160+4.0 99 -61 
Controls (9+0.4) (16+0.4) (27+0.6) (16+0.3) (0) - - 
OThe 'control' activities were measured either in the absence of substrate or, for HOAD activity, with cysteamine instead of the 
substrate. The different 'control' activities recorded for the two NAD-dependent enzymes are due to the different pH values at which 
these are done, in accordance with the different pH optima of the enzymes 
pentose-shunt and for the Embden-Meyerhof path- 
VVay. That is, it reflects the maximum oxidation 
produced from glucose 6-phosphate from either 
route, and therefore is an indication of the max- 
irnum capability of the cells to use glucose as a 
substrate for the energy-requirements of the cells. 
on this basis the results show that the capacity of 
the cells of the growth-plate to oxidize sugar or fatty 
acids is roughly equivalent, indicating that as much 
as 50% of the 'energy' of these cells could come from 
the oxidation of fatty acids. Thus, for example, the 
osteoblasts were capable of 24.2 units of GAPD 
activity, and 19.6 units of HOAD activity. Chondro- 
cytes of the resting zone were capable of 8.6 units of 
C, APD activity and 10.1 units of HOAD activity. 
In the Embden-Meyerhof pathway, the substrate- 
products of GAPD activity are finally converted to 
pyruvate. For this to be utilized in the Krebs' cycle, 
aind so to be used for the generation of ATP for the 
einergy-requirements of the cell, it must be con- 
. Verted to acetate and linked to coenzyme A (CoA) to 
forrn acetyl-CoA. It is noteworthy that the oxidation 
of fatty acids yields acetyl-CoA directly. Thus the 
gLrnount of activity of GAPD and of HOAD is a 
Ojeasure of the total amount of acetyl-CoA that 
could be available to be fed into the Krebs' cycle. 
jjowever, the SDH activity can be taken as the 
. 0aximum Krebs' cycle activity of which the cell is 
capable 
17 
. Thus the calculation (Tables 1 and 2) of 
(CxAPD activity plus HOAD activity) - SDH 
activity gives a measure of whether there could be 
sufficient, or excessive amounts of acetyl-CoA 
produced in the cells, relative to the maximum 
arnount that could be dealt with by the Krebs' cycle. 
It is clear (Table 1) that in all the skeletal cells 
studied, particularly the osteoblasts and the chon- 
drocytes of the hypertrophic region, excessive 
amounts of acetyl-CoA could be produced over and 
above what could be accommodated by the Krebs' 
cycle activity. If such conditions were to occur in life, 
the acetyl-CoA produced directly by fatty acid 
oxidation, and produced within the mitochondria 
close to the site of most of the Krebs'cycle enzymes, 
might be expected to be favoured. Moreover, the 
conversion of pyruvate to acetyl-CoA is very readily 
inhibited by acetyl-CoA', '. It follows, therefore, that 
fatty acid oxidation, producing acetyl-CoA, could 
inhibit the conversion of pyruvate (Figure 1). 
Blockage of the Embden-Meyerhof pathway at the 
level of pyruvate would stop not only the normal 
glycolytic pathway, but also the pentose shunt 
(Figure 1). This blockade would be relieved if the 
pyruvate were to be converted into lactate (by the 
pyruvate-reductase/LDH enzyme), with loss of lactic 
acid from the cells. This hypothesis is supported by 
the finding (Table 1) that there was a direct 
relationship between the LDH activity in these cells 
and the excess of (GAPD + HOAD) activities over 
the SDH activity, i. e. (GAPD + HOAD) - SDH. In contrast to cartilage and bone, liver does not 
normally produce lactic acid. The results with rat liver (Table 2) showed that the value of (GAPD 
activity + HOAD activity) - SDH activity gave a 
negative value. This implies that the maximal 
activity of the succinate dehydrogenase was well in 
excess of the combined activities of the glycolytic 
pathway and of fatty acid oxidation. If these results reflect something of what might 
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occur in life, the hypothesis would explain the 
apparent paradox of 'aerobic glycolysis' in bone and 
cartilage. This phenomen could be due to normal 
aerobic respiration, using the acetyl-CoA provided 
by fatty acid oxidation, with the removal of excess 
pyruvate (as lactate) produced by the glycolytic 
pathways. Thus lactic acid would be produced even 
though the cells showed full oxidative metabolism. 
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Effects on Fracture Healing of an Antagonist of the Vitamin K Cycle 
R. A. Dodds, A. Catterall, I Lucille Bitensky, and J. Chayen 
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Summary. The anticoagulant, dicumarol, inhibits 
the vitamin K cycle by blocking the conversion of 
the vitamin K epoxide. The effects of dicumarol 
on ossification have been tested by feeding it to rats 
in which a closed fracture of the metatarsals had 
been induced; the effects were studied up to 12 days 
postfracture. At 12 days, treatment with dicumarol 
caused a highly significant decrease in the amount 
of bone produced, without affecting the total size 
of the callus. Quantitative cytochemistry of un- 
fixed, undernineralized sections showed that dicu- 
marol also markedly affected the periosteal activi- 
ties of glucose 6-phosphate dehydrogenase and of 
alkaline phosphatase in the first 2 mm from the frac- 
ture measured at 3 and 5 days postfracture when 
normally, new bone is first formed. In contrast, di- 
cumarol had little effect on these activities in the 
fully formed callus. 
dioxide to form the -t-carboxyglutamate residue 
[3,41. 
Previous studies on cellular metabolic activities 
in healing fractures in rats [7] had shown that there 
was a marked increase in periosteal glucose 6-phos- 
phate dehydrogenase (GOD) activity at the site at 
which new bone formed on the shaft. This activity 
preceded the first signs of new bone. The simple 
assumption would be that the NADPH, generated 
by this stimulated G6PD activity at this site, would 
be used in the vitamin K cycle for ossification. This 
assumption has now been tested by treating the rats 
with dicumarol (chemically related to warfarin) 
which antagonizes the effect of vitamin K, in the 
vitamin K cycle by blocking the reversible conver- 
sion of vitamin K to the vitamin K epoxide [8]. 
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Quantitative cytochemistry. 
There is considerable evidence that calcification of 
bone may involve the -y-carboxylation of glutamate 
residues, as is found in osteocalcin [1-31. The pro- 
duction of these calcium-binding -y-carboxygluta- 
mate (Gla) residues is effected by a microsomal 
mixed-function oxidation-carboxylation reaction in 
which vitamin KI, or a similar naphthoquinone sub- 
stituted at the 3 position [4], is reduced by 
NAD(P)H [5,61. The reoxidation of the quinol is 
required for the process in which a proton is ab- 
stracted from the y-methylene of a glutamate res- 
idue [51; the resulting carbanion fixes carbon 
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Materials and Methods 
Animals 
For these studies, male Sprague-Dawley rats (230-250 g) were 
used instead of the Wistar rats used in previous studies [7] be- 
cause the latter were too sensitive to dicumarol. The rats were 
anesthetized with pentobarbitone sodium given intraperitoneally. 
Closed fractures were imposed by digital pressure on two meta- 
tarsals of one hind limb. The rats were allowed to revive and 
were killed up to 6 weeks later. Those rats that were treated with 
dicumarol received it in the drinking water as soon as they re- 
vived. A standard dose was achieved by giving each rat, daily, 
25 ml of drinking water containing 0.125 mg bis hydroxycumarin 
(Sigma) after which the water bottle was replenished with ordi- 
nary water. To obtain a "solution" of dicumarol, 25 mg of di- 
cumarol was dissolved initially in 10 ml of IM sodium hy- 
droxide, the pH was decreased to pH 10 with 5M HCI; this 
solution was diluted 1: 500 with tap water, giving it a final pH of 
between 8 and 9. It proved palatable to the rats. The control rats 
were given ordinary water only. The clotting time of normal rats 
was 2.0 min; in the dicumarol-treated rats it became prolonged 
from day 4, to reach 7.5 min on day 10 and 9 min on day 12. 
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Experimental Procedures 
At suitable times, the rats were killed by asphyxiation with ni- 
trogen. The fractured bone, with its associated plantar muscle, 
was dissected free and immersed briefly in a 5% (w/v) solution 
of polyvinyl alcohol (G04/140). The bone was then chilled to 
- 70'C in hexane (BDH "low in aromatic hydrocarbons" grade, 
boiling range 67-70oQ, as described previously [7,91, and stored 
in dry tubes at this temperature for up to 7 days. The bones were 
sectioned at 10 ýLrn in a Bright's bone cryostat equipped with a 
tungsten-tipped steel knife (Autoradiographic Products, 
Cheshire) with the haft packed around with solid carbon dioxide 
[7,101. 
Cytochemical Reactions 
The sections were reacted in triplicate for a number of enzymatic 
activities. Serial sections were stained with toluidine blue [9] for 
histological study. For G6PD activity, the reaction medium con- 
tained glucose 6-phosphate (5 mM), NADP' (3 mM), phenazine 
methosulphate (0.7 mM) and 0.3% (5 mM) purified neotetrazo- 
lium chloride in a 0.05 M glycyl glycine buffer, pH 8.0, con- 
taining 30% (w/v) of the G04/140 grade of polyvinyl alcohol 
(Wacker Chemicals, Mount Felix, Bridge St., Walton-on- 
Thames, KT12 IAS, UK). 
The medium for demonstrating alkaline phosphatase activity 
contained a-naphthyl acid phosphate (Sigma, 2 mg), Fast blue 
RR (Sigma, 50 mg), with 0.2 ml of a 10% solution of magnesium 
chloride, in 50 ml of a 2% solution of sodium 5,5-diethylbarbi- 
turate at a final pH of pH 9.2. For demonstrating hydroxyacyl- 
coenzyme A dehydrogenase activity [ 11], the medium contained 
DL-S-p-hydroxybutyryi-N-acetyl cysteamine (Sigma, 37 mM, or 
5 mM cysteamine, as control), NAD' (2 mM), menadione (3 
mM), sodium nitroprusside (5 mM), and 0.6% (10 mM) of puri- 
fied neotetrazolium chloride in a 0.05 M glycyl glycine buffer 
containing 30% of the polyvinyl alcohol with a final pH of 8.5. 
The colored reaction product of these cytochemical reactions 
was measured in the periosteum, and in histologically defined 
cell types in the developing callus, by means of a Vickers M85 
scanning and integrating microdensitometer. It had ax 40 ob- 
jective, spot size I (equivalent to 0.4 ýtm in the plane of the 
specimen), with light corresponding to the absorption maximum 
of the chromophore for the alkaline phosphatase reaction (580 
nm) and to the isobestic point for the formazan from the dehy- 
drogenase methods (585 nm). The reaction times required to 
obtain ideal concentrations of the colored reaction product for 
measurement were 10 min for G6PD, 45 min for hydroxyacyl 
dehydrogenase (HOAD), and 3 min for alkaline phosphatase ac- 
tivity. 
For histological examination, sections were selected that 
passed through approximately the mid-axis of the endosteal 
space. To confirm that this gave a good representation of the 
distribution of the various cellular components, one bone was 
sectioned serially from side to side, and the relative size of each 
component was ascertained at different levels. The image of the 
selected sections was thrown onto a screen; the enlarged image 
was traced onto tracing paper, and the areas of the selected 
tissue components were measured by planimetry. 
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Table 1. Total area and area of new bone formation (mean ±: 
SD) of dorsal and plantar callus in sections through the greatest 
diameter (midshaft) of fractured rat metatarsals 12 days post- 
fracture 
Dicumarol- 
Control (n = 16) treated (n = 13) 
Dorsal Plantar Dorsal Plantar 
Area (MM2 X 16) 29 --ý 13 6t4 25 --t 99 --t 6 New bone 15 :t64±3 10 ±43±3 
New bone % 56 ± 14a 45 ± 10a 39 ±5 30 ±6 
IP<0.001 as compared with dicumarol-treated: Student's i test 
Results 
Histological Results 
In all cases, the callus on the dorsal side of the 
fracture was considerably larger than that on the 
plantar side (Table 1). The total projected area of 
the dorsal callus in the treated and control animals 
was very similar (Table 1). However, the callus in 
the dicumarol-treated rats appeared to be less ad- 
vanced in terms of the degree of differentiation that 
it achieved (Fig. 1). As a test of this suggestion, the 
area occupied by new bone was expressed as a per- 
centage of the total area of the callus. When ex- 
pressed in this way (Table 1), 12 days after fracture, 
the proportion of the callus occupied by new bone 
was significantly higher (P < 0.001) in the control 
rats (e. g. 56% :t 10; mean t: SD) than in those 
treated with dicumarol (38% -_ 6). In the controls, 
the center of the callus around the fracture site (Fig. 
1) was occupied by fibrocartilagelike material, dif- 
ferentiating into mature cartilage further from the 
fracture. In the rats treated with dicumarol, the re- 
gion which should have contained fibrocartilagelike 
material contained effete, fibrous material with 
few cells. At 6 weeks, the fracture in the control 
rats was fully united, but union was still incomplete 
in those given dicumarol. 
Glucose 6-Phosphate Dehydrogenase Activity in 
the Periosteum 
The activity was measured in individual periosteal 
cells at measured distances from the fracture. In 3 
control rats, 3 days postfracture, there was consid- 
erable activity close to the fracture, reaching a 
mean extinction value of 22 units at 0.4 mm from 
the fracture, and rising to 27 units 1.2 mm from the 
fracture. In contrast, the activity in the dicumarol- 
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Fig. I. Sections of fractures. 12 days postfracture. stained with toluidine blue. In the control bone (a), the upper part of the callus has 
been largely converted to new bone (tib) with very little residual cartilage. In the fracture from the animal treated with dicumarol (b), 
most of the callus consists of cartilage, staining dark. Magnification x 24. 
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Fig. 2. G6PD activity (integrated extinction x 100) at discrete 
distances from the fracture in the periosteum of 3 control rats 
(open symbols) and of 3 rats treated with dicumarol (closed sym- 
bols) 3 days postfracture. 
treated rats declined over this region of the perios- 
teum (Fig. 2). 
In the periosteum of the fractured bones from 15 
otherwise untreated and 14 dicumarol-treated rat s 
taken 5 days after fracture, the mean activity was 
depressed in the latter and was found even in the 
face of wide individual variations (Fig. 3). The dif- 
ferences at 0,0.2, and 0.4 mm from the fracture site 
were significant at the level of P _- 0.02; at 0.6 mm 
the difference was significant at P=0.03. 
Because the precise location of the peaks of ac- 
tivities varied slightly in the different animals, the 
mean results did not adequately represent the 
changes in activity either along the periosteum of 
any one animal, or the differences induced by the 
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Fig. 3. The mean G6PD activity (integrated extinction x 100) at 
discrete points from the site of fracture in the periosteum of 15 
control rats (solid line) and 14 rats, 5 days after fracture. that 
had been treated with dicumarol (broken line). The bars repre- 
sent the standard error of the means. 
treatment. In general, all the bones from the control 
rats, and most of the bones from the treated rats, 
showed two regions of elevated G6PD activity (Fig. 
4). The region closest to the fracture had relatively 
low activity, with higher activities over part or all 
of the first 0.8 mm from the fracture. Particularly 
in the controls, another peak of activity occurred 
in the region of 1.0- 1.8 mm from the fracture. How- 
ever, because the precise location of these elevated 
activities varied from one rat to the next, the overall 
mean values (Fig. 3) did not clearly show these vari- 
ations. Thus, to express the first of these activities 
numerically, the activity in each section was plotted 
against the distance from the fracture, as in Fig. 4, 
and the area under the graph up to the beginning of 
the second peak was measured by planimetry. 
The results (Table 2) showed that there was a 
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Fig. 4. Examples of how the G6PD activity (integrated extinction x 100) was measured at different sites in the periosteum, 5 days 
postfracture (a control rat; b dicumarol-treated rat). The first measurement merely involved measuring the area under the graph up 
to the beginning of the second peak. The second measurement was of the area under the graph for the second peak of activity (stippled). 
Table 2. Glucose 6-phosphate dehydrogenase activity (mean - 
SEM) in periosteal cells of fractured rat metatarsals 5 days post- 
fracture 
Control Dicumarol 
15) (n = 15) 
Area of first region 
of activity from the 
frac tu re 25 ± 201 17.7 ± 1.7 
Area of second peaký 
of activity 16 ± 2.7c 3±0.98 
'A peak was defined as a change in activity of greater than 5 
units MIE x 100/0.2 mm 
b 0.05 >P>0.02 and IP<0.001 as compared with dicournarol- 
treated rats: Student's i test 
barely significant depression of G6PD activity over 
this region of the periosteum in the dorsal callus of 
the rats treated with dicumarol (0.05 >P>0.02). 
A similar device was used to achieve a numerical 
representation of how the treatment influenced the 
second peak of activity in the region of 0.8-1.8 mm 
from the fracture. For this purpose, an increase 
from one measurement to the next (a distance of 
0.2 mm) of more than 5 units of mean integrated 
extinction x 100 (corresponding to 0.05 of absolute 
extinction) was defined as a "peak. " The area of 
such peaks was marked on the graphs (as in Fig. 
4); these were measured by planimetry. The results 
(Table 2) showed that treatment with dicumarol had 
markedly suppressed this second peak (P < 0.001). 
Alkaline Phosphatase Activity in the Periosteum 
In a control rat, 3 days after fracture, there was very 
low activity up to 0.8 mm from the fracture site, 
becoming markedly elevated thereafter to values 
exceeding those found uniformly throughout this re- 
gion in intact metatarsal bones of this strain of rat 
(38 -t 0.8; mean ± 
SEW n= 4). This loss of ac- 
tivity, close to the fracture site, was very much less 
marked in the dicumarol-treated rat. This pattern 
was found in 14 control and 16 dicumarol-treated 
rats 5 days after fracture (Fig. 5). At all points in 
the periosteum. up to and including 0.6 mm from 
the fracture, the alkaline phosphatase activity was 
very significantly lower in the control rats than in 
those treated with dicumarol (P < 0.0004); it was 
significantly lower also at 0.8 mm from the fracture 
(P = 0.01) but the activities thereafter were not 
significantly different. 
HOAD Activity in the Periosteum 
This enzymatic activity was measured in the per- 
iosteum from the fractures of 10 control rats and of 
11 rats that had been treated with dicumarol. Be- 
cause inspection of the graphs of activity/distance 
for individual bones disclosed no obvious patterns, 
the results from all the specimens were plotted (Fig. 
6). There was no difference in activity as a conse- 
quence of treatment with dicumarol. 
Enzymatic Activity in the Cells of the Callus 
Glucose 6-phosphate dehydrogenase activity was 
measured in 5 specified cell types in the callus of 
the fractures of 9 or 10 control, and 6-8 dicumarol- 
treated rats, 12 days postfracture. Only in the cells 
of the mature cartilage (Table 3) was the activity in 
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Fig. 5. Alkaline phosphatase activity (integrated extinction 
x 100) measured at discrete distances from the fracture site in 
the periosteurn of control rats (solid line) and of dicumarol- 
treated rats 5 days postfracture. The mean values (solid or empty 
circles) and SEM of 14 control and 16 dicumarol-treated rats are 
shown. 
the dicumarol-treated rats significantly lower (P = 
0.01; n= 19) than in the controls. No differences 
were found in the activities of either alkaline phos- 
phatase or HOAD in any of these cell types. 
Discussion 
The histological evaluation of the effect of dicu- 
marol on these fractures (Table 1) showed that al- 
though the treatment had no effect on the total size 
of the callus that developed, it markedly delayed 
maturation so that at 12 days postfracture, whereas 
56% of the area of the callus of the controls was 
occupied by bone, only 38% was occupied by bone 
in the treated rats. Moreover, the latter showed 
large regions of cartilaginous material (Fig. 1) and 
effete, fibrous material. This is in keeping with the 
earlier studies, for example, by Stinchfield et al [12] 
who found fibrous tissue and immature bone in the 
healing fractures of rabbits and a dog given dicu- 
marol at the rate of 2 mg/kg body weight each day. 
Superficially, the results reported here seem to 
be at variance with the results of Price and Wil- 
liamson [131 who detected no abnormality in the 
repair of fractures in rats fed with warfarin. How- 
ever, these workers studied young rats, in which 
the radius was fractured at 17 days of age. Because 
the amount of warfarin given was apparently toxic, 
vitamin K, was also administered simultaneously. 
Thus, the conditions were very different from those 
used in the present study. Moreover, evidence of 
repair was obtained radiologically and not histolog- 
icafly, thus allowing for the possibility that an outer 
cuff of bone, overlying a region of unossified car- 
tilage (as found in the present study), could have 
confused the radiological evidence. 
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Fig. 6. HOAD activity (integrated extinction x 100; mean t 
SEM) at discrete distances from the fracture site, 5 days post- 
fracture, in 10 control rats (solid line) and II rats that had been 
treated with dicumarol (broken line). 
Over the first 15 days after fracture of metatarsal 
bones, G6PD activity has been shown to be ele- 
vated in the region near the fracture and also in a 
region about 1.2 mm behind the fracture [7]. The 
first peak of activity was apparently associated with 
the proliferation to form the callus, since this en- 
zyme is the regulatory enzyme of the pentose shunt 
[141 which is required for growth. The second peak 
of activity was shown to be associated with the re- 
gion at which bone first formed on the shaft of the 
fractured bone [7]. The biochemical function of this 
second peak of G6PD activity may be related to the 
fact that this enzymatic activity is a major source 
of cytosolic NADPH which may be used in the vi- 
tamin K cycle [6]. 
The results in the present study indicated that 
treatment with dicumarol only slightly depressed 
G6PD activity in the first region of the periosteum 
(Tables 2 and 3), but virtually obliterated the second 
peak. Moreover, it depressed G6PD activity in the 
cells of the mature cartilage. Thus, not only could 
it be acting as an antagonist of the vitamin K cycle, 
blocking the conversion of the epoxide to the 
naphthoquinol, but it also depressed the amount of 
reducing equivalents, from NADPH, available for 
the cycle at these points of ossification. 
This action of dicumarol was not a universal ef- 
fect in that it 
' 
had no influence on the G6PD activity 
of the other cells of the callus (and therefore on the 
proliferative capacity of the callus or its ultimate 
size); nor did it influence fatty acid oxidation, as 
shown by the hydroxyacyl dehydrogenase activity. 
Furthermore, it enhanced periosteal alkaline phos- 
phatase activity (Fig. 5) and left that of the various 
cells of the callus unaltered (Table 3). Thus it would 
seem, from the histological results, that it retarded 
the ossification of the callus; this would be consis- 
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Table 3. Enzyme activities (MIE x 100/10 min) in the various cell types of the callus 12 days postfracture 
Cell Type Enzyme 
G6PD HOAD Alk. phos 
Mature chondrocytes 
Control 28 ±2 5,3 ±: 0.5 107 t 6.3 
Dicumarol 20 -t 2 5.5 t 0.4 100 t 8.3 Chondrocytes in Control II -t 1.2 2.5 t 0.2 53 t 8.3 
calcified cartilage Dicumarol 10 ± 1.0 3.0 t 0.2 53 t 6.0 
Cellular granulation Control 51 t 6.0 7t1.2 70 ± 6.7 
tissue Dicumarol 32 ± 7.0 7t1.0 73 :t 7.0 
Loose granulation Control 18 ± 1.7 3.0 . 1: 0.4 3.3 t: 2.2 tissue Dicumarol 14 ± 1.5 3.0 ± 0.3 3.3 ± 3.2 
Osteoblasts Control 37 :t3.7 9.0 ± 0.8 140 ± 7.3 
Dicumarol 20 ±: 3.0 9.0 --!: 0.9 
123 
. 2: 
12 
G6PD: glucose 6-phosphate dehydrogenase; HOAD: hydroxyacyl dehydrogenase; Alk. phos: alkaline phosphatase 
tent with its having an antagonistic effect against 
vitamin K, in the vitamin K cycle. In addition, di- 
cumarol decreased the amount of reducing equiva- 
lents for this cycle selectively at points at which 
ossification should have occurred. 
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Histochemical and cytochemical 
demonstration of ornithine decarboxylase 
It has proved remarkably difficult to demonstrate the 
products of ornithine decarboxlyase (ODC) activity 
cytochemically. This is because it is unlikely that a way 
will be found of specifically precipitating the decarboxy- 
lated substrate, namely putrescine, and it is not easy to 
precipitate the other product of the reaction, namely C02, 
at the pH at which the enzyme works optimally. 
Consequently histochemical procedures have concen- 
trated on localizing the site of the enzyme itself. Two types 
of method have been suggested. 
Use of a labelled suicidal enzyme inhibitor 
The more direct histochemical approach to localizing the 
site of the enzyme has been to use an enzyme-activated 
irreversible inhibitor, or 'suicidal inhibitor', namely 
a-difluoromethylomithine'. In one procedure, the inhibi- 
tor is linked to a fluorescent moiety, such as rhodamine 2; 
the site of the inhibitor-rhodamine conjugate, and 
presumably that of the enzyme, is demonstrable by 
fluorescence microscopy. In the other 4 
procedure', the 
inhibitor is labelled radioactively with 'C and its site in 
sections is determined by autoradiography. The results 
obtained by the autoradiographic technique correlated 
quantitatively with previous biochemical results in that 
the ODC staining was high in the kidney and was lost 
rapidly when protein-synthesis was inhibited. 
Neither method has been used quantitatively. Both 
require more validation. As far as can be seen, neither is 
likely to define changes in ODC activity, although further 
validation may dispel this criticism. A major criticism of 
both procedures is the methods used for preparing the 
sections. The histochemical localization of many 'soluble 
proteins' can vary greatly according to the procedures 
used for fixing, embedding, sectioning and removing the 
embedding wax. Moreover, water-soluble material can 
move considerable distances when such processed sections 
are immersed in aqueous media or aqueous autoradiog- 
raphic film. 
Immunohistochemistry 
The second type of histochemical procedure" involved the 
preparation and purification of the enzyme; the produc- 
tion of a rabbit antibody to it; and then the use of 
goat-anti-rabbit IgG conjugated with fluorescein 
isothiocyanate. After specificity tests, the localization of 
the goat-anti-rabbit IgG, and presumably of the ODC, was 
detected by fluoresence microscopy. 
No quantitative results have been presented for this 
procedure. Moreover, assuming complete specificity, the 
anti-ODC antibody may be expected to react with any 
molecule that has sufficient antigenicity to yield an 
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appreciable response to this antibody. Thus, at best, the 
method probably could not distinguish between active and 
inactive enzyme; nor would it demonstrate the enzyme if 
the antigenic sites were masked, for example by binding 
to some other protein, or were not immediately available 
to the antigen. As before, the localization of the enzyme 
will also depend critically on the conditions under which 
the sections are prepared and treated with the primary 
and secondary antibodies. Clearly much work remains to 
be done even to validate the localization produced by this 
procedure. 
Preli in=ý studies towards a quantitative Im 
al cytoche method 
In normal cytochemistry, the activity of an enzyme such 
as a phosphatase or decarboxylase would be measured by 
precipitating the smaller moiety released, namely either 
phosphate or carbon dioxide. Care has to be taken that the 
precipitating ion should be sequestered from the active 
site of the enzyme so as to avoid inhibition5. The 
localization of the enzyme is not the primary concern of 
such techniques as long as the products of the enzyme- 
activity are retained within the cell that contains that 
activity. However, a series of procedures has been 
developed, designed to stop the movement of 'soluble' 
enzymes. These include particular ways of chilling and 
sectioning tissues; flash-drying the sections; and the use of 
inert colloid stabilizers to protect the sections, and stop 
diffusion, during the chromogenic reaction'. 
It was found by Frost (personal communication) that 
lead, in the form of lead hydroxyisobutyrate, is sufficient- ly chelated not to inhibit the enzyme, but can be 
precipitated, apparently as lead carbonate, byC02 at 
neutral pH values. This, therefore, could act as the 
precipitating agent. All the solutions have to be prepared 
inC02-free water and care must be taken not to introduce 
other ions that could compete successfully against the hydroxyisobutyrate for the lead. At present, the provision- 
al method, outlined below, seems to yield a quantitative 
estimation of ODC activity in tissues, showing inhibition 
with a-difluoromethylomithine, and stimulation by re- levant hormones in tissues that respond to these hormones. However, the method is not finalized because, 
with prolonged reaction-times, the nature and intracellu- lar localization of the reactibn-product changes. This may be due to the formation of a complex lead precipitate 
containing the more soluble lead bicarbonate. For all that, 
measurement of total activity per cell increases linearly 
with time, irrespective of the localization of the lead- 
precipitate. The lead carbonate is converted to the brown-black lead sulphide which is measured by mic- 
rodensitometry. 
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Reaction-medium 
All solutions have to be prepared in C02-free water. To 
three volumes of 0.2 m triethanolamine buffer, pH 8.0, 
containing 40% G04/140 grade of polyvinyl alcohol (PVA) 
(Wacker Chemicals, Mount Felix, Bridge Street, Walton- 
on-Thames KT12 1AS, UK) is added I volume of the 
solution of lead hydroxyisobutyrate (17.85% Pb); 
L-ornithine, 3.4 mg ml-'; pyridoxal-5-phosphate, 0.62 mg 
mi-I ; D, L-dithiothreitol, 0.08 mg ml-1; L-P- 
bromotetramizole, 0.15 mg ml-1 (to inhibit alkaline 
phosphatese activity). The final pH should be adjusted, if 
necessary, to pH 7.1. Before incubating the sections in this 
reaction medium, a pre-rinse is required to remove 
'background' colouration, possibly caused by free phos- 
phates retained in, or close to, the sections, by the 
stabilizer. The pre-rinse consists of 0.2 m triethanolamine 
buffer, pH 8.0, containing 20% G04/140 PVA. The final pH 
is pH 7.1. This medium is poured into Perspex rings 
surrounding the sections and left for 10 min at 37*C after 
which time it is sucked off and replaced by the reaction 
medium. 
procedure 
(1) Incubate in the medium at 37T, (cryostat sections of 
unfixed mouse kidney may require 10-30 min). 
(2) Wash inC02-free water. 
(3) Immerse in a 0.5% aqueous solution of ammonium 
Sulphide (1 min). 
(4) Rinse in distilled water. 
(5) Mount in an aqueous mounting medium (e. g. 
Farrants' medium). 
Measurement 
By microdensitometry at 580 nm. 
Specificity 
30 mm or-difluoromethyl ornithine caused up to 42% 
inhibition of the activity in cryostat sections (10 Wn) of 
unfixed mouse kidney reacted for 30 min. 
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, q,,. Adenosyhnethionine decarboxylase: a brief 
ireview 
A, n outline of the pathway for polyamine biosynthesis in 
%nammalian cells is shown in Figure I- It can be seen that 
S-adenogyl-L-methionine (AdoMet) plays a key role in this 
pathway. In most living organisms AdoMet is the 
precursor of the aminopropyl groups of spermidine and 
spermine". Before it can be used as an aminopropyl 
donor, AdoMet must be decarboxylated. The enzyme (EC 
4.1.1-50) which catalyses this reaction was first discovered 
by H. and C. W. Tabor' in E. coli and is termed, AdoMet 
decarboxylase (AdoMetDC). This enzyme is an important 
regulatory step in polyamine bosynthesis and in AdoMet 
Vaetabolism since decarboxylated AdoMet is virtually 
inactive as a methyl donor; once the decarboxylation has 
occurred AdoMet is irreversibly committed to polyamine 
biosynthesis. In mammalian cells AdoMetDC is the rate 
limiting step in the synthesis of polyamines and the 
, normal cellular content of decarboxylated AdoMet is very 
low amountiTj to less that 5% of the AdoMet 
concentration . This review covers the properties and regulation of 
AdoMetDC, describes briefly work on inhibitors of ita 
gictivity and concludes with a description of the changes in 
AdoMetDC activity and AdoMet levels brought about by 
inhibition of other steps in the polyamine biosynthetic 
pathway. No attempt has been made to cover all of the 
voluminous literature on this enzyme and many early 
references can be obtained from previous reviews". 
cation and properties of AdoMetDC 
Homogeneous preparations of AdoMetDC have been 
obtained from E. ColilO-12 ý S. cerevisiae 
12, '3, rat liver 14-17 
rat psoas muscle 17, mouse liver and mammary gland" 
and bovine liver". Partial purifications and characteriza- 
tions of the enzyme from other sources including plants 
have also been reported (Bee2,12,20-23). The Most ConVe- 
nient purification step involves affinity chromatography 
on MGBG_SepharoSe14. Methylglyoxal bis(guanylhyd- 
razone) (MGBG) is a powerful competitive inhibitor and 
the enzyme binds to MGBG-Sepharose even in the 
presence of a high salt concentration which can be used to 
wash off contaminating proteins. All of the homogeneous 
preparations of AdoMetDC from eukaryotes have been 
obtained with the aid of this methodology'2-19. More 
recently, it has been observed that the bacterial 
AdoMetDC can also be purified on MGBG-Sepharose even 
though MGBG is a weaker inhibitor of the bacterial 
enzyme 11 . 12 . AdoMetDCs from E. coli'O, ", yeast13 and rat liver" 
have been shown to contain a covalently linked pyruvate 
which is essential for enzyme activity. Presumably this 
pyruvoyl residue forms a Schiff base with the substrate 
and thus facilitates the decarboxylation. A small class of 
amino acid decarboxylases having pyruvate rather than 
pyridoxal phosphate for this purpose is now knovm". 
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Figural Pathway of polyamine biosynthesis in mammalian cells. The reactions involved and their inhibition are described in detail in 
Ref. 3. Inhibition of the steps shown is brought by a-difluoromethylornithine (DFMO), methylglyoxal bis(guanylhydrazone) (MGBG) 
and S-adenosyl-1,8-diamino-octene (AdoDATO). 
Mammalian AdoMetDC has a subunit MW of about 
32 000 and is normally present as a dimer of MW about 
65-70 000, although larger aggregates occur quite 
readily2,15-19. AdoMetDC from S. cerevisiae is also a dimer 
with a subunit MW of about 41000", but the enzyme from 
E. colil I has six subunits of MW 17 000. Although the first 
determinations of pyruvate in the latter enzyme showed 
only one molecule per molecule of enzyme", more recent 
preparations produced with less harsh isolation conditions 
give one pyruvate per subunit and have a 5-6 fold higher 
activityl - The stereochemistry and kinetic isotope effects in the 
decarboxylation of AdoMetDC were investigated and it 
was shown that the reaction proceeds with retention of 
the configuration at the 1C and a tritium isotope effect of 
4.5 25 . The gene coding for the E. coli AdoMetDC has been 
mapped at 2.7 minutes and deletion mutants lacking this 
enzyme constructed 26. S. cerevisiae mutants lacking 
AdoMetDC are also known and are closely linked to argl 
which is on chromosome XV17 . The AdoMetDC mutants are 
unable to produce spermidine confirming the absolute 
requirement for decarboxylated AdoMet in these organ- 
isms. No mammalian mutants lacking AdoMetDC are yet 
available. Convincing evidence that at least two forms of AdoMetDC occur in mammalian cells was obtained by 
P6s6 and pegg17,28 who purified the enzyme to homogenei- 
ty from rat liver and rat psoas. The enzymes from these 
sources differed with respect to activation by putrescine, 
K,. for AdoMet inhibition by MGBG and repression by 
spermidine 17,28,19. They also differed in isoelectric point 
and could readily be separated by polyacrylamide gel 
electrophoresis under isoelectric focusing conditionS17, -29. 
However, the nature of the difference is not yet known and 
could relate to post-translational modifications rather 
than to the presence of multiple genes for AdoMetDC in 
mammalian cells. 
AdoMetDC preparations from E. coli, certain plants and 
some other microorganisms require Me' for activityl, 2-10-- 
12,20,21. AdoMetDC from other micro-organisms including 
the slime moulds, Physarum polycephalum and Dictyoste- 
lium discoideum, and the protozoan, Tetmhymena * or- 
mis did not require Cations for maximal aCtiVity2,1? 
V;. 
In contrast, the enzyme from all higher eukaryotes 
(including invertebrates, reptiles, amphibia, and mam- 
mals) and from many yeasts including S. cerevisiae are 
activated by putrescine 2,12-14,17-20,22,23-. 29-31. This aCtiVa_ 
tion which was first noted by Pegg and Williams- 
Ashman 31 is an important regulatory mechanism which 
ensures that the synthesis of decarboxylated AdoMet is 
increased 
5, 
in response to increased availability of 
putrescine '. Therefore, an increase in ornithine decar- 
boxylase activity brings about an increased synthesis of 
spermidine (see Figure 1). Similarly, spermidine and 
spermine rather than putrescine are the predominant 
polyamines in those organisms with a pptrescine- 
activated AdoMetDC. It has been suggested', ' that the 
presence of a putrescine-activated AdoMetDC correlates 
with the ability to synthesize spermine (which is not 
normally present in many micro-organisms), but the 
generality of this correlation is not fully established. 
Putrescine can be partially replaced as an activator of 
AdoMetDC by a variety of other diamines although these 
are not as potent2,20,29,31-34. The activation is pH 
dependent and is considerably greater at pH 6.5 than 
8.52,29,33 . Early reports that spermidine was able to 
activate AdoMetDC could not be confirmed with hijftdy 
purified spermidine and the homogeneous enzymew. A 
minor spermidine-activated AdoMetDC could be present 
in crude extracts and would explain the earlier results, 
but another explanation is that putrescine or another 
diamine was a contaminant of the spermidine used for 
activation. 
Inhibition of AdoMetDC activity 
Williams-Ashman and colleagues3', 33 made the extremely 
important discovery that MGBG was a potent inhibitor of 
the putrescine-activated AdoMetDC. This observation has 
been repeated and confirmed by many subsequent 
experiments 1-7,12--19,3"7. MGBG is a competitive inhibi- 
tor with respect to AdoMet and has a Ki of law than 
VM2,12 -A number of congeners of MGBG are also shmg inhibitorS2,12,17,33 and the ethyl analogue, EGBG is about 
12 Cell Biochemistry and Function, 1984, Vol 2, January 
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CUtCULATING VITAKM K, IJIVEIS IN FRACTURED 
NIR 7- OF FRMUIIt 
SIR, -Vitarnin K cycle PIVS 8 sifnificalit Pa" in calcification. ' When glutamate (Glu) residues are carboxylated to 
y-carboxyglutarnec (Glaý this carboxylation is mediated by the 
hydroquitione fam of vitamin K, (phylloquincint) which is 
283 
astidised to the and then reduced back W the quitione form. 
Vitenjin Kl- antagonists inhibit the conversion of eposide to 
qUinone, 2 no bia"g the Cycle and retarding raw bane fornsetion. 3 
77be role ofostoocalcin, (bone Gla-protein) in bone formation is less 
ClkW. 4 A critical in the maintenance oftormal bone msy dun 
be the circulating level of vitamin KI, and this can now be 
messured-51a We have compared circulating levels ofiritsmin Ki in 
normal subjects and in elderly osteoporotic subjects with fiactures 
of the neck of femur. 
Estimates or normal circulating levels were obtained from 34 contivis (14 
nudes, 20 females) apd 15-81 at Cmy's, Northwick Park, mid Cbering Crow 
Hospitals. Plood was also talm at operation, within 48 It offrecture, from 16 
pa*M0 mile, 15 knWa)apd 63-98 with fractured neck offeestur. 
20 ml blood was xvithdram item lithium-beperin tubes. The phism was 
seletrated after minimeldelayand sadreelet - 2DOC. Forthe normalcircularing 
levels 10 ml or 3 ad of'pheass wasextracted twice with edeareol-bantrat (1: 2: 4; 
eths-Lbessueek 5, ml was required. for the samples fiýom tk* 
porotic patients. I'let dried exam was dissolved in beaspe and pond 
throusha'Sep-Pak'cartridge(W te Associates). The frectioucentai0fttlet 
vitamin K, waselmedins 3%solutionoNicthyletberinhen six1purified by NMC with a 'Portiall-T cohmm. The final wage ofthe may was by HPLCý 
with a'SpberWorW OctYl coh, 8110 with 95% nmMnolM mmoM acetere buffer 
(pH 3- 0) n the mobile Phase. ' The vitamin was detected either by means ofa 
glassy carbon flov. -through call (TLS) with an LC4B amperometm datcw, 
in the reductive mode' (Bicandytical Systemzý or by the ust ofa Coulochtm 
model 5lQQA electrochemical detector, equipped with two Porous graphite 
electrodes in write (model 90 11) operaltd in the Mine: mode (Environmental 
Science Awocistesý 
I In the controls the mean plum vitamin K, was 340 pglml; gfter 
exclusion of two outriders (950 and 1240 pgIml) the mean (and 
SEM) was 299 (32). p9/ml. 
The value in 16 osteoporotic patients with fracture$ was 98 (20) 
pgltd. We compared this result with the data from the 10 controls at Northwick Park Hospital (274*W Pg/ml, excluding the outriderý 
whose ages were mom comparable with those of patients with 
factured neck of femur. The difference was significant (p<o-ol). 
When 4 other controls aged 57,59,72, and 81 were included the 
rtsuhs were significant at p<O - 06 1- 
The circulating level of vitamin KI, in patients with fractured 
neck offemur, seems to be about one-third ofnormal. We cannot ssy 
whether then low values are related solely to the fracture or to the 
osteopomis although, since the blood was taken at operation, it is 
likely that the osteoporosis is decisive in respect of the circulating 
lev, el of this vitamin. That patients do seem to have a deficit of 
circulating vitamin K I, and this may be significant in view of the 
importance'of the vitamih K, cycle in the maintenance of normal 
bone and in fracture heslin . 
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